JPH0480052B2 - - Google Patents
Info
- Publication number
- JPH0480052B2 JPH0480052B2 JP57101271A JP10127182A JPH0480052B2 JP H0480052 B2 JPH0480052 B2 JP H0480052B2 JP 57101271 A JP57101271 A JP 57101271A JP 10127182 A JP10127182 A JP 10127182A JP H0480052 B2 JPH0480052 B2 JP H0480052B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrogel according
- hydrogel
- item
- formula
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000017 hydrogel Substances 0.000 claims description 101
- -1 carbonate ester Chemical class 0.000 claims description 45
- 150000001875 compounds Chemical class 0.000 claims description 34
- 229920001577 copolymer Polymers 0.000 claims description 29
- 150000004292 cyclic ethers Chemical group 0.000 claims description 29
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical group C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 claims description 24
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 125000002947 alkylene group Chemical group 0.000 claims description 11
- 125000000524 functional group Chemical group 0.000 claims description 9
- 238000010382 chemical cross-linking Methods 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 150000001299 aldehydes Chemical class 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 6
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 239000012736 aqueous medium Substances 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 125000006413 ring segment Chemical group 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 2
- 150000001241 acetals Chemical class 0.000 claims description 2
- 150000007824 aliphatic compounds Chemical class 0.000 claims description 2
- 230000009477 glass transition Effects 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- 150000001923 cyclic compounds Chemical class 0.000 claims 1
- 150000002338 glycosides Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 55
- 229920000642 polymer Polymers 0.000 description 42
- 239000013543 active substance Substances 0.000 description 39
- 239000003814 drug Substances 0.000 description 28
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 26
- 229940079593 drug Drugs 0.000 description 26
- 230000008961 swelling Effects 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 229960005274 benzocaine Drugs 0.000 description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 150000002334 glycols Chemical class 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 150000001261 hydroxy acids Chemical class 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 150000002989 phenols Chemical class 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 229940088623 biologically active substance Drugs 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 150000001991 dicarboxylic acids Chemical class 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229920001477 hydrophilic polymer Polymers 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- BRRSNXCXLSVPFC-UHFFFAOYSA-N 2,3,4-Trihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000244206 Nematoda Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003619 algicide Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013065 commercial product Substances 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229940053934 norethindrone Drugs 0.000 description 3
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000186 progesterone Substances 0.000 description 3
- 229960003387 progesterone Drugs 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000002522 swelling effect Effects 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- YJCJVMMDTBEITC-UHFFFAOYSA-N 10-hydroxycapric acid Chemical compound OCCCCCCCCCC(O)=O YJCJVMMDTBEITC-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 2
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 2
- IBHWREHFNDMRPR-UHFFFAOYSA-N 2,4,6-Trihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=C(O)C=C1O IBHWREHFNDMRPR-UHFFFAOYSA-N 0.000 description 2
- UIAFKZKHHVMJGS-UHFFFAOYSA-N 2,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1O UIAFKZKHHVMJGS-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- AKEUNCKRJATALU-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O AKEUNCKRJATALU-UHFFFAOYSA-N 0.000 description 2
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 2
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- 239000003377 acid catalyst Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229940125681 anticonvulsant agent Drugs 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- GGNQRNBDZQJCCN-UHFFFAOYSA-N benzene-1,2,4-triol Chemical compound OC1=CC=C(O)C(O)=C1 GGNQRNBDZQJCCN-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000010538 cationic polymerization reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- QMNFFXRFOJIOKZ-UHFFFAOYSA-N cycloguanil Chemical compound CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1 QMNFFXRFOJIOKZ-UHFFFAOYSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 229960002568 ethinylestradiol Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000013081 microcrystal Substances 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920001289 polyvinyl ether Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229960000611 pyrimethamine Drugs 0.000 description 2
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004306 sulfadiazine Drugs 0.000 description 2
- 208000037972 tropical disease Diseases 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- REHJTMDOJHAPJV-IVTQUDKZSA-N (6s,8r,9s,10r,13s,14s,17s)-17-hydroxy-6,10,13-trimethyl-17-prop-1-ynyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one;hydrate Chemical compound O.C1([C@@H](C)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C#CC)(O)[C@@]2(C)CC1 REHJTMDOJHAPJV-IVTQUDKZSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RBACIKXCRWGCBB-UHFFFAOYSA-N 1,2-Epoxybutane Chemical compound CCC1CO1 RBACIKXCRWGCBB-UHFFFAOYSA-N 0.000 description 1
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 1
- ZNCCGGMWVUBVBO-UHFFFAOYSA-N 1-(oxiran-2-ylmethyl)pyrrolidin-2-one Chemical compound O=C1CCCN1CC1OC1 ZNCCGGMWVUBVBO-UHFFFAOYSA-N 0.000 description 1
- OZFIGURLAJSLIR-UHFFFAOYSA-N 1-ethenyl-2h-pyridine Chemical compound C=CN1CC=CC=C1 OZFIGURLAJSLIR-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- NVUUMOOKVFONOM-GPBSYSOESA-N 19-Norprogesterone Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 NVUUMOOKVFONOM-GPBSYSOESA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 1
- PQXKWPLDPFFDJP-UHFFFAOYSA-N 2,3-dimethyloxirane Chemical compound CC1OC1C PQXKWPLDPFFDJP-UHFFFAOYSA-N 0.000 description 1
- OIFAHDAXIUURLN-UHFFFAOYSA-N 2-(fluoromethyl)oxirane Chemical compound FCC1CO1 OIFAHDAXIUURLN-UHFFFAOYSA-N 0.000 description 1
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 1
- CBECDWUDYQOTSW-UHFFFAOYSA-N 2-ethylbut-3-enal Chemical compound CCC(C=C)C=O CBECDWUDYQOTSW-UHFFFAOYSA-N 0.000 description 1
- LODHFNUFVRVKTH-ZHACJKMWSA-N 2-hydroxy-n'-[(e)-3-phenylprop-2-enoyl]benzohydrazide Chemical compound OC1=CC=CC=C1C(=O)NNC(=O)\C=C\C1=CC=CC=C1 LODHFNUFVRVKTH-ZHACJKMWSA-N 0.000 description 1
- SNKAANHOVFZAMR-UHFFFAOYSA-N 2-hydroxycyclohexanecarboxylic acid Chemical compound OC1CCCCC1C(O)=O SNKAANHOVFZAMR-UHFFFAOYSA-N 0.000 description 1
- JJMFNXJCDGGBEV-UHFFFAOYSA-N 3-(8-cyclohexyloctyl)-4-hydroxynaphthalene-1,2-dione Chemical compound O=C1C(=O)C2=CC=CC=C2C(O)=C1CCCCCCCCC1CCCCC1 JJMFNXJCDGGBEV-UHFFFAOYSA-N 0.000 description 1
- NIAXWFTYAJQENP-UHFFFAOYSA-N 3-ethenyl-2h-1,3-oxazole Chemical compound C=CN1COC=C1 NIAXWFTYAJQENP-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- GJOHLWZHWQUKAU-UHFFFAOYSA-N 5-azaniumylpentan-2-yl-(6-methoxyquinolin-8-yl)azanium;dihydrogen phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 GJOHLWZHWQUKAU-UHFFFAOYSA-N 0.000 description 1
- CQNNLXQECGKHEH-APNJTCTJSA-N A-norpregn-3(5)-ene-2,20-dione Chemical compound C1CC2=CC(=O)C[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](C(=O)C)CC[C@H]3[C@@H]21 CQNNLXQECGKHEH-APNJTCTJSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- ATXHVCQZZJYMCF-XUDSTZEESA-N Allylestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 ATXHVCQZZJYMCF-XUDSTZEESA-N 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- 208000026368 Cestode infections Diseases 0.000 description 1
- 208000022636 Cestode infectious disease Diseases 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical class OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 241000242711 Fasciola hepatica Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241000243976 Haemonchus Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000243789 Metastrongyloidea Species 0.000 description 1
- STNJBCKSHOAVAJ-UHFFFAOYSA-N Methacrolein Chemical compound CC(=C)C=O STNJBCKSHOAVAJ-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 206010062701 Nematodiasis Diseases 0.000 description 1
- ZXSWTMLNIIZPET-ZOFHRBRSSA-N Normethandrolone Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 ZXSWTMLNIIZPET-ZOFHRBRSSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XMUAORABVRJUDU-LEKSSAKUSA-N Pregna-4,11-diene-3,20-dione Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)C=C2 XMUAORABVRJUDU-LEKSSAKUSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000223777 Theileria Species 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 229910021623 Tin(IV) bromide Inorganic materials 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004015 abortifacient agent Substances 0.000 description 1
- 231100000641 abortifacient agent Toxicity 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229950006704 aldesulfone Drugs 0.000 description 1
- NEDPPCHNEOMTJV-UHFFFAOYSA-N aldesulfone Chemical compound C1=CC(NCS(=O)O)=CC=C1S(=O)(=O)C1=CC=C(NCS(O)=O)C=C1 NEDPPCHNEOMTJV-UHFFFAOYSA-N 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229960002692 allylestrenol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PQLAYKMGZDUDLQ-UHFFFAOYSA-K aluminium bromide Chemical compound Br[Al](Br)Br PQLAYKMGZDUDLQ-UHFFFAOYSA-K 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- DKVNAGXPRSYHLB-UHFFFAOYSA-N amoscanate Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC1=CC=C(N=C=S)C=C1 DKVNAGXPRSYHLB-UHFFFAOYSA-N 0.000 description 1
- 229950008286 amoscanate Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 229940070021 anabolic steroids Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000006730 anaplasmosis Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000567 anti-anemic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002519 antifouling agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940033495 antimalarials Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical compound C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229940114055 beta-resorcylic acid Drugs 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- WDQPAMHFFCXSNU-BGABXYSRSA-N clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 description 1
- 229960004287 clofazimine Drugs 0.000 description 1
- 229950004178 closantel Drugs 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229950004734 cycloguanil Drugs 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- XBZSBBLNHFMTEB-UHFFFAOYSA-N cyclohexane-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCCC(C(O)=O)C1 XBZSBBLNHFMTEB-UHFFFAOYSA-N 0.000 description 1
- 229960000860 dapsone Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940000033 dermatological agent Drugs 0.000 description 1
- 239000003241 dermatological agent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical class C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 229950006690 dimethisterone Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- JGMOKGBVKVMRFX-HQZYFCCVSA-N dydrogesterone Chemical compound C1=CC2=CC(=O)CC[C@@]2(C)[C@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 JGMOKGBVKVMRFX-HQZYFCCVSA-N 0.000 description 1
- 229960004913 dydrogesterone Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- CHNXZKVNWQUJIB-CEGNMAFCSA-N ethisterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 CHNXZKVNWQUJIB-CEGNMAFCSA-N 0.000 description 1
- 229960000445 ethisterone Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- ONKUMRGIYFNPJW-KIEAKMPYSA-N ethynodiol diacetate Chemical compound C1C[C@]2(C)[C@@](C#C)(OC(C)=O)CC[C@H]2[C@@H]2CCC3=C[C@@H](OC(=O)C)CC[C@@H]3[C@H]21 ONKUMRGIYFNPJW-KIEAKMPYSA-N 0.000 description 1
- 229940012028 ethynodiol diacetate Drugs 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 208000006275 fascioliasis Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- UPWPDUACHOATKO-UHFFFAOYSA-K gallium trichloride Chemical compound Cl[Ga](Cl)Cl UPWPDUACHOATKO-UHFFFAOYSA-K 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 125000000743 hydrocarbylene group Chemical group 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HCFSGRMEEXUOSS-JXEXPEPMSA-N medrogestone Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(C)[C@@]1(C)CC2 HCFSGRMEEXUOSS-JXEXPEPMSA-N 0.000 description 1
- 229960000606 medrogestone Drugs 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- 229960004296 megestrol acetate Drugs 0.000 description 1
- 229950008312 menoctone Drugs 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- IMSSROKUHAOUJS-MJCUULBUSA-N mestranol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 IMSSROKUHAOUJS-MJCUULBUSA-N 0.000 description 1
- 229960001390 mestranol Drugs 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229960000270 methylestrenolone Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- VKXQZROIIKPELG-UHFFFAOYSA-N n-(6-methoxyquinolin-8-yl)-n'-propan-2-ylpentane-1,5-diamine Chemical compound N1=CC=CC2=CC(OC)=CC(NCCCCCNC(C)C)=C21 VKXQZROIIKPELG-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- JTHNLKXLWOXOQK-UHFFFAOYSA-N n-propyl vinyl ketone Natural products CCCC(=O)C=C JTHNLKXLWOXOQK-UHFFFAOYSA-N 0.000 description 1
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 239000011356 non-aqueous organic solvent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- QTQWMSOQOSJFBV-UHFFFAOYSA-N pamaquine Chemical compound C1=CN=C2C(NC(C)CCCN(CC)CC)=CC(OC)=CC2=C1 QTQWMSOQOSJFBV-UHFFFAOYSA-N 0.000 description 1
- 229950000466 pamaquine Drugs 0.000 description 1
- AFAIELJLZYUNPW-UHFFFAOYSA-N pararosaniline free base Chemical compound C1=CC(N)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=N)C=C1 AFAIELJLZYUNPW-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229950009635 pentaquine Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000003186 pharmaceutical solution Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920006216 polyvinyl aromatic Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960002957 praziquantel Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960005179 primaquine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 125000004309 pyranyl group Chemical class O1C(C=CC=C1)* 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000018040 scab formation Effects 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 description 1
- 229960005158 sulfamethizole Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 229940127230 sympathomimetic drug Drugs 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IEXRMSFAVATTJX-UHFFFAOYSA-N tetrachlorogermane Chemical compound Cl[Ge](Cl)(Cl)Cl IEXRMSFAVATTJX-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- LTSUHJWLSNQKIP-UHFFFAOYSA-J tin(iv) bromide Chemical compound Br[Sn](Br)(Br)Br LTSUHJWLSNQKIP-UHFFFAOYSA-J 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000011240 wet gel Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Polyethers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
Description
æ¬çºæã¯ãã€ããã²ã«ãéå®çã§ã¯ãªãããç¹
ã«äººéãŸãã¯åç©ã®æå·å€éšçµç¹ãäŸãã°è¡šç®ãŸ
ãã¯å€ç®çµç¹ïŒä»¥äžãå·ãšããïŒãšãã®å€éšç°å¢
éã®å¢çãšããŠäœ¿çšãåŸããã€ããã²ã«ã«é¢ã
ãã ããã©ãŸãã¯ä»ã®ïŒå±éšæè¡ãäºæ ãŸãã¯ç®è
çŸæ£ã®ïŒçµç¹æå·ã®æ²»çã«ãããŠã¯åè¿°ã®ããšã
å¢çãæäŸããããšãç¹ã«æãŸãããçæ³çã«ã¯
å¢çã¯ç©ççãªå€å·ïŒtraumaïŒãææãäŸãã°ç©º
æ°äŒææ§çèïŒfungiïŒããã¯ããªã€ããã³ãŠã€ã«
ã¹çãå·ã«æ¥è¿ããã®ã劚ããå·ã®æ°Žåã調ç¯ã
ãŠããã¶ãã®ãµãããé²ãçµç¹ãæ²»çãããã®ã§
ããã¹ãã§ãããææãªãã°å·ãšæ¥è§ŠããŠè¬å¹ã
æç¶ããã çŸåšã®ã¬ãŒãŒå 垯ãäŸãã°ãªãã»ãŠãšãŒã
ïŒleno weaveïŒå 垯ã¯é©çšåŸã¯äžéæã§æ²»çéçš
ã芳å¯ããæè¬ããããã«ãã°ãã°åæ¿ããå¿ èŠ
ããããããã¯æ£è ã«äžæå¿«ãªæãããããç¹ã«
å·ã®æµžåºç©ã也ç¥ããå 垯ãšå·ãåºããŠããŸãã
ããã«ãããã¯ææãé²æ¢ã§ããªãã®ã¿ãªããå·
ã®æ°Žåã調ç¯ãã§ãããåã«åžåããã®ã¿ã§ã
ãã ãã€ããã²ã«ãå 垯ãšããŠäœ¿çšããããšã¯ãã§
ã«ææ¡ãããŠãããããããããããã¯äžè¬ã«å€©
ç¶ãŸãã¯ååæç©ãäŸãã°ã³ã©ã²ã³ããŒã©ãã³ã
ãã³æŸ±ç²è£œåã§ããããããã®ç©è³ªã¯éåžžéæã§
ã¯ãªãããã«èçœè³ªç³»ãã€ããã²ã«ã¯ã¢ã¬ã«ã®ãŒ
ãèªçºããããšãããããã®äžææäœçšãæå¶ã
ãªãããããæ é€æºãšãªãã æ¬çºæã¯ïŒïŒåŒïŒ åŒäžãR1ãšR2ã¯åäžãŸãã¯ç°ãªãæ°ŽçŽ ååã
ãŸãã¯çœ®æãŸãã¯é眮æã®ãããã«ã«ãã«ããã
ã¯ãããã«ã«ãããã·åºïŒR3ã¯çœ®æãŸãã¯é眮
æã®ã¡ãã¬ã³ããšãã¬ã³ããŸãã¯ïŒïŒïŒâããã
ã¬ã³åºã瀺ãã§è¡šããããäžé£œåç°åŒãšãŒãã«
åºãæããéåå¯èœãªã¢ãããŒïŒããã³ïŒïŒåœ
éãå°ãªããšã250ã§ããããªã¢ã«ãã¬ã³ãªãã·
ãæ®åºãæãã芪氎æ§ãã¢ãŸãã¯ã³ããªããŒãšã
åå¿ãããŠåŸãããéåéšåãå«ããã€ããã²ã«
ãæäŸããã æ¬çºæã®ç¹åŸŽã®äžã€ã¯ãã€ããã²ã«ãæ°Žæ§åªäœ
äžã§å æ°Žå解å¯èœãªããšã§ããããã®ãããã¯ã
ãããã®å æ°Žå解å¯èœãªå®èœåºã¯ïŒïŒãŸãã¯
ïŒïŒãŸãã¯ïŒïŒããã³ïŒïŒäž¡æ¹ã«å«ãŸããŠ
ããŠãããã奜ãŸããã¯ãã€ããã²ã«ã¯å æ°Žå解
å¯èœãªã«ã«ããã·ã«ãšã¹ãã«ãã«ãŒãããŒããšã¹
ãã«ãã¢ããããŠã¬ã¿ã³ãŸãã¯ã°ãªã³ã·ãå®èœåº
ãå«ãã æãŸããã¯éåå¯èœãªäžé£œåç°ç¶ãšãŒãã«
ïŒïŒã¯åŒïŒ åŒäžãR1ïŒR2ããã³R4ã¯åäžãŸãã¯ç°ãªã€
ãŠããããããããæ°ŽçŽ ååãŸãã¯çœ®æãŸãã¯é
眮æã®ãããã«ã«ãã«ãŸãã¯ãããã«ã«ããã·ã«
åºïŒR3ã¯çœ®æãŸãã¯é眮æã®ã¡ãã¬ã³ããšãã¬
ã³ãŸãã¯ïŒïŒïŒâãããã¬ã³åºïŒR5ã¯ïŒäŸ¡ã®é
åå¯èœãªåºïŒããã³ïŒžã¯ ïŒåŒäžãã¯é žçŽ ååãŸãã¯âNR6âåºïŒR6
ã¯R1ãšåæ矩ïŒãïœã¯ïŒãŸãã¯ïŒãïœã¯ïŒãŸãã¯
ïŒãïœã¯ïŒãŸãã¯ïŒïŒïœã¯ïŒãŸãã¯ïŒïŒäœããïœ
ãŸãã¯ïœã®å°ãªããšãäžæ¹ã¯ïŒã§ããïŒïŒã§è¡šã
ãããååç©ãå«ãã§ãããã ç¹ã«å¥œãŸããéåå¯èœãªäžé£œåç°åŒãšãŒãã«é¡
ã¯åŒïŒ
ã«äººéãŸãã¯åç©ã®æå·å€éšçµç¹ãäŸãã°è¡šç®ãŸ
ãã¯å€ç®çµç¹ïŒä»¥äžãå·ãšããïŒãšãã®å€éšç°å¢
éã®å¢çãšããŠäœ¿çšãåŸããã€ããã²ã«ã«é¢ã
ãã ããã©ãŸãã¯ä»ã®ïŒå±éšæè¡ãäºæ ãŸãã¯ç®è
çŸæ£ã®ïŒçµç¹æå·ã®æ²»çã«ãããŠã¯åè¿°ã®ããšã
å¢çãæäŸããããšãç¹ã«æãŸãããçæ³çã«ã¯
å¢çã¯ç©ççãªå€å·ïŒtraumaïŒãææãäŸãã°ç©º
æ°äŒææ§çèïŒfungiïŒããã¯ããªã€ããã³ãŠã€ã«
ã¹çãå·ã«æ¥è¿ããã®ã劚ããå·ã®æ°Žåã調ç¯ã
ãŠããã¶ãã®ãµãããé²ãçµç¹ãæ²»çãããã®ã§
ããã¹ãã§ãããææãªãã°å·ãšæ¥è§ŠããŠè¬å¹ã
æç¶ããã çŸåšã®ã¬ãŒãŒå 垯ãäŸãã°ãªãã»ãŠãšãŒã
ïŒleno weaveïŒå 垯ã¯é©çšåŸã¯äžéæã§æ²»çéçš
ã芳å¯ããæè¬ããããã«ãã°ãã°åæ¿ããå¿ èŠ
ããããããã¯æ£è ã«äžæå¿«ãªæãããããç¹ã«
å·ã®æµžåºç©ã也ç¥ããå 垯ãšå·ãåºããŠããŸãã
ããã«ãããã¯ææãé²æ¢ã§ããªãã®ã¿ãªããå·
ã®æ°Žåã調ç¯ãã§ãããåã«åžåããã®ã¿ã§ã
ãã ãã€ããã²ã«ãå 垯ãšããŠäœ¿çšããããšã¯ãã§
ã«ææ¡ãããŠãããããããããããã¯äžè¬ã«å€©
ç¶ãŸãã¯ååæç©ãäŸãã°ã³ã©ã²ã³ããŒã©ãã³ã
ãã³æŸ±ç²è£œåã§ããããããã®ç©è³ªã¯éåžžéæã§
ã¯ãªãããã«èçœè³ªç³»ãã€ããã²ã«ã¯ã¢ã¬ã«ã®ãŒ
ãèªçºããããšãããããã®äžææäœçšãæå¶ã
ãªãããããæ é€æºãšãªãã æ¬çºæã¯ïŒïŒåŒïŒ åŒäžãR1ãšR2ã¯åäžãŸãã¯ç°ãªãæ°ŽçŽ ååã
ãŸãã¯çœ®æãŸãã¯é眮æã®ãããã«ã«ãã«ããã
ã¯ãããã«ã«ãããã·åºïŒR3ã¯çœ®æãŸãã¯é眮
æã®ã¡ãã¬ã³ããšãã¬ã³ããŸãã¯ïŒïŒïŒâããã
ã¬ã³åºã瀺ãã§è¡šããããäžé£œåç°åŒãšãŒãã«
åºãæããéåå¯èœãªã¢ãããŒïŒããã³ïŒïŒåœ
éãå°ãªããšã250ã§ããããªã¢ã«ãã¬ã³ãªãã·
ãæ®åºãæãã芪氎æ§ãã¢ãŸãã¯ã³ããªããŒãšã
åå¿ãããŠåŸãããéåéšåãå«ããã€ããã²ã«
ãæäŸããã æ¬çºæã®ç¹åŸŽã®äžã€ã¯ãã€ããã²ã«ãæ°Žæ§åªäœ
äžã§å æ°Žå解å¯èœãªããšã§ããããã®ãããã¯ã
ãããã®å æ°Žå解å¯èœãªå®èœåºã¯ïŒïŒãŸãã¯
ïŒïŒãŸãã¯ïŒïŒããã³ïŒïŒäž¡æ¹ã«å«ãŸããŠ
ããŠãããã奜ãŸããã¯ãã€ããã²ã«ã¯å æ°Žå解
å¯èœãªã«ã«ããã·ã«ãšã¹ãã«ãã«ãŒãããŒããšã¹
ãã«ãã¢ããããŠã¬ã¿ã³ãŸãã¯ã°ãªã³ã·ãå®èœåº
ãå«ãã æãŸããã¯éåå¯èœãªäžé£œåç°ç¶ãšãŒãã«
ïŒïŒã¯åŒïŒ åŒäžãR1ïŒR2ããã³R4ã¯åäžãŸãã¯ç°ãªã€
ãŠããããããããæ°ŽçŽ ååãŸãã¯çœ®æãŸãã¯é
眮æã®ãããã«ã«ãã«ãŸãã¯ãããã«ã«ããã·ã«
åºïŒR3ã¯çœ®æãŸãã¯é眮æã®ã¡ãã¬ã³ããšãã¬
ã³ãŸãã¯ïŒïŒïŒâãããã¬ã³åºïŒR5ã¯ïŒäŸ¡ã®é
åå¯èœãªåºïŒããã³ïŒžã¯ ïŒåŒäžãã¯é žçŽ ååãŸãã¯âNR6âåºïŒR6
ã¯R1ãšåæ矩ïŒãïœã¯ïŒãŸãã¯ïŒãïœã¯ïŒãŸãã¯
ïŒãïœã¯ïŒãŸãã¯ïŒïŒïœã¯ïŒãŸãã¯ïŒïŒäœããïœ
ãŸãã¯ïœã®å°ãªããšãäžæ¹ã¯ïŒã§ããïŒïŒã§è¡šã
ãããååç©ãå«ãã§ãããã ç¹ã«å¥œãŸããéåå¯èœãªäžé£œåç°åŒãšãŒãã«é¡
ã¯åŒïŒ
ãåŒããŸãã¯
ãåŒã
ãåŒäžãR5ã¯å¥œé©ã«ã¯ã¢ãã¡ãªãã¯ããªãªãŽ
ã¡ãªãã¯ãŸãã¯ããªã¡ãªãã¯ãã°ã«ãŒãã§ãã€ãŠ
éåå¯èœãªåºãå«ããã®ãè¡šããïŒããã¯ãã€ã
ãã²ã«ã圢æããããã®ã«ããªã³éåã«é¢äžãã
éåå¯èœãªäžé£œåç°åŒãšãŒãã«ãšåå¿ãããæã
ã¯èŠªæ°Žæ§ã®ãã¢ãŸãã¯ã³ããªããŒãŸãã¯ãã®äž¡è
ãšåå¿ãããããæããäž¡æ¹ã®æåãšåå¿ãã奜
ãŸããäŸã¯ããã«ãšãŒãã«ãšãšããã·åºã§ããã R5ã¯ç°åŒããã«ãšãŒãã«ãç¹ã«åŒïŒ ãåŒäžãRâ²1ïŒRâ²2ïŒRâ²3ããã³Râ²4ã¯R1ïŒR2ïŒ
R3ããã³R4ãšåæ矩ã§ãããããããåäžãŸã
ã¯ç°ãªã€ãŠããŠãããïŒïŒã¯åºâZXâ²âãè¡šã
ãïŒXâ²ã¯ïŒžãšåæ矩ïŒããã³ïŒºã¯åçµåãŸãã¯
ã«ãŒãã³æ§ã¢ãããªãªãŽãŸãã¯ãã¢âãããã¯ã³
ãŒããªïŒçœ®æãŸãã¯é眮æã®ã¢ã«ãã¬ã³ãããã¯
ã¢ã«ãã³ãªãã·ãïŒã°ã«ãŒããè¡šããããè¡šãã
ã®ãç¹ã«å¥œãŸããã ç¹ã«å¥œãŸããéåå¯èœãªäžé£œåç°åŒãšãŒãã«é¡
ã¯ãžããããã©ã³ã¢ã«ãããé¡ã®äžçš®ãªãããã®
æ··åç©ãTischenkoåå¿ã«ãããŠåœ¢æãããåå¿
çæç©ã§ããããã®ç©ã¯åŒïŒ ãåŒäžãRâ²1ïŒRâ²2ããã³Râ²4ã¯R1ïŒR2ããã³R4
ãšåæ矩ã§ãããåäžãŸãã¯ç°ãªã€ãŠããŠãã
ããã§è¡šããããååç©ã§ããã奜ãŸããååç©
ã¯ã¢ã¯ãã¬ã€ã³ããã©ããŒïŒå³ã¡ãã¯å šãŠæ°ŽçŽ
ååãè¡šããïŒã§ããã ãCOOãŸãã¯âCH2OCOâåºãå«ãéåå¯
èœãªäžé£œåç°åŒãšãŒãã«é¡ã¯äŸ¿å®çã«ã¯ãã€ãã·
ãšã³ã³ïŒTischenkoïŒåå¿ã«ãã€ãŠè£œé ãããã
çžåœããäžé£œåã¢ã«ãããã®ããã©ããŒãç¹ã« ãã調補ããŠãããã å³ã¡ããCOOåºãå«ãäžé£œåç°åŒãšãŒãã«
é¡ã¯ãšã¹ãã«äº€æ觊åªãçšãããã®ããã©ããŒãš
ã¢ã«ã³ãŒã«R5OHã®åå¿ã«ãã€ãŠèª¿è£œããŠãã
ãããã®åå¿ã¯ïŒ ã§ç€ºãããã ãâCH2OCOâåºãå«ãäžé£œåç°åŒãšãŒã
ã«é¡ã¯ãšã¹ãã«äº€æ觊åªãçšãããã®ããã©ããŒ
ãšäœçŽã¢ã«ãã«ã«ã«ãã³é žR5COOR9ïŒåŒäžãR9
ã¯äœçŽã¢ã«ãã«åºãè¡šããïŒãšã®åå¿ã«ãã€ãŠèª¿
補ããŠããããåå¿åŒã¯ ã§è¡šããããã ããããã®å¯çæç©ã¯R5COOR9ãŸãã¯R5OH
ã§ãšã¹ãã«åããçžåœããååç©ïŒ
ã¡ãªãã¯ãŸãã¯ããªã¡ãªãã¯ãã°ã«ãŒãã§ãã€ãŠ
éåå¯èœãªåºãå«ããã®ãè¡šããïŒããã¯ãã€ã
ãã²ã«ã圢æããããã®ã«ããªã³éåã«é¢äžãã
éåå¯èœãªäžé£œåç°åŒãšãŒãã«ãšåå¿ãããæã
ã¯èŠªæ°Žæ§ã®ãã¢ãŸãã¯ã³ããªããŒãŸãã¯ãã®äž¡è
ãšåå¿ãããããæããäž¡æ¹ã®æåãšåå¿ãã奜
ãŸããäŸã¯ããã«ãšãŒãã«ãšãšããã·åºã§ããã R5ã¯ç°åŒããã«ãšãŒãã«ãç¹ã«åŒïŒ ãåŒäžãRâ²1ïŒRâ²2ïŒRâ²3ããã³Râ²4ã¯R1ïŒR2ïŒ
R3ããã³R4ãšåæ矩ã§ãããããããåäžãŸã
ã¯ç°ãªã€ãŠããŠãããïŒïŒã¯åºâZXâ²âãè¡šã
ãïŒXâ²ã¯ïŒžãšåæ矩ïŒããã³ïŒºã¯åçµåãŸãã¯
ã«ãŒãã³æ§ã¢ãããªãªãŽãŸãã¯ãã¢âãããã¯ã³
ãŒããªïŒçœ®æãŸãã¯é眮æã®ã¢ã«ãã¬ã³ãããã¯
ã¢ã«ãã³ãªãã·ãïŒã°ã«ãŒããè¡šããããè¡šãã
ã®ãç¹ã«å¥œãŸããã ç¹ã«å¥œãŸããéåå¯èœãªäžé£œåç°åŒãšãŒãã«é¡
ã¯ãžããããã©ã³ã¢ã«ãããé¡ã®äžçš®ãªãããã®
æ··åç©ãTischenkoåå¿ã«ãããŠåœ¢æãããåå¿
çæç©ã§ããããã®ç©ã¯åŒïŒ ãåŒäžãRâ²1ïŒRâ²2ããã³Râ²4ã¯R1ïŒR2ããã³R4
ãšåæ矩ã§ãããåäžãŸãã¯ç°ãªã€ãŠããŠãã
ããã§è¡šããããååç©ã§ããã奜ãŸããååç©
ã¯ã¢ã¯ãã¬ã€ã³ããã©ããŒïŒå³ã¡ãã¯å šãŠæ°ŽçŽ
ååãè¡šããïŒã§ããã ãCOOãŸãã¯âCH2OCOâåºãå«ãéåå¯
èœãªäžé£œåç°åŒãšãŒãã«é¡ã¯äŸ¿å®çã«ã¯ãã€ãã·
ãšã³ã³ïŒTischenkoïŒåå¿ã«ãã€ãŠè£œé ãããã
çžåœããäžé£œåã¢ã«ãããã®ããã©ããŒãç¹ã« ãã調補ããŠãããã å³ã¡ããCOOåºãå«ãäžé£œåç°åŒãšãŒãã«
é¡ã¯ãšã¹ãã«äº€æ觊åªãçšãããã®ããã©ããŒãš
ã¢ã«ã³ãŒã«R5OHã®åå¿ã«ãã€ãŠèª¿è£œããŠãã
ãããã®åå¿ã¯ïŒ ã§ç€ºãããã ãâCH2OCOâåºãå«ãäžé£œåç°åŒãšãŒã
ã«é¡ã¯ãšã¹ãã«äº€æ觊åªãçšãããã®ããã©ããŒ
ãšäœçŽã¢ã«ãã«ã«ã«ãã³é žR5COOR9ïŒåŒäžãR9
ã¯äœçŽã¢ã«ãã«åºãè¡šããïŒãšã®åå¿ã«ãã€ãŠèª¿
補ããŠããããåå¿åŒã¯ ã§è¡šããããã ããããã®å¯çæç©ã¯R5COOR9ãŸãã¯R5OH
ã§ãšã¹ãã«åããçžåœããååç©ïŒ
ãåŒããŸãã¯
ãåŒããäžããŠãããã
çžåœããã¢ããé¡ã¯åæ§ã«ããŠèª¿è£œããã°ã
ãã ãCOOâåºãå«ãäžé£œåç°åŒãšãŒãã«é¡ã¯
çžåœããäžé£œåã¢ã«ãããã®ãã€ããŒã®ç·©åãªé ž
åããã³ãã®å¡©ãäŸãã°éå¡©ã®ãšã¹ãã«åã«ãã€
ãŠåŸãŠãããã ã¡ã¿ã«ãŒãããŒãé¡ãšãªãã¶ã¬ãŒãé¡ã¯ããã
ã以äžã®ãšã¹ãã«åïŒ ã«ãã€ãŠåŸãŠãããã ç¶ããªãããã¢ã¯ãã¬ã€ã³ããã©ããŒã¯åžè²©ã®
ã¢ã¯ãã¬ã€ã³ãã容æã«èª¿è£œããã容æã«ç²Ÿè£œã
åŸãããšããã³æ¬çºæãå®æœããäžã§æºè¶³ãã¹ã
ãã®ã§ããããšã匷調ããã éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã¯åŒïŒ ãåŒäžãR1ïŒR2ïŒR3ïŒR4ïŒR5ããã³ïŒ±ã¯åèš
ãšåæ矩ã㯠ïŒåŒäžãã¯é žçŽ ååãŸãã¯âNR6âåºãR6
ã¯R1ãšåæ矩ãïœã¯ïŒãŸãã¯ïŒãïœã¯ïŒãŸãã¯
ïŒãïœã¯ïŒãŸãã¯ïŒã§ããïŒäœãïœïŒïœã¯ïŒã§ã
ãïŒïŒã§è¡šãããããã®ååç©ãå«ãã§ããŠãã
ãã éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã¯ãŸãçž
åœããäžé£œåã¢ã«ãããã®å°ãªããšãïŒåã®ãã€
ããŒã®ã¢ã«ããŒã«çž®åçæç©ïŒ ç¹ã« ãå«ãã§ããŠãããã éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã¯æŽã«å°
ãªããšãäžçš®ã®äžé£œåã¢ã«ããããšããªãããã
ã·ååç©ã®ããªããã«ãšãŒãã«ïŒ ãåŒäžãR7ã¯ïœâããããã·ååç©ã®ïœäŸ¡ã®
çåæ°ŽçŽ ãŸãã¯ããªïŒãªãã·çåæ°ŽçŽ ïŒæ®åºãè¡š
ãããã®ãã€ãŒã«ã¹ãã¢ã«ããŒçæç©ãå«ãã§ã
ããã éåå¯èœãªäžé£œåç°åŒãšâãã«ïŒïŒã¯æŽã«å
åç© ãåŒäžãR8ã¯ïœäŸ¡ã®éå æ°Žå解æ§æ¶æ©æ®åºã
è¡šããããå«ãã§ãããã äžèšæåŸã®ïŒçš®ã®ååç©ã¯å®¹æã«ã¯å æ°Žå解ã
ããªããã€ããã²ã«ãäžããããããã®äœ¿çšã«ã
ããææã®å æ°Žå解é床ãæããæ¬çºæãã€ãã
ã²ã«ãæäŸããããã®äž»èŠãªæ¹æ³ãäžããã ææã®å æ°Žå解å®å®æ§ã¯ãŸãä»ã®å€ãã®ç°ãªã€
ãã¡ã«ããºã ã«ãã€ãŠãå®æœãåŸããå³ã¡ãã¢ã¯
ãã¬ã€ã³ããã©ããŒåæäœãäŸãã°ã¡ã¿ã¢ã¯ãã¬
ã€ã³ããã©ãŒãŸãã¯ã¢ã¯ãã¬ã€ã³ïŒã¡ã¿ã¢ã¯ãã¬
ã€ã³æ··åããã©ããŒã¯ãR4ã倧ãããªãã«ã€ã
ãŠå¢å ããç«äœé害ãå æ°Žå解å¯èœãªãšã¹ãã«ãŸ
ãã¯ã¢ããå®èœåºïŒžã«åãŒããããã«ãã€ãŠèªå°
äœã®å®å®æ§ãåäžããããã¢ãããžããã³ããªâ
ã«ã«ããã·ããã³ããšããŒã«æ§ããããã·çœ®æç
åæ°ŽçŽ ã¯å æ°Žå解ãæãèªå°äœã圢æãããã®äž
ã«è§Šåªäœçšã®ããé žæ§éšåãäžããïŒïŒžããã³
Xâ²ïŒããã¯åäžã§ãã€ãŠãç°ãªã€ãŠãããïŒãã
ãããCOOâãŸãã¯CH2OCOâåºãããã³ïŒºã
眮æãŸãã¯é眮æã®ãããã«ã«ãã¬ã³åºãè¡šãã
èªå°äœã¯ãŸãå æ°Žå解ã容æã«ãããããã«ãŸã
ïŒãªãããã以äžã®ã«ã«ããã·ãŸãã¯ããããã·
åºãä¿æããèªå°äœã¯æ¯èŒçé«ãã¬ãã«ã®æ°Žãå«
ã¿ãããèªäœã¯å æ°Žå解ã容æã«ããã åºR1ïŒR2ããã³R3ã¯ãããã眮æãŸãã¯é眮
æã®ãããã«ã«ãã«ãŸãã¯ãããã«ã«ãããã·åº
ãè¡šããïŒå ·äœäŸãšããŠã¯é眮æãŸãã¯ãã眮æ
C1âC4ã¢ã«ãã«ãäŸãã°ã¡ãã«ãããã¯ãšã
ã«ïŒé眮æC6âC10ã¢ãªãŒã«ãããã¯ã¢ã©ã«ãã«ã
äŸãã°ããšãã«ãŸãã¯ãã³ãžã«ïŒããã³ãªãã·å
æäœããããR4ã®å Žåãåºã®å€§ããã®å¢å ã¯å š
ãŠã®å æ°Žå解å¯èœãªãšã¹ãã«ãŸãã¯ã¢ããå®èœåº
ã«å¯Ÿããç«äœé害ãå¢å€§ãããã®çµæãã€ããã²
ã«ã®å®å®æ§ãåäžãããç¶ããªããã補é ã®å®¹æ
æ§ããã³æçšæ§ã®ç¹ã§å°ãªããšãäžåãæãŸãã
ã¯å šãŠã®R1ïŒR2ããã³R4ãæ°ŽçŽ ååã§ããã®ã
奜ãŸãããåºR3ã¯ã¢ããŸãã¯ããªçœ®æãšãã¬ã³
åºã奜ãŸããã¯é眮æãšãã¬ã³åºãè¡šãããŠãã
ããå³ã¡ãžãããïŒãã¢ïŒãã©ã³èªå°äœã§ãã€ãŠ
ãããã 奜ãŸããååç©ïŒïŒã¯ãšãŒãã«é¡ã§ããäžèš
åŒã®ååç©ãç¹ã«ãžããããã©ã³ã§ããã é©åœãªèŠªæ°Žæ§ãã¢ãŸãã¯ã³ããªããŒïŒïŒã¯å°
ãªããšãäžåã®äžèšã¢ãããŒçŸ€ïŒ (a) ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ã
ããé眮æãŸãã¯ããããã·çœ®æãšãã«ãŸãã¯
ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãããŸãã¯ïŒã¡
ã¿ïŒã¢ã¯ãªã«é žã®ããªïŒãªãã·ãšãã¬ã³ïŒãšã¹
ãã«ïŒ (b) ïŒãïŒã®ç°ååãæãã眮æãŸãã¯é眮æã®
ç°åŒã¢ããŸãã¯ããªãšãŒãã«ãŸãã¯ïŒå¡ç°ãæ
ããç°ç¶ã€ãã³ããŸã㯠(c) 眮æãŸãã¯é眮æã®ããã«ã¢ã«ã³ãŒã«ãã¢ã«
ãããããšãŒãã«ãã¢ã»ã¿ãŒã«ãã±ãã³ããšã¹
ãã«ããŸãã¯çœ®æãŸãã¯é眮æã®ïŒ®âããã«ç°
é ç°ååç© ããèªå°ãããæ®åºãå«ããããã§ïŒã¡ã¿ïŒã¢ã¯
ãªã«ã¯âã¡ã¿ã¯ãªã«âãŸãã¯âã¢ã¯ãªã«âãŸãã¯
ãã®äž¡æ¹ãè¡šããæå³ã§çšããã 矀(b)ã®ã¢ãããŒé¡ã¯ãšããã·ãé¡ãäŸãã°é žå
ãšãã¬ã³ãé žåãããã¬ã³ãïŒïŒïŒâãšããã·ã
ã¿ã³ãïŒïŒïŒâãšããã·ãã¿ã³ãã°ãªã·ãžã«ãšãŒ
ãã«é¡ãâïŒãšããã·çœ®æïŒç°é ç°ååç©ãäŸ
ãã°ïŒ®âïŒïŒïŒïŒâãšããã·ãããã«ïŒâãããªã
ã³ïŒãšããããããªã³é¡ãããèªäœã¯ç°åŒãšãŒã
ã«é¡ã§ã¯ãªããããããèªå°å¯èœãªãã¢ããã³ã³
ããªããŒé¡ãäžããïŒå ·äœçã«ã¯ãšããã«ãªã«ã
ããªã³ããšãã¯ãã«ãããªã³ããã³ãšãããã ã
ããªã³çããããä»ã®ç°åŒã¢ãâãŸãã¯ããªãšãŒ
ãã«é¡ã¯é žåããªã¡ãã¬ã³ïŒoxetaneïŒãããã©
ããããã©ã³ããžããããã©ã³ããžããããã©
ã³ããžãªããœã©ã³ãããã³ããªãªããµã³çãã
ããããããèªå°ããããã¢ããã³ã³ããªããŒé¡
ãšããŠã¯éšåçã«C1âC4ã¢ã«ãã«ã§ãšãŒãã«å
ãããã»ã«ããŒã¹é¡ããã³æŸ±ç²é¡ããŠã¬ã¿ã³ã§æ¶
æ©ãããŠããŠãããããã¢ãŸãã¯ã³ããªïŒã¢ã«ã
ã¬ã³ãªãã·ãïŒãŸãã¯äžé£œåç°åŒãšãŒãã«åºãäŸ
ãã°ããªãªãã·ã¡ãã¬ã³ãããªãšãã¬ã³ã°ãªã³ãŒ
ã«é¡ããã³ããªãããã¬ã³ã°ãªã³ãŒã«é¡ããã³ã
ãããšãžã«ã«ãã³é žïŒäŸãã°ãã¬ã€ã³é žïŒãšã®ã
ãªãšã¹ãã«é¡çãããã 矀(c)ã«ãããã¢ãããŒé¡ã¯ã¡ãã«ããã³ãšãã«
ããã«ãšãŒãã«ãã¡ãã«ããã«ã±ãã³ãã¡ã¿ã¢ãª
ã«ã¢ã«ã³ãŒã«ãâããã«ãããªãã³ãâãã
ã«ã«ã«ããŸãŒã«ãâããã«ããªãžã³ãâãã
ã«ãªããµãŸãŒã«ãâããã«ã¡ãã«ãªããµãŸãªãž
ã³ãããã«ãã«ããŒã«ãããã«ããã©ãŒã«ããã
ã«ã¡ããã·ã¢ã»ã¿ãŒã«ãå å«ãããããããèªå°
ããããã¢ããã³ã³ããªããŒé¡ã¯ããªããã«ã¢ã»
ããŒãããã³ããªããã«ã¢ã«ã³ãŒã«çãå å«ã
ãã 奜ãŸãã芪氎æ§ãã¢ãŸãã¯ã³ããªããŒé¡ã¯çŸ€(b)
ã¢ãããŒé¡ããèªå°ãããæãŸããã¯éåããé ž
åã¢ã«ãã¬ã³ãç¹ã«é žåãšãã¬ã³æ®åºãå«ãã奜
ãŸããã¯è©²èŠªæ°Žæ§ãã¢ãŸãã¯ã³ããªããŒã¯ãã¢ãŸ
ãã¯ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒãç¹ã«ã³ããª
ïŒãšãã¬ã³ãªãã·ãïŒã§ããã å®èœåºã«å¯Ÿããæ°å¹³åååéã®æ¯ïŒä»¥äžãåœé
ïŒequivalent weightïŒãšäºãïŒã750以äžã奜ãŸ
ããã¯1000以äžã®ããªãšãã¬ã³ãªãã·ãæ®åºãæ
ãããã¢ãŸãã¯ãããã¯ã³ããªïŒã¢ã«ãã¬ã³ãªã
ã·ãïŒé¡ãç¹ã«å¥œãŸãããåœéã500ãã250ãªã
ããã以äžã®ãã®ã䜿çšã§ãããããã®æ§ãªããª
ããŒã¯èšæœ€æ§ãäœããªãåŸåãããã å·ã®å 垯ãšããŠäœ¿çšããããã«ã¯ããã¢ãŸãã¯
ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒã¯åœé1200ã
1800ã奜ãŸããã¯çŽ1400ã1600ã®ããªãšãã¬ã³ãª
ãã·ãæ®åºãæãããã®ãçšããã®ã奜ãŸããã
æŸåºèª¿ç¯çµæç©ã«äœ¿çšããã«ã¯åœé1200ã4000ãª
ãããã以äžã奜ãŸããã¯çŽ1500ã3000ãäŸãã°
2000ãªãããã以äžã®ããªãšãã¬ã³ãªãã·ãæ®åº
ãæãããã¢ãŸãã¯ã³ããªïŒã¢ã«ãã¬ã³ãªãã·
ãïŒé¡ã䜿çšããã®ã奜ãŸããã ç¹ã«å¥œãŸãã芪氎æ§ããªããŒé¡ïŒïŒã¯åèšã®
ããšãåœéãæããããªïŒãšãã¬ã³ãªãã·ãïŒé¡
ã§ããã ãããã調補ããããããã²ã«é¡ã¯ä¹Ÿç¥åœ¢æ ã§
ã¯çµæ¶ã§ããã湿最ç¶æ ã§é¢æ¶²çŸè±¡ïŒsyneresisïŒ
ãçŸããããã®äž¡æ¹ã®æ§è³ªãåŸè¿°ããããšãæ¬çº
æã«æçšã§ããããšãããã€ãã éåã¢ã«ãã¬ã³ãªãã·ãæ®åºãæãã芪氎æ§ã
ã¢ãŸãã¯ã³ããªããŒé¡ã¯äŸ¿å®çã«ã¯ã¢ã«ãã¬ã³ãª
ãã·ã(a)ãäŸãã°é žåãšãã¬ã³ãšåå¿æ§æ°ŽçŽ åå
å«æååç©(b)ãäŸãã°èèªæãŸãã¯è³éŠæããã
ãã·ãã«ã«ããã·ãã¢ãããŸãã¯ã¡ã«ã«ããåå
ç©ãšã®ä»å éåã«ãã€ãŠèª¿è£œããããã®ååç©ã¯
ããèªäœãåŸããã芪氎æ§ã³ããªããŒäžã§ããã
ããã¹ïŒblockinessïŒãšãªãããªããŒãŸãã¯ãªãª
ãŽããŒã§ãã€ãŠãããããããã¯ãã¢ããªããŒ
ïŒããã§ã¯å¯äžçš®ã®ã¢ã«ãã¬ã³ãªãã·ããéåã
ãïŒãŸãã¯ã©ã³ãã ã³ããªãïŒããã§ã¯ã¢ã«ãã¬
ã³ãªãã·ãã®æ··åç©ãéåããïŒã«å°ãã¢ãããŒ
ã§ãã€ãŠããããåè ã®å ŽåãåŸãããããªããŒ
ãŸãã¯ãªãªãŽããŒã¯ããèªäœãã¢ãŸãã¯ã³ããªã
ïŒã¢ã«ãã¬ã³ãªãã·ãïŒã§ãã€ãŠããã ååç©(b)ã¯åå¿æ§æ°ŽçŽ å«æå®èœåºã§ïŒïŒïŒïŒïŒ
ãŸãã¯ãã以äžçœ®æããããã®ãå«ã¿ããããã¯
ã¢ãã¡ãªãã¯ããªãªãŽã¡ãªãã¯ãŸãã¯ããªã¡ãªã
ã¯ã§ãã€ãŠãããäžä»¥äžã®åã®æŽ»æ§æ°ŽçŽ å«æå®èœ
åºãæ°Žé žåºãã«ã«ããã·ã«åºãç¹ã«æ°Žé žåºïŒãã
ãã®åºã¯å¥œãŸããã®ã§ããïŒãšå ±ã«ååç©(b)äžã«
ååšããŠããŠããããèèªæååç©ã¯ç¹ã«å¥œãŸã
ããååç©(b)ã®æ··åç©ãçšããŠãããã ãžã«ã«ããã·ãŸãã¯ããããã·ååç©ã®äŸã¯ã
ãžã«ã«ãã³é žé¡ããžãããªãã¯ããšããŒã«é¡ãã
ãããã·é žé¡ããã³ã°ãªã³ãŒã«é¡ã§ãããæãŸã
ãã¯ççŽ æ°18以äžã奜ãŸããã¯10以äžã®ãã®ã§ã
ããäŸãã°èé žãããã³é žããã¯ãé žãã°ã«ã¿ãŒ
ã«é žãã¢ãžãã³é žãïŒïŒïŒâã·ã¯ããããµã³ãžã«
ã«ãã³é žãïŒïŒïŒâã·ã¯ããããµã³ãžã«ã«ãã³
é žãïŒïŒïŒâã·ã¯ããããµã³ãžã«ã«ãã³é žããã¿
ãŒã«é žãã€ãœãã¿ãŒã«é žããã³ãã¬ãã¿ãŒã«é žã
ïŒïŒ4â²âãžããããã·ããšãã«âïŒïŒïŒâããã
ã³ãã¬ãŸã«ã·ããŒã«ããããŒã«ããã³ãªã«ã·ããŒ
ã«ãä¹³é žãïŒâããããã·ã€ãœé ªé žã10âããã
ãã·ãã«ã³é žã12âããããã·ãªã¯ã¿ãã«ã³é žã
12âããããã·âã·ã¹âïŒâãªã¯ã¿ãã«ã³é žãïŒ
âããããã·ã·ã¯ããããµã³ã«ã«ãã³é žãïŒâã
ãããã·âïŒâããšãã«ïŒïŒ€ïŒããããªã³é žããž
ããšãã«ããããã·é ¢é žãïŒâããããã·å®æ¯éŠ
é žãïŒâããããã·å®æ¯éŠé žããã³ïŒâãããã
ã·å®æ¯éŠé žãã°ãªã³ãŒã«ããããã³ãžãªãŒã«é¡ã
ãã³ãã¿ã³ãžãªãŒã«é¡çãäŸç€ºããããã°ãªã³ãŒ
ã«é¡ã¯æãé©ããŠãããç¹ã«C2âC6ããã®äžã§
ãC2âC4ã°ãªã³ãŒã«é¡ã奜ãŸããã ãžã«ã«ãã³é žé¡ããžãããªãã¯ããšããŒã«é¡ã
ããããã·é žé¡ãšã°ãªã³ãŒã«é¡ã®æ··åç©ã䜿çšã
ãŠãããã奜ãŸããã¯ãžã«ã«ãã³é žé¡ããžãããª
ãã¯ããšããŒã«é¡ãããããã·é žããã³ã°ãªã³ãŒ
ã«é¡ãçŽéã®ãã®ã§ããã ïŒä»¥äžã®ã«ã«ããã·ãŸãã¯ããããã·åºã«ãã€
ãŠçœ®æãããååç©(b)ã®äŸã¯ããªã«ã«ãã³é žé¡ã
ããªãããªãã¯ããšããŒã«é¡ãããããã·é žé¡ã
ãã³ããªãããªãã¯ã¢ã«ã³ãŒã«é¡ãæãŸããã¯ç
çŽ æ°18以äžã奜ãŸããã¯10以äžã®ãã®ã§ããïŒäŸ
ãã°èèªæããªãªãŒã«é¡ãäŸãã°ã°ãªã³ãŒã«ããš
ãªã¹ãªããŒã«ããã³ã¿ãšãªã¹ãªããŒã«ããœã«ãã
ãŒã«ããã«ã·ããŒã«ãã€ãã·ããŒã«ãïŒâãšãã«
âïŒâããããã·âã¡ãã«ãããã³âïŒïŒïŒâãž
ãªãŒã«ããã³ïŒïŒïŒïŒïŒâãããµã³ããªãªãŒã«ïŒ
è³éŠæããªãªãŒã«é¡ãäŸãã°ïŒïŒïŒïŒïŒâããªã
ãããã·ãã³ãŒã³ãïŒïŒïŒïŒïŒâããªããããã·
ãã³ãŒã³ãïŒïŒïŒïŒïŒâããªããããã·ãã³ãŒ
ã³ïŒã¢ã«ã¢ãªãã¢ãã€ãã¯ããªãªãŒã«é¡ïŒããã
ãã·ã¢ãªãã¢ãã€ãã¯ãã¢ãªãµã€ã¯ãªãã¯ããã³
è³éŠæã«ã«ãã³é žé¡çããã³ã¯ã¬ãã¹ã»ãµã€ã¯ã«
é žãäŸãã°ãããé žããããé žãé ç³é žãïŒâã
ãããã·âïŒâã¡ãã«ïŒïŒ€ïŒãã¯ãé žãã¢ã¹ã³ã«
ãã³é žãïŒïŒïŒâãžããããã·å®æ¯éŠé žãïŒïŒïŒ
âãžããããã·å®æ¯éŠé žãïŒïŒïŒâãžããããã·
å®æ¯éŠé žãïŒïŒïŒâãžããããã·å®æ¯éŠé žãïŒïŒ
ïŒïŒïŒâããªããããã·å®æ¯éŠé žãïŒïŒïŒïŒïŒâ
ããªããããã·å®æ¯éŠé žãïŒïŒïŒïŒïŒâããªãã
ããã·å®æ¯éŠé žããã³ïŒïŒïŒïŒïŒâããªãããã
ã·å®æ¯éŠé žçã§ããã ããªã«ã«ãã³é žé¡ãããªãããªãã¯ããšããŒã«
é¡ãããããã·é žé¡ããã³ããªãããªãã¯ã¢ã«ã³
ãŒã«é¡ã®æ··åç©ã䜿çšããŠãããã奜ãŸããã¯ã
ãªã«ã«ãã³é žé¡ãããªãããªãã¯ããšããŒã«é¡ã
ããããã·é žé¡ããã³ããªãããªãã¯ã¢ã«ã³ãŒã«
é¡ãçŽéã®ãã®ã§ããã ãªãªãŽããŒãŸãã¯ããªããŒã§ãã€ãŠãããä»ã®
äŸã¯ç¡¬ããããã¯æè»ãªããªãŒã å·¥æ¥ã®åéã«è©³
ããè ã«ããç¥ãããç©è³ªãäŸãã°ãªãã·ããã
ã«åããªãªãŒã«é¡ãããããŒã«é¡ããã³åº¶ç³é¡ãª
ãã³ã«ããªãšã¹ãã«é¡ãå å«ãããç¶ããªããã
äžè¬ã«äœååéååç©ã奜ãŸãããããã¯é«åå
éã®ãã®ããã€ããã²ã«ã®èª¿è£œãããå°é£ã«ãã
çžæº¶æ§ã®åé¡ãäžããããã§ããã 芪氎æ§ããªããŒé¡ïŒïŒã¯éåã¢ã«ãã¬ã³ãªã
ã·ãæ®åºãå«ãããªããŒé¡ã§ãããå žåçã«ã¯å
è¿°ã®ããšãããŠèª¿è£œããããããã¯é žåãšãã¬ã³
ã«å ããŠå°éã®æåãå«ãã®ã奜ãŸãããäŸãã°
ãã倧ããã¢ã«ãã¬ã³ãªãã·ããäŸãã°é žåãã
ãã¬ã³ãŸãã¯é žåããã¬ã³ã§ãããå žåçã«ã¯ã
ã®éã¯ã³ããªããŒã®20ééïŒ ä»¥äžã奜ãŸããã¯10
ééïŒ ä»¥äžãªããããããå°ãªãéã§ãããç¶ã
ãªãããã®æ§ãªã³ããªããŒã¯ãããªïŒã¢ã«ãã¬ã³
ãªãã·ãïŒé¡ã®ãã¡ã§ãããªïŒãšãã¬ã³ãªãã·
ãïŒãæ¬çºæã«ç¹æã®äŸ¡å€ããããã芪氎æ§ã«ã
ã€ãŠçããç¬ç¹ã®æ§è³ªãæããŠããã®ã§ããçšè
å³ã®ãããã®ã§ã¯ãªããåŸã€ãŠæ¬çºæã®å¥œãŸãã
èŠå°ããã¯ãã®èŠªæ°Žæ§ããªããŒã¯(a)é žåãšãã¬ã³
ãš(b)èèªæãŸãã¯è³éŠæããããã·ãã«ã«ãã
ã·ãã¢ãããŸãã¯ã¡ã«ã«ããååç©ãšã®åå¿çæ
ç©ã§ããããªïŒãšãã¬ã³ãªãã·ãïŒã§ããã ïŒãªãããã以äžã®ååç©ïŒïŒã¯ïŒãŸãã¯ã
ã以äžã®ååç©ïŒïŒãšéåããŠãããã éåå¯èœãªç°åŒãšãŒãã«ïŒïŒãšèŠªæ°Žæ§ãã¢ãŸ
ãã¯ã³ããªããŒïŒïŒãéåããŠãããã²ã«ã圢
æãããéåžžããããå¿ ããããå¿ èŠã§ã¯ãªãã
ïŒïŒãšïŒïŒã¯ååŠçã«æ¶æ©ãããŠãããã²ã«
ã圢æããããŸãããã«ä»£ããŠãããããéåã
ããŠçŽéã®é«ååéç©è³ªãåŸã次ãã§ãããå¥ã®
éåãåŸãç³»äžã«åæ£ããããã®åŸãã®ç³»ãéå
ããŠè©²é«ååéç©è³ªã絡ãã ãããã¯ãŒã¯äžã«æ
ããŠãããããããã¯ããããéåããŠçæ°Žæ§ã
ããã¯ãæããã³ããªããŒã圢æããŠäž¡èŠªåªæ§ã®
ç©è³ªãåŸãŠããããããããªããååŠçæ¶æ©ãç
ããã®ã奜ãŸããã ååŠçæ¶æ©ã¯ã«ããªã³éåã«é¢äžãåŸãå°ãªã
ãšãïŒåã®åºãå«ãååç©ããã€ããã²ã«äžã«å°
å ¥ããããšã«ããè¡ãªã€ãŠãããã奜ãŸããã¯å
åŠçæ¶æ©ã¯ïŒããå€ã掻æ§æ°ŽçŽ ååãæããåå
ç©ããã€ããã²ã«äžã«å°å ¥ããããšã«ããè¡ãªã€
ãŠãããããã®æ§ãªååç©ã¯ããªãããã©ãŸãã¯
ããé«åºŠã®çœ®æãããèèªæãŸãã¯è³éŠæããã
ãã·ã«ãã«ã«ããã·ã«ãã¢ãããŸãã¯ã¡ã«ã«ãã
ååç©ãå å«ããããããã¯ïŒããå€ã掻æ§æ°ŽçŽ
ååãæããäžèšååç©(b)ã®ãããã§ãã€ãŠãã
ãããã®æ¶æ©ååç©ãååç©(b)ãšããŠå©çšããã¢
ãŸãã¯ã³ïŒããªã¢ã«ãã¬ã³ãªãã·ãïŒã圢æãã
ãããšã¯å¯èœã§ãããããã«ä»£ããŠããã®æ¶æ©å
åç©ãéåæ··åç©äžã«å°å ¥ããŠãããã ååŠçæ¶æ©ãïŒããå€ãéåå¯èœãªäžé£œåç°åŒ
ãšãŒãã«åºãæããååç©ããã€ããã²ã«äžã«å°
å ¥ããããšã«ãã€ãŠéæããŠãããããã®æ§ãªå
åç©ã®äŸã¯ååŠéè«çéã®é眮æã®ã¢ã¯ãã¬ã€ã³
ããã©ããŒãŸãã¯ããªãããã©ãŸãã¯ãã以äžã®
眮æãããèèªæãŸãã¯è³éŠæããããã·ã«ãã«
ã«ããã·ã«ãã¢ãããŸãã¯ã¡ã«ã«ããååç©ã§çœ®
æãããã¢ã¯ãã¬ã€ã³ããã©ããŒïŒäŸãã°ã¢ã¯ã
ã¬ã€ã³ããã©ããŒãã°ãªã»ããŒã«ã®ããšãããªã
ããªãã¯ã¢ã«ã³ãŒã«ã§ãšã¹ãã«äº€æããŠåŸããã
çæç©çãå«ãã ãã€ããã²ã«ã¯ãŸãåè¿°ããã¢ã«ããŒã«çž®åç
æç©ã®å Žåã®ããšããïŒåã®éåå¯èœãªäžé£œåç°
åŒãšãŒãã«åºããã³ïŒåã®åå¿æ§æ°ŽçŽ ååãŸãã¯
ïŒåã®éåå¯èœãªäžé£œåç°åŒãšãŒãã«åºããã³ïŒ
åã®åå¿æ§æ°ŽçŽ ååãå«ãååç©ã§ååŠçã«æ¶æ©
ããŠãããã ãã€ããã²ã«ãžã®ååŠéè«çéå°éã®æå
ïŒïŒã®å°å ¥ã¯ãŸãååŠçæ¶æ©ãéæããã æ¶æ©å€ã®æ··åç©ã䜿çšããŠãããã å æ°Žå解å¯èœãªãã€ããã²ã«ã¯å°ãªããšãäžçš®
ã®éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒãšå°ãªã
ãšãäžçš®ã®èŠªæ°Žæ§ãã¢ãŸãã¯ã³ããªããŒïŒïŒãš
ãå°ãªããšãäžçš®ã®æ¶æ©å€ããã³æèŠã«ããé žè§Š
åªã®ååšäžã«ã«ããªã³éåããŠèª¿è£œããŠãããã æå©ã«ã¯éåã¯ææž©äžãäŸãã°50ã120âã奜
ãŸããã¯60ã100âãç¹ã«70ã90âã§è¡ãªããåš
å²å§ãŸãã¯èªç¶å§ïŒautogenous pressureïŒã䜿
çšããŠãããã 奜é©ãªé žè§Šåªã¯ãã³ã¹ãããããã³ã«ã€ã¹é žã®
äž¡æ¹ãå«ããåè ã¯éåæ¡ä»¶äžã§ã¯ã¬ãã¯ã¹è©Šè¬
ã§ã¯ãªã匷é±é žãäŸãã°å¡©é žãç¡«é žãïœâãã«ãš
ã³ã¹ã«ãã³é žïŒtosylic acidïŒãããã·ã«é ž
ïŒbrosylic acidïŒããã³ãã®ã¡ã¿ããŒã«ä»å ç©ã
ãã³äžããåç¡ŒçŽ ãäžå¡©åç¡ŒçŽ ãäžèåç¡ŒçŽ ãäž
å¡©åã¢ã«ãããŠã ãäžèåã¢ã«ãããŠã ãäžå¡©å
ã¬ãªãŠã ãåå¡©åã²ã«ãããŠã ãåèåé«ãå¡©å
äºéããã³å¡©å第äºéçã§ãããå¡©å第äºéã奜
ãŸãããéåæ··åç©ã®0.01ãïŒééïŒ ã奜ãŸãã
ã¯0.04ãïŒééïŒ äœ¿çšããã æåïŒïŒïŒïŒïŒã®ã¢ã«æ¯ã¯åºç¯å²ã«ããã€ãŠ
å€ããŠããããããããªãããæ¬çºæã®å¥œãŸãã
æ æ§ã«ãã€ãŠã¯äžé£œåç°åŒãšãŒãã«ãååŠéè«ç
ã«èŠè«ãããéããéå°ãå žåçã«ã¯ïŒã1000é
éïŒ ã奜ãŸããã¯10ã500ééïŒ ãç¹ã«20ã100é
éïŒ éå°ã§ããã®ã奜ãŸãããé©ãã¹ãããšã«
ã¯ããã®å Žåã«ã¯äžé£œåç°åŒãšãŒãã«ãããèªäœ
ã§éåããã®ã¿ãªãããåŸãããããªããŒã®å šçž
åé¢ïŒgross phase separationïŒãçããªãã
ãšãå³ã¡ãã®ç³»ã¯ãããåäžã§ãããã³ãã€ãé
åã圢æãããŠãã€ããã²ã«ã匷åããç©çç匷
床ã®èãããé«ãæŸåºèª¿ç¯çµæç©ãäžããããšã
ããã€ãã ãã®ããšã¯æŸåºèª¿ç¯çµæç©ã«äœ¿çšãããã§ãã
ããããªãã€ã«ã ãŸãã¯ãã倧ããå¡ã«æ圢ãã
ãã€ããã²ã«ã®å Žåã«ã¯ç¹ã«éèŠã§ãããããã
åœé1200ãã1800ã®ããªãšãã¬ã³ãªãã·ãæ®åºã
å«ãããªããŒããååŠéè«çéã®åå¿è©Šå€ãçšã
ãŠäžèšç©è³ªãäœããšåŸããããããã²ã«ã¯éåžžã
也ç¥ããã³èšæœ€ãããã®ç¶æ ã§ã匱ããªãã§ãã
ããããã¯å·ã®å 垯çšã®çŽ°ç²çæç©ãåŸãã®ã«äŸ¿
å©ã§ãããä»ã®çæç©ã«ãšã€ãŠã該çæç©ãåæ±
ãããã³èšæœ€ã«èããŠïŒäŸãã°æŽ»æ§ç©è³ªãæ æã
æŸåºããããšïŒãéå°ã奜ãŸããã¯å®è³ªçã«éå°
ã®æåïŒïŒã確ä¿ããããšãç¹ã«æãŸããã ãã®æ§ãªãã€ããã²ã«ã®æ¯æ§ã¯éåžžã«äœããå€
ããã®ïŒadventitiousïŒæ°Žåã®ååšã«ãã€ãŠåœ¢æ
ããããšãã¬ã¹ãçºçãããåŸã€ãŠèããã€ã«ã
ããã³é³é ç©ãæãŸãããªãæ°æ³¡ãªãã«å®¹æã«èª¿
補ãããããŸãç©ççæ§è³ªã«å€åããããããªã
åå¿å€ã®æ¯çã®å®è³ªçãªèš±å®¹åºŠãåºãã å ããŠãïŒïŒãšã«ããªã³çã«éåãåŸãä»ã®
ååç©ãå žåçã«ã¯ãã€ããã²ã«ã®30ééïŒ ãè¶
ããªãéã奜ãŸããã¯20ééïŒ ä»¥äžééæ··åç©äž
ã«å°å ¥ããŠããããå ·äœäŸã¯ (a)â² çŽéã¢ãããã³ããªããã«ãšãŒãé¡ãäœã
ãããã¯ãããã²ã«ã«æ¥éã«å æ°Žå解ããæ§è³ª
ãäžããåŸåãããã (b)â² å°ãªããšãäžçš®ã®ïŒãŸãã¯ïŒâå¡ãªããµãŸ
ãã¯ãã¢â眮æç°ãäŸãã°ã¢ããŸãã¯ããªãšã
ãã·ãé¡ (c)â² ïŒâå¡ç°ãæããã©ã¯ãã³é¡ (d)â² ãã¬ã€ã³é žç¡æ°Žç©ãå å«ããç°åŒèèªæç¡
æ°Žç©é¡ (e)â² èèªæã¢ã«ãããé¡ (f)â² ãã«ãã©ãŒã«ããã³ãã«ãã©ãŒã«ã¢ã«ã³ãŒ
ã« (g)â² ã¢ãããã³ããªããã«è³éŠæçåæ°ŽçŽ é¡äŸ
ãã°ã¹ãã¬ã³ãã¢ã«ãã«ã¹ãã¬ã³ããã³ãžãã
ã«ãã³ãŒã³ çãããã ãããã®ååç©ã®å šãŠã¯é¡åŸ®é¡ççžåé¢ã«ãã
匷åçµæç©ãæäŸãåŸãããã®æ§ãªååç©ã®æ··å
ç©ã䜿çšããŠãããã æ¬æ现æžã«ãããŠãçšèªããã€ããã²ã«ãã¯æ°Ž
æ§åªäœã«ãã€ãŠèšæœ€ããããªããŒãæå³ããæªèš
最ã也ç¥ç¶æ ãèšæœ€ãŸãã¯æ¹¿æœ€ç¶æ ã®ãããã®ã
ãªããŒã«ã€ããŠãçšããããã 也ç¥ãã€ããã²ã«ã¯çµæ¶æ§ã瀺ããŠããããå
è¿°ã®ããšããããã¯èŠªæ°Žæ§ããªããŒïŒïŒãåœé
1000以äžã奜ãŸããã¯2000以äžã®ããªïŒãšãã¬ã³
ãªãã·ãïŒãå«ãå Žåã§ããããã®ãã€ããã²ã«
é¡äžã®åŸ®çµæ¶ã®ååšã¯äžèšã®ããšã«å ããŠã也ç¥
ãã€ããã²ã«ãŸãã¯èšæœ€ãã€ããã²ã«ã®åŒ·åºŠã«ã
ãéèŠãªè²¢ç®ãããã æ¬çºæã®ãã€ããã²ã«ã¯æãŸããã¯â120âã
ãïŒ15âã®ã¬ã©ã¹è»¢äœæž©åºŠãæãã也ç¥æïŒ10â
ããïŒ60âã®åŸ®çµæ¶èç¹ãæããã æ¬çºæãã€ããã²ã«ã¯æ¯æããããããã¯æ¯æ
ãããŠããªããã€ã«ã ãšããŠäœ¿çšããŠããããå
è ã®å Žåãæ¯æäœã¯äŸãã°ãã€ãã³çã®é£ç¶ã
ãã奜ãŸããã¯éæã®è£åŒµãæãŸãã¯ã¡ãã·ãŠã§
ãã€ãŠããããã®ãŸããã§ãã€ããã²ã«ãéåã
ããé¡åŸ®é¡ççžåé¢ã«ãã€ãŠåŒ·åãããã€ããã²
ã«ã®å Žåã¯ç¹ã«ãã€ã«ã ãæ¯æããªããŠãããã ãã€ããã²ã«ã¯ãŸãç¹ç¶ãšããŠçŽ¡ãç¹åžã«ç¹ã€
ãŠãããã æåŸã«ããã³æã奜ãŸããã¯ãã€ããã²ã«ã¯ç²
æ«ãšããŠäœ¿çšããŠãããããã®ç²æ«ã¯æã ã®è±åœ
ç¹èš±åºé¡ç¬¬8138713å·ã«é瀺ãããŠããããšãé
åã«ãããŠãããªãã«åœ¢æããŠããããããã¯å
è±åœç¹èš±åºé¡ç¬¬8118087å·ã«èšèŒããããšã圢æ
åŸã«ç²ç ããŠãããã æ¬çºæã®å¥ã®ç¹åŸŽã¯æŽ»æ§ç©è³ªãç¹ã«çç©åŠçã«
掻æ§ãªç©è³ªäŸãã°è¬ç©ïŒmedication systemïŒã
å«ãæŸåºèª¿ç¯çµæç©ããã³ããã«èšèŒã®ãã€ãã
ã²ã«ãå«ããã€ãªã€ãŒãæäŸããã è¬ç©ãšã¯äºé²ãŸãã¯æ²»çã®ããã«ã€ã³ããã«äŸ
絊ãããã®ãæãŸããå šãŠã®ççåŠçã«æŽ»æ§ãªç©
質ãæå³ããã æ¬çºæã¯æŽ»æ§ç©è³ªã®è£œå€ã«åºãé©çšæ§ãæãã
ç¹ã«ãéå®çã§ã¯ãªãããäžå®ã®é床ã§çç©åŠç
ã«æŽ»æ§ãªç©è³ªãæŸåºãåŸã補å€ã«é©çšãåŸããæ¬
çºæã®æ¯æãããæŸåºçµæç©ã«å°å ¥ããŠãããç
ç©åŠçã«æŽ»æ§ãªç©è³ªã®çŸ€ã®äŸã¯éŠæãå»è¬ãéè
å€ãéŠå³æãè¬ç©ãå¶èå€ããŠã€ã«ã¹æ²æ» å€ããŸ
ã殺è«å€ãç·è«æ²æ» å€ãè»äœåç©æ²æ» å€ã幌è«æ²
æ» å€ãªã©ã®è«æ²æ» å€ããããŠé€èå€ã殺èå€ã殺
è»å€ãå±æè¬ãããã¯ç®èç æ²»çè¬ãæµ·æŽçç©ä»
çé²æ¢å€ãé µçŽ ã®ãããªèçœè³ªãããããã埮ç
ç©ãæ€ç©æ°Žæ§å¹é€å¡©åïŒplant hydroculture
saltsïŒãæ é€çŽ ãé²è å€ãç£å»çšãã¬ãŒã¹éå±é
åç©ïŒveterinary trace metal formulationsïŒã
ããã«ä»ã®èŸ²æ¥çšæé·ä¿é²å€ïŒããšãã°æ貧è¡
è¬ãååã¹ããã€ããªã©ïŒçã§ããã ç¹ã«èå³ããæ¬çºæçµæç©ã¯çç©åŠç掻æ§ç©è³ª
ãšããŠå°ãªããšãäžçš®ã®å»è¬ãå«ããã®ã§ããã åŸã€ãŠãæ¬çºæçµæç©ã¯ç£å»ãå«ãå»åŠãå€
ç§ãã³ã³ããã¯ãïŒcontextsïŒãåèžããã³èŸ²æ¥
ãªãã³ã«ãããã®é åå€ã®ãã®ã«åºãé©çšããã
ãšããããã ãã®æŽ»æ§ç©è³ªã¯ãã°ãã°ããçšåºŠã®æ°Žæº¶æ§ãæ
ãããã氎溶æ§ã§ããå¿ èŠã¯ãªãïŒ å¿ èŠãªå šãŠã®ããšã¯æŽ»æ§ç©è³ªããããå æ°Žå解
å¯èœãªãã€ããã²ã«ãã€ãªã€ãŒäžã«å°å ¥ããéã
ãã®ãã€ãªã€ãŒãèšæœ€ããããã«äœ¿çšããæ°ŽãŸã
ã¯ææ©æº¶å€ã«æ¬çºææŸåºèª¿ç¯çµæç©ã«å¿ èŠãªæ¿åºŠ
ã«çžåœããé溶解ããããšã§ããã æ¬çºæã®æŸåºèª¿ç¯çµæç©äžã«çšããŠãããå žå
çãªäŸã¯ ããã¹ã¿ã°ã©ã³ãžã³ã®ãããªå èè¬ãå¬ç è¬ã
é®éå€ããã©ã³ãã©ã€ã¶ãŒãäžç±è¬ãæççè¬ã
æãã¹ã¿ãã³å€ãé®å³é®åœè¬ãæçæ£è¬ãçåŒç·©
å€æè «çå€ïŒäŸãã°æªæ§è «çãæ²»çããè¬ç©ïŒã
å±æ麻é å€ãããŒãã³ãœã³æ°ç æ²»çè¬ãå±æãã
ãã¯ç®èç æ²»çè¬ãå©å°¿è¬ïŒäŸãã°ãšãŠåã«ãªãŠ
ã ã®ããã«ã«ãªãŠã ãå«ãè¬ç©ïŒã粟ç¥ç æ²»çè¬
ïŒäŸãã°èºãã€ç æ²»çã«çšãããªããŠã å«æ補å€ã
ãããã¯ç²Ÿç¥åè£ç ã«çšããããã¹ã¿ã°ã©ã³ãžã³
å«æ補å€ïŒãæçæ£è¬ãæ朰çè¬ãæèå€ãå«ã
ãŠç åäœäŒææ²»ççšã®çš®ã ã®ç©è³ªãå«æãã補å€
ïŒäŸãã°åå®®è¬ïŒmetronidazoleïŒãé§è«è¬ãããŠ
ä»ã®æ®ºèå€ïŒãæãã©ãªã¢å€ãå¿èè¡ç®¡çšè£œå€ã
ãã«ã¢ã³å«æ補å€ïŒäŸãã°ç·æ§ãã«ã¢ã³
ïŒandrogenïŒãçºæ ãã«ã¢ã³ïŒestrogenïŒãããŠ
é»äœãã«ã¢ã³ïŒprogesteroneïŒãå«ã補å€ïŒã女
æ§ãã«ã¢ã³ã®ãããªæçœãªã¹ããã€ãã亀æç¥çµ
è奮å€ãäœè¡ç³çå€ãåŠåš 調ç¯å€ãæ é€å€ãçš®ã
ã®ã¿ã€ãã®å¹æã瀺ãé µçŽ ãå«æãã補å€ïŒäŸã
ã°ãã¢ããªãã·ã³ãå«ã補å€ïŒãé®çå€å«æ補å€
ïŒäŸãã°ã¢ã¹ããªã³ïŒããŸãç·è«æ²æ» å€ãä»ã®ç£å»
åŠçšè£œå€ãå«ã¿ããã®ä»ã®å€ãã®ã¿ã€ãã®å¹æã
瀺ãè¬åãããã æ¬çºææŸåºèª¿ç¯çµæç©ã¯æŽ»æ§ç©è³ªãšããŠå°ãªã
ãšãäžçš®ã®å€©ç¶ãŸãã¯åæã¹ããã€ãæ§ãã«ã¢ã³
äŸãã°ãšã¹ããã²ã³ãŸãã¯ããã²ã¹ãã²ã³ãé©åœ
ã«å«ãé¿åŠçšçµæç©ãšããŠäœ¿çšããŠãããã奜ãŸ
ããããã²ã¹ãã²ã³é¡ã¯å€©ç¶ããã²ã¹ããã³ãã
ã³åæåæäœãäŸãã°11âããããããã²ã¹ãã
ã³ããã©ã«ãã³ã21âãã«ãªãâ17âã¢ã»ããã·
âïŒâã¡ãã«ããã²ã¹ããã³ãé ¢é žã¡ãããã·ã
ãã²ã¹ããã³ãé ¢é žã¡ã²ã¹ãããŒã«ãé ¢é žã¯ãã«
ããžãã³ããšãã¹ããã³ããžã¡ãã¹ããã³ãâ
ãã«ããã²ã¹ããã³ã19âãã«ããã²ã¹ããã³ã
21âãã«ããã²ã¹ããã³ããã«ã¡ã¿ã³ããã³ãã
ã«ãšãããã¬ã«ããã«ãšãã³ããã³ãšãã®é ¢é ž
å¡©ãDLâããã³ïŒ€âãã«ãžãšã¹ãã¬ã«ããã«ãž
ãšã¹ããªãšãã³ãäºé ¢é žãšãããžãªãŒã«ããªã³ã¹
ãã¬ããŒã«ããšããã«ãšã¹ãã©ãžãªãŒã«ããªãã
ããã²ã¹ããã³ããã€ããã²ã¹ããã³ããã«ãã€
ããã¬ã«ãé ¢é žãã³ã°ãšã¹ãã©ããŒã«ããã«ãšã
ã¹ããã³ãšãã®é ¢é žå¡©åã³ãšãã³ãã«é žå¡©ãé ¢é ž
ã¢ãã²ã¹ããã³ãã¡ããã²ã¹ãã³ãã¯ããã²ã¹ã
ã³ãã¢ãªã«ãšã¹ãã¬ããŒã«åã³ã¢ãªã«ã·ã³ã²ã¹ã
ãŒã«ããããããããããã²ã¹ããã³ã奜ãŸã
ãã çºæ ãã«ã¢ã³ïŒãšã¹ããã²ã³ïŒãšããŠã¯ã倩ç¶
ã®Î²âãšã¹ãã©ãžãªãŒã«ãåã³ãã®åæé¡äŒŒç©
ïŒäž»ãšããŠãšããã«ãšã¹ãã©ãžãªãŒã«ãããã¯ã¡
ã¹ãã©ããŒã«ãªã©ïŒïŒÎ²âãšã¹ãã©ãžãªãŒã«ã®æ¹
ããã奜ãŸãããïŒãªã©ãé©åœã«ãããããã æ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ç³å°¿ç ãæªæ§è²§è¡ã®
åŠçœ®ã«ãæçšã§ãããããã§ã¯äŸãã°ã€ã³ã·ãŠãª
ã³ããã³ã³ãã©ãã³ã®æŸåºã®èª¿ç¯ã«ããããå©çš
ããŠãããã ããã«æ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ç±åž¯æ§çŸç ã
äŸãã°ãã©ãªã¢ãç©ãäœè¡åžè«çããã³èåžè«ç
ã®äºé²ããã³æ²»çã«ç¹ã«é©ããŠãããæ¬çºæã«ã
ãæŸåºçµæç©äžã®çç©æŽ»æ§ç©è³ªããããã¯ä»ã®ç±
垯æ§çŸç ã®åŠçã«äœ¿çšãåŸãè¬å€ã®äŸãšããŠã¯ã
ãã³ãã¹ã«ãã³ã¢ããé¡ããªãã¢ã ã·ã³ãã¯ãã
ã¢ãžãã³ããã¢ã³ããã·ã³ãã¯ãã«ããšãã«èªå°
äœãã¯ãã«ã°ã¢ãããã·ã¯ãã°ã¢ãã«ãããªã¡ã¿
ãã³ãã¹ã«ãã¢ãžã¢ãžã³ãããªã¡ãããªã ããã
ãªã³èªå°äœãäŸãã°ãããã³ãã¯ãããã³ããã³
ã¿ãã³ãããªããã³ããã³ã¢ã¢ãžãã³ããã©ããµ
ããªã³ãã¹ã«ãã¢ã¡ããŸãŒã«ãããã¯ãªã³ããã
ãœã³ããœãžãŠã ã¹ã«ãããœã³ãã¹ã«ããšããã³ã
ãœãžãŠã ã»ãããã«ã«ãã€ãããã³å€§é¢šåé žãã
ãªãŠã çããããç¹ã«æå¹ãªè¬å€ã¯ã·ãã°ã¢ã
ã«ãããªã¡ã¿ãã³ããã³ã¹ã«ãã¢ãžã¢ãžã³ã§ã
ãã æ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ç£å»è¡ãžã®é©çšã«ã
é©ããŠãããäŸãã°éåžžã®æè掻æ§ã®ããã®ãã
ãã³ä»çã®ã¢ããã©ãºãææç ã®åŠçœ®çšæèå€ã®
調補ïŒå€éšå¯çäœãäŸãã°ç¯è¶³åç©ãçºè²ã®åæ¢
ãã幌è«æ®µéã®ããããŒããã©ã³ã°ãŠãªãŒã
ïŒlungwormsïŒãäžè¬ã®ã¹ããã³ã®ã«ã¹é¡ãå«ã
å€éšå¯çäœããã³çœè»é¡ã®äž¡æ¹ã«å¯ŸããŠåºç¯å²ã®
掻æ§ãæäŸããããã®èª¿è£œïŒãããã¯ã¢ãã«ã¡ã¯
ãã³é¡ãå«ãã§ããŠãããïŒãã¬ã¢ããŒã
ïŒtremotodeïŒãã»ã¹ããŒãããã³åè«
ïŒroundwarmïŒææã«å¯Ÿãã掻æ§ã®æäŸçšèª¿è£œïŒ
ãããã¯ã¢ã¢ã¹ã«ããŒãããã³ãã©ãžã«ã³ãã«ã
å«ãã§ããŠãããïŒä»çäžã®ã¿ã€ã¬ãªã¢ã«å¯Ÿã掻
æ§ã®æäŸçšèª¿è£œïŒããã¯ã¡ãã¯ãã³ã®ããšãçç©
åŠçã«æŽ»æ§ãªãããããã³é¡ãå«ãã§ããŠãã
ãïŒä»çã銬ããã³ç¬ã®ããã·ãªã·ã¹ã«å¯Ÿãã掻
æ§æäŸçšèª¿è£œïŒããã¯ãã¬ãã«ãã¢ããã«ãŒãã
ãã³ãžã¢ã³ããã³ãå«ãã§ãããïŒçŸããã³ä»çŸ
ã®èåžè«é¡ããã³ãã¢ã³ã«ã³ïŒHaemonchusïŒçš®
ã«å¯Ÿãã掻æ§ã®æäŸçšèª¿å€ïŒããã¯ã¯ããµã³ãã«
ãå«ãã§ãããïŒãå å«ãããã ãã®æŽ»æ§ç©è³ªã¯åæ£ç¶æ ã§ãããšå ±ã«ãã€ãªã€
ãŒäžã«æ··åããŠããããããã奜ãŸããã¯ããã
é©åœãªç©çç圢ç¶ã«æåããåŸããã€ãªã€ãŒäžã«
å°å ¥ãããåŸã€ãŠéåžžã®çç©åŠçã«æŽ»æ§ãªç©è³ªã®
å°å ¥æ³ã¯é©åœãªç©çç圢ç¶ã§ãã€ãªã€ãŒã溶液
ïŒæ°Žæ§ã§ãã€ãŠãããïŒãçšããŠèšæœ€ããããšã§
ãããããããªãããç¹ã«ãã容æã«å æ°Žå解ã
ããã€ãªã€ãŒã§ã¯ææ©ã®èšæœ€å€ãçšããã®ã奜ãŸ
ãããææ©èšæœ€å€ã®äœ¿çšã¯ãã°ãã°æŽ»æ§ç©è³ªã溶
解ããããã«ãå¿ èŠã§ãããããã«ãããã¯æ°Žæ§
åªäœãè¶ããèšæœ€æ§ãåããããšãã§ããããã
å Žåã«ã¯ãå®å šã«éæ°Žæ§ã®ææ©æº¶å€ãäŸãã°ã¯ã
ããã«ã ããšã¿ããŒã«ïŒã¯ãããã«ã ãããã©ã
ããããã¿ã¬ã³ãããããã³ãŒã³ãå®æ¯éŠé žã¡ã
ã«ããããã©ã¯ãã³ãŸãã¯ãã³ãžã«ã¢ã«ã³ãŒã«ã
çšããŠããããèšæœ€ããã³æŽ»æ§ç©è³ªã®åžååŸãæŸ
åºèª¿ç¯çµæç©ã也ç¥ã溶å€ãé€å»ããããããã
ã¯èšæœ€ç¶æ ã§äœ¿çšããŠããããèšæœ€å·¥çšãç¹ã«èš±
容ãããããšã®å®¹ç©ã«å¯Ÿããèšæœ€æ¯ã¯ãããã䜿
çšå也ç¥ããããšããŠããã€ã³ããã«ãããæŸåº
çµæç©ã®ãã®åŸã®æåã«æ¥µããŠéèŠãªåœ±é¿ãæã
ããåŸã€ãŠã奜ãŸããã¯çç©åŠçã«ã¯æŽ»æ§ãªç©è³ª
ã®å°å ¥äžã®èšæœ€ã®çšåºŠã¯ããšã®ä¹Ÿç¥å®¹ç©100éšåœ
ã150ã700éšãç¹ã«200ã500éšã§ããã åè¿°ã®ããšãã䜿çšãããã€ãªã€ãŒã¯ãã€ãã
ã²ã«ã§ãã€ãŠãããã¯åæ也ç¥ç¶æ ã§ãããã¯å
æèšæœ€ç¶æ ã§äœ¿çšããŠããããããããã®å Žåã§
æŸåºã®ã¢ãŒãã¯ç°ãªãã也ç¥çµæ¶ã²ã«ã¯èšæœ€æã«
ããããŽã ç¶ã²ã«ãäžè¬ã«ã¯æããªãç¹æ®ãªæ§è³ª
ãæãããäŸãã°äœæ¶²ã«ããã²ã«ã®ã·ãªã³ããŒç¶
ãããµãªãŒããèšæœ€ãŸãã¯ãŽã ç¶ã®å€æ®»ãçµæ¶ç©
質ã®åšå²ã«åœ¢æããããããã¯ããç¹æ®ãªå©çã
ããããããŸããŽã ç¶ã²ã«ã§éåžžèŠãããããªã
æ¥éãªææ°ãŸãã¯t-1/2ã®æžå°ã«æ¯ã¹ãé·æéã«ã
ãã€ãŠéåžžã«åäžãªç©è³ªã®æŸåºãäžè¬ã«éæãã
ããããã«æŽ»æ§ç©è³ªãåªãã氎溶æ§ãšæ¯èŒçå°ã
ãååéãæããŠãããšãã¯æŸåºã®ãã¿ãŒã³ãçŽ
ç²ãªïŒentireïŒæŸåºçµæç©ã®æ§è³ªããããããã€
ãªã€ãŒã®æ§è³ªã«ãã€ãŠéåžžã«å€§ããã³ã³ãããŒã«
ããããã®çµæãç¹å®ã®æŸåºé床ãåŸãããã®æŸ
åºçµæç©ã®èª¿å€ã¯ããªãåçŽåãåŸããäœã氎溶
æ§ããã³ïŒãŸãã¯é«ãååéã®æŽ»æ§ç©è³ªã®å Žåã«
ã¯æŸåºã¯åã ã®ç©è³ªã«ããäŸåããã§ãããã ããããªãããé©ãã¹ãããšã«ãæ¬çºæã®å®å š
ã«èšæœ€ãããã€ããã²ã«ã¯æŽ»æ§ç©è³ªã®åæ倧æŸåº
ã®åŸã«åäžãªæŸåºãäžããããšãããã€ãããã®
ããšã¯å€ãã®è¬ç©å°±äžãé«ãæ²»çææ°ã®è¬å€ã«ã
ããŠé«ãå©çãããã 湿最ã²ã«ã¯æŽ»æ§ç©è³ªã貯èµãã枩床ãããã®äž
æã®çµæçããã€ã³ããã§ã®ãã©ã¹ã®äœçšã«ãã
æŸåºçµæç©ãã掻æ§ç©è³ªãæåºããããšã«ããã
ããã³ãã®çµæãšããŠã®ãã€ãªã€ãŒããã®æŸåºæº¶
å€ããã³æŽ»æ§ç©è³ªã®é¢æ¶²ã«ãã€ãŠæ©èœãæããŠã
ããããã®ããšã¯ãã€ãªã€ãŒã䜿çšãã枩床以äž
ã®æž©åºŠã§ã®æŽ»æ§ç©è³ªã®å°å ¥ããã³æŸåºèª¿ç¯çµæç©
ã®è²¯èµãå¿ èŠãšãããã®ãšè§£ãããããã®æ§ã«æŽ»
æ§ç©è³ªãå»è¬çšã§ãããšãããã€ãªãŒã¯äŸ¿å®çã«
ã¯20âãªãããã以äžãäŸãã°ïŒâãªããâ19â
ã®æž©åºŠã§ææçšåºŠã®æŽ»æ§ç©è³ªã®åžåããã³èšæœ€ã
éæããå»è¬æº¶æ¶²ã§åŠçããŠãããããã®æ§ã«åœ¢
æãããæŸåºçµæç©ã®æ£è ãžã®æäžã¯ãã®æž©åºŠã
äœæž©ãŸã§é«ãïŒäººéã§ã¯çŽ37âïŒã次ãã§ããªã
ãŒã®åçž®ã§æº¶å€ããã³æŽ»æ§ç©è³ªã®æåºãçããã
èšæœ€ã²ã«ã®å®å®æ§ã«é¢ããŠééãããããªãå Žå
ã§ãã䜿çšåçæéã«èšæœ€ãéæããããšãå¯èœ
ã§ããã æ¬çºæã¯ããã«ãã枩床ã§æŽ»æ§ç©è³ªãå«ã液ç¶
åªäœã§ãã€ãªã€ãŒãèšæœ€ããããšã«ãã該ãã€ãª
ã€ãŒã«æŽ»æ§ç©è³ªãå°å ¥ãã次ãã§ã第äºã®ããé«
ã枩床ç°å¢äžã§èšæœ€ãã€ãªã€ãŒãå©çšããŠã該èš
最ããªããŒãã掻æ§ç©è³ªãšæ¶²ç¶åªäœã®æåºãçã
ãããæ¹æ³ã«é¢ãããããã«æ¬çºæã¯äººãŸãã¯å
ç©ã®æ£è ã«çç©åŠçã«æŽ»æ§ãªç©è³ªãšãã€ãªã€ãŒãš
ãå«ãçµæç©ïŒè©²çµæç©ã¯çµæ¶ããã³ïŒãŸãã¯èš
最åã§ããïŒãæäžããããšãç¹åŸŽãšããã 掻æ§ç©è³ªã®ç©çç圢æ ãå«ããŠããã€ãªã€ãŒäž
ã«çç©åŠçã«æŽ»æ§ãªç©è³ªãå°å ¥ããããã«äœ¿çšã
ãæ¹æ³ã®è©³çŽ°ãªæ æ§ã¯ææã®æŸåºç¹æ§ãåŸããšäº
ã芳ç¹ããé©åœã«éžæããã°ããã第ïŒã®ç®æšã¯
é©åœãªæéå ã«èª¿ç¯ããæŸåºãéæããããšã§ã
ãã䟿å®çã«ã¯æŽ»æ§ç©è³ªã®å€§éšåãäŸãã°80ïŒ ãª
ãã90ïŒ ãéããããããšã§ãããå®è³ªäžäžå®ã®
å²åã§ã®æŸåºãå³ã¡ã»ãŒçŽç·ç¶ã®æŸåºã¯ããå Žå
ã«ã¯é©åœãªç®æšã§ãããå¹³æ¿ç¶ãŸãã¯å¹³åŠãªã·ãŒ
ãã®ãšããæ¬çºæãã€ããã²ã«ã«ããããªãã®çš
床ãŸã§éæãããã ããããªããéåžžã§ãªãæŸåºãããã¢ã€ã«ã¯é
æŸãã€ããã€ãŒãäŸãã°äžãªãããã以äžã®åã
窪ã¿ãæããäžç©ºã·ãªã³ããŒãŸãã¯ã¹ã©ããæã
ããã€ãªã€ãŒã䜿çšããããšã«ããåŸãŠãããã
ãã®æ§ãªéåäœãã€ãªã€ãŒã®æŸåºãããã¢ã€ã«ã¯
çµæçã«æ倧䟡ãéãããšãããã€ãããã®æ§ãª
幟äœåŠçæŸåºèª¿ç¯ãããã¢ã€ã«ã¯æ¹è¯æŸåºããã
ã¢ã€ã«ãåŸããã³èª¿ç¯ããä»ã®éåžžã«æçšãªæ段
ãæäŸããã ããããªãããä»ã«ãæ¬çºæã«çšãããã奜ãŸ
ãããã€ãªã€ãŒã¯é«èšæœ€é åã«ãããŠã§ããã ã
é·æéã«ããã€ãŠã»ãŒçŽç·ç¶ã®æŸåºé床ãç¶æã
ãå©ããšãªãæåã瀺ãããšãããã€ããå³ã¡ã
é©ãã¹ãããšã«ãã®ãã€ãªã€ãŒã¯ãäžåºŠçŽ10åã®
ãã¢ã¯ã¿ãŒã§èšæœ€ãããšãå žåçã«ã¯çŽïŒåã®èš
最ã¬ãã«ã«èªç¶åçž®ããããšãããã€ãã䜿çšäž
也ç¥ãã€ãªã€ãŒãèšæœ€ããããããã¯æ¹¿æœ€ãã€ãª
ã€ãŒãããã«èšæœ€ããããã掻æ§ç©è³ªã®æŸåºé床
ãäžåºŠäœäžãå§ãããšããããã«ãããã®é床ã
ããæŒãããã ããã«ãã€ããã²ã«ã®å æ°Žå解ã¯çŽç·ç¶æŸåºé
床ã®æç¶æ§ãŸãã¯å æ°Žå解ãæ¥éã«è¡ãªããããš
ãã¯æŸåºé床ã«ãããåææ倧å€ã«è²¢ç®ããã§ã
ãã掻æ§ç©è³ªã®æŸåºã®å¢å ãããããã æ¬çºæçµæç©ã®å»çãžã®å©çšã®ããåéãäŸã
ã°ãã«ã¢ã³ãçš®ã ã®æ¡ä»¶ã§ã®åŠçããã³äºé²çšè¬
å€ãäŸãã°ç åæ§åŸ®çç©ã«å¯Ÿãã掻æ§ãæããç©
質ã¯ç¹ã«è©²æŽ»æ§ç©è³ªã®è£ãŸãã¯çŽè žæäžã«ç¹ã«é©
ããŠããããããµãªãŒã¯ãã®æ§ãªçšéã«ç¹ã«æãŸ
ãããããããªããçµæç©ã¯äœã®ä»ã®éšåã®å±æ
æäžãäŸãã°å£è ãçŒã®ç æ°ãäŸãã°ç·å éã«äœ¿
çšããŠãããããã®çµæç©ã¯ãŸãçµå£æäžãŸãã¯
æ²»çããããã¯ç®èã«ãã€ãŠåžåãããè¬å€ãæŸ
åºããããã®å±éšãããããã³æ³šå ¥
ïŒimplantarionïŒã«ãã€ãŠäœ¿çšããããã«å©ç¹ã
ããã 湿最ããªããŒã»ãã€ãªã€ãŒããã®æŸåºã¢ãŒãã¯
ããçš®ã®ç¹å¥ã®çšéã«çšããŠãããããšãæå³ã
ãŠãããäŸãã°è¬å€ãæ¯æ¥å°éäœå ã«æŸåºããå¿
èŠã®ããç æ°ã®æ²»ççã§ããã人ã®äœæž©ã¯äžæ¥ã
éããŠå€åããŠãããäžè¬ã«ãµã€ã¯ã«ã圢æããŠ
ãããããªããŒã®èšæœ€ã®çšåºŠã¯æž©åºŠã«äŸåããŠã
ãã®ã§ãã®äžã«åžåãããé©åœãªè¬å€ã®æº¶æ¶²ãæ
ããèšæœ€ããªããŒã®ãã€ãªã€ãŒãäœã«æ€ãã€ããŠ
ããããããªããŒã¯äœæž©ã®å€åã«å¿çããŠåçž®ã
ãããèšæœ€ããããããåçž®æéäžãå³ã¡æŽæµæž©
床æéäžãåžåããè¬å€ã®å¢å éšåã¯ããªããŒã®
ãã€ãªã€ãŒããè¡æ¶²æµäžã«æŸåºãããè¬å€ã®æ¯æ¥
ã®ãµã€ã¯ã«æäžãæäŸããã æ¬çºæã®æŸåºèª¿ç¯çµæç©äžã«å°å ¥ããã掻æ§ç©
質ã®æ¿åºŠã¯éåžžã«é«ãããäœãç¯å²ããšãåŸãã
åŸã€ãŠãããäŸãã°1000pph以äžã«ããªããŒãèš
最ããïœâã¯ã¬ãŸãŒã«ã®ããšã液ç¶ã®çç©åŠçã«
掻æ§ãªç©è³ªãããªããŒãèšæœ€ããããã«äœ¿çšãã
ãšãã¯æŽ»æ§ç©è³ªã¯æŸåºçµæç©ã®90ééïŒ ä»¥äžå«ã
ããšãã§ããã1000pphã«èšæœ€ãã25ïŒ ã®è¬å€ã
å«ã液äœã¯ä¹Ÿç¥ããªããŒäžã«70ïŒ ä»¥äžã®è¬å€ãæ®
ãåŸãã30ã70ïŒ ã®è¬å€ãå«ãŸãããšã¯ããæ®é
ã«ãªãåŸãããšã§ãããããã«äœãè£ å¡«ãäŸãã°
1.0ã0.5ïŒ ã容æã«éæãåŸãã é«åºŠã®ããªããŒèšæœ€ïŒããã¯å¯èœã§ããïŒãšèª
ç¶ãªäœæž©ãµã€ã¯ã«ã§çãã枩床ã®åŸ®ããªçžç°ã¯å°
éã®è¬å€ãé·æéã«ããã€ãŠæ¯æ¥äœå ã«æŸåºãã
ãããšãå¯èœã«ããåŸã€ãŠãã®ããšã¯äŸãã°æ°Žæº¶
æ§ã®äœãé·æäœçšåé¿åŠè¬çã®é åã§èå³æ·±ãã 湿最ããªããŒã®å¥ã®å¿çšã¯å»è¬åéå€ã«ãã
ããäžã€ã®èŸ²æ¥çšçšéã¯è²¯èµç§èã®éé µã®æå¶ã«
ããããã®éé µã¯é«æž©ã§ä¿é²ãããã®ã§ãäžææž©
床ã§æŽ»æ§åãããæå¶å€ãæãŸããããã掻æ§ç©
質ãšããŠéé µæå¶å€ãå«ãèšæœ€ããªãšãã¬ã³ãªã
ã·ããåšå²æž©åºŠãäœãæã«è²¯èµç§èäžã«æ³šå ¥ãã
ãšã枩床ã®äžæã¯ããªããŒãåçž®ãããŠæå¶å€ã
æŸåºã貯èµç§èã®éé µãé²æ¢ãŸãæå¶ããã ããªããŒã®èšæœ€ã®æž©åºŠäŸåæ§ã¯ãŸã埮éæåã
å¿ é æè²æåã幎ãŸãã¯æ¥ãããšã«ããŠåå£äžã«
æŸåºãããã®ãå¯èœã«ããå€ã®æž©åºŠã®äžæã«ã€ã
ãŠãèšæœ€ããªãšãã¬ã³ãªãã·ãã«ãåžåããã埮
éæåãçè²æå溶液ãæŸåºããããåŸã€ãŠæ¬çº
æçµæç©ã§ã®åå£ã®åŠçã¯éé¢æ¶²æ©æ§ã§çããæŸ
åºã®çšåºŠã«ããããæ°å¹Žã«ããã€ãŠæå¹ã§ããã æ¬çºæçµæç©ã®ä»ã®çšéã¯æŒã®æž©åºŠã®äžæã®çµ
æãšããŠæã¹ã©ã€ã å€ïŒãŸãã¯æ®ºè»å€ïŒã®é©çšã«
ããã¹ã€ãã³ã°ã»ããŒã«ã®è»ã®ããšãã¹ã©ã€ã ã®
圢æã®é²æ¢ãããã³è²¯èµéåæ§ã¢ãããŒäžã®æž©åºŠ
ã®äžæã«å¿çããéåæå¶å€ã®æŸåºã«ããéåã®
æå¶çãããããããã®å Žåãèšæœ€ããªãšãã¬ã³
ãªããµã€ãäžã«åžåããã掻æ§ç©è³ªã¯ããããæ
ã¹ã©ã€ã å€ïŒãŸãã¯æ®ºè»å€ïŒããã³éåæå¶å€ã§
ãããæ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ä¹Ÿç¥ç¶æ ã§çµæ¶
ãããªãã¯ã¹äžãžã®å°å ¥ã«ããäœçœ®çã«äžå®å®ãª
ååç©ã®è²¯èµå®å®æ§ã«ãããŒãå¹æã«é¢ããŠãé
èŠã§ããã 掻æ§ç©è³ªã®åœ¢æã«ãããŠæ¬çºæã«äœ¿çšãããé
åãã€ãªã€ãŒã®äžè¬çãªå©ç¹ããæ¬ç®çã®ããã«
åœè©²æè¡åéã«ãããŠèšèŒãããŠããä»ã®ããªã
ãŒé¡ãšæ¯èŒããŠä»¥äžã«èŠçŽããããã®ããªããŒã¯
éçŽç·ç¶ã§ãæ¶æ©ãããæ¬è³ªçã«æ°Žããã³ææ©æº¶
å€ã«äžæº¶æ§ã§ããé«åœéç³»ïŒhigh equivalent
weight systemsïŒã§ãããæ°Žããã³é氎系溶å€
ã®äž¡æ¹ã§é«åºŠã®èšæœ€æ§ã瀺ãã也ç¥ããã³æ¹¿æœ€å
äž¡æ¹ã§åŒ·é±ãªç©è³ªã圢æããïŒäœãåŸè ã®å Žåã
ããå°ããç¯å²ã«ãªãïŒãéåãã€ãªã€ãŒã¯ãŸã
也ç¥ã²ã«äžã«ååšããçµæ¶å床ãŸãã¯æ¹¿æœ€ããªã
ãŒã§åŸãããé¢æ¶²å¹æã®ããããã§æå¶ããã奜
ãŸããæŸåºãããã¢ã€ã«ã瀺ãã åŸã€ãŠæ¬çºæã¯ããã«æŽ»æ§ç©è³ªããã³ãã®ãã
ã®éåãã€ãªã€ãŒãå«ãæŸåºèª¿ç¯çµæç©ãå«ã¿ã
該ãã€ãªã€ãŒã¯ããªãšãã¬ã³ãªãã·ããå«ã¿ã也
ç¥åœ¢æ ã§é©åºŠã®çµæ¶å床ãæã湿最ç¶æ ã§é¢æ¶²ã
瀺ãããšãç解ãããã§ããããäžã§äœ¿çšããã
çšèªãé¢æ¶²ãã¯100âãããïŒâã«ãããæ¹ãæ°Ž
æ§åªäœäžã§å®è³ªçã«å€§ããèšæœ€ãè¡ãªãæ§è³ªãæ
å³ããŠãããçµæ¶å床ã¯ä¹Ÿç¥åã®æ£ç¢ºãªåæãè¡
ãªãå©ããšãªãã 以äžãå®æœäŸã«ããæ¬çºæã説æããã å®æœäŸ ïŒã37 ãããµã³âïŒïŒïŒïŒïŒâããªãªãŒã«ïŒHTïŒ
ãã¢ã«ããªãã瀟ïŒAldrich Chem.Co.ïŒåžè²©åã
宀枩ã§24æéç空也ç¥ãããã®ã2.443ïœãã觊
åªãšããŠã®ç¡æ°Žå¡©å第äºéïŒã¢ã«ããªãã瀟ã®åž
販åãã³ãŒã«ããã€ã³ã¬ãŒã³ã³ãã³ãµãŒå ã§æè¯
ãããããšã«ãã€ãŠããã«ç²Ÿè£œãããã®ïŒ0.5349
ïœãšããŒã«ãŒå ã§æ··åãããæ··åç©ã90âã§15å
éæŸçœ®ããæ°å¹³åååé3100ã®ããªãšãã¬ã³ãªã
ã·ãïŒPEOïŒããã€ãŒç€ŸïŒHythe Chemicals
Ltd.ïŒã®åžè²©åã也ç¥çªçŽ ããŒãžäžãç空ã§ïŒã
ïŒæé也ç¥ãããã®ã40ïœãå ããæªææ··åãã
æ··åç©ã90âã§15åéæŸçœ®ãããèžçããã¢ã¯ã
ã¬ã€ã³ããã©ããŒïŒC1ïŒãã«ããã€ã¢ã³ã»ã€ã³ã
ã¹ããªãŒãºç€ŸïŒCanadian Industries Ltd.ïŒã®æ
äŸåããæ·»å ããŠïŒåéæªæãããã¢ã¯ãã¬ã€ã³
ããã©ããŒã¯çªçŽ æ°æµäžã§ã®æžå§äžã§ïŒåèžçã
ããæåŸã®èžçã«ãããŠã¯ãæåã®çåïŒ10ïŒ ïŒ
ãšæåŸã®çåïŒ20ïŒ ïŒãé€ããäžéã®çåïŒæ²žç¹
78ã80âïŒãäžæŽ»æ§é°å²æ°äžã«æéãã䜿çšãã
ãŸã§ã¬ã©ã¹ã¢ã³ãã«ã«å°ã蟌ãã ãæ··åç©ã¯äºç±
ããããªãããã¬ã³è£œã¢ãŒã«ãå ã«æ³šã蟌ã¿ãæ
æ°ãã¢ã³ãåããéæ°å®€å ã«ãããŠ90âã§4.5æ
éä¿æããããšã«ãã€ãŠç¡¬åãããã å¡©å第äºé觊åªã®äœ¿çšéã¯åå¿æåã®å šééã®
0.1ïŒ ãšããããããµã³ããªãªãŒã«ã®äœ¿çšéã¯ã
ãªãšãã¬ã³ãªãã·ãã®1.394ã¢ã«åœéãšããã䜿
çšããã¢ã¯ãã¬ã€ã³ããã©ããŒã¯24ïŒ éå°ãšã
ãã ã¢ãŒã«ãããªãŒãã³ããåãåºãã宀枩ãŸã§å·
åŽããããããã²ã«ãã¢ãŒã«ãããåãåºããã¹
ã©ã€ã¹ãåãåããçµæ¶å床ãšæ°Žäžã§ã®ééå¢å
ã枬å®ãããïŒãã匟æ§ã®ãããã²ã«ã¯ã¢ãŒã«ã
ããåãåºãåã«â25âã§çŽïŒæéå·åŽãããïŒ çµæ¶å床ã¯è解ç±ã®æž¬å®ãã決å®ããïŒããªã
ãŒã®è解ç±ã¯çµæ¶å床ã«æ¯äŸããïŒããããã²ã«
ã®è解ç±ã¯åŸ®çµæ¶ãè解ããã®ã«å¿ èŠãªç±ã枬å®
ããããšã«ãã€ãŠæ±ºå®ããçµæ¶å床ïŒïŒ ïŒã¯ãå®
å šãªçµæ¶æ§è©ŠæããåŸãããå€ã«å¯Ÿãããã®å€ã®
æ¯ããèšç®ããããå®å šãªçµæ¶æ§è©Šæã¯å ¥æã§ã
ãªãã€ãã®ã§ãçŽç²ãªPEOã®è解ç±ãçšããã
ãã®å€ã¯ãã©ãŠã³ãã«ãã€ãŠ220.12Jg-1ãšæ±ºå®ã
ããŠããïŒBraun et al.Kolloid Zeit.第215å·»ã
第10é ã1967幎ïŒãã æå®éïŒçŽ10ã40mgïŒã®ãããã²ã«è©Šæã®è解
ãšã³ãã°ã©ã ïŒfurion endogramsïŒãç±åæåš
ïŒããŠãã³ç€Ÿè£œ910åããã³990åïŒãçšããŠïŒå
æããåã ã®è解ãšã³ãã°ã©ã ã®äžã®é¢ç©ããã©
ãã¡ãŒã¿ãŒãçšããŠæž¬å®ãããããŒã¯ã®äžã®æž¬å®
é¢ç©ã®å¹³åå€ããè解ç±ãèšç®ããã æ°Žäžã§ã®ééå¢å ã¯ãééãšåãïŒçŽ1.35±
0.2mmïŒãæ¢ç¥ã®è©Šæã¹ã©ã€ã¹ãèžçæ°Žäžã«æµžæŒ¬
ãã宀枩ïŒçŽ20âïŒã§çŽ24æéæŸçœ®ããããšã«ã
ã€ãŠæ±ºå®ãããã¹ã©ã€ã¹ãåãåºããæ°Žåããã
ã·ãŠãçšããŠåžåãã秀éããã å®æœäŸïŒã37ã¯ãããšå®è³ªäžåãæäœã§ãããª
ã€ãã觊åªãšããŠãã·ã«é žïŒtosylicacidïŒïŒïŒ°â
ãã«ãšã³ã¹ã«ãã³é žïŒïŒPTSAïŒããã€ãœã³ãºç€Ÿ
ïŒFisonsïŒããäžæ°Žåç©ãšããŠåžè²©ãããŠããã
ã®ããããŒã³ã»ã¹ã¿ãŒã¯ãã©ããïŒDeanïŒStark
trapïŒãåãããã©ã¹ã³å ã«ãããŠãã«ãšã³250
cm3ãšå ±ã«ä¹Ÿç¥çªçŽ ããªãŒãäžã§ïŒæééæµããŠè±
æ°Žããæ¿çž®ããç空äžã§åçµä¹Ÿç¥ãããã®ããçš
ãããšãã¯ãåå¿æåã®å šééã®0.35ïŒ ãšããã
PTSAãçšãããšãã¯ããããã²ã«ã®èåãé²ã
ããã«è§Šåªã溶é¢ãããå¿ èŠããã€ãã è¡šâïŒã«ãããŠããB.I.F.ãã¯20æé以å ã«ã
ã©ã°ã¡ã³ãã«ç Žå£ããããšãæå³ããã PTSAãçšããŠãããã²ã«ã調補ãããšçµæ¶å
床ãé«ããªããçŽïŒãïŒæ¥éæŸçœ®ãããšèåãã
ïŒãããã²ã«ãçŽâ25âã«åçµãããšå¹Ÿåé·ãæ
éã芳枬ãããïŒãèåããè©Šæã¯å®¹æã«æ°Žåã
ãã厩å£ããåŸåãã¿ãããããã®äžå©ãªç¹ã¯ã
調補çŽåŸã®ããªããŒãæ°Žäžã«æµžæŒ¬ãã也ç¥ããã
ãšã«ãã€ãŠå®å šã«å æãããïŒãã®äœçšã¯è§Šåªã
浞åºããããã®ãšèããããïŒãFeCl3ãçšããŠ
調補ãããããã²ã«ã¯ãã®ãããªæåã瀺ããªã
ã€ãã HTãšC1ã®äž¡æ¹ã®æ¯ãå¢å ããã«ã€ããŠçµæ¶å
ã¯å¢å ããæ°Žã®åžæ°Žã¯æžå°ãããéå°ã®C1ã®äœ¿
çšã¯çµæ¶å床ãçŽ56ïŒ ãçŽïŒïŒ ã«ããã€ãŠå€åã
ãããŸãæ°Žã®åžåãçŽ956ïŒ ãçŽ103ïŒ ã«ããã€ãŠ
å€åãããç¹ã«æçšãªæè¡ã§ãã€ããC1ããèª
äœãããªããŒã®æ¶æ©å¯åºŠãå€åãããããšãçµæ
ããæããã§ããã å®æœäŸ 38 æ¬å®æœäŸã«ãããŠã¯ãåã ïŒçš®é¡ã®ãããã²ã«
ããæãïŒç³»åã®è©Šæãå®è³ªäžå®æœäŸïŒã«èšèŒã
ãããã«ããŠèª¿è£œããããããã®è©Šæã®çµæã¯æ¬¡
ã®éãã§ããã ç³»åïŒïŒPEOïŒoïŒ3100ïŒïŒHTïŒ1.394ïŒïŒC1 ïŒ1.ååŠéè«éïŒ ïŒ2.9.789ïŒ éå°ïŒ ïŒ3.17.27ïŒ éå°ïŒ ïŒ4.24.03ïŒ éå°ïŒ ïŒ5.57.8ïŒ éå°ïŒ ïŒ6.12.5ïŒ éå°ïŒ ïŒ7.200ïŒ éå°ïŒ ç³»åïŒïŒPEOïŒïœïŒ7000ïŒïŒHT(2)ïŒC1 ïŒ1.ååŠéè«éïŒ ïŒ2.10ïŒ éå°ïŒ ïŒ3.20ïŒ éå°ïŒ ïŒ4.30ïŒ éå°ïŒ ïŒ5.50ïŒ éå°ïŒ ïŒ6.100ïŒ éå°ïŒ ïŒ7.200ïŒ éå°ïŒ ãããã²ã«ã®äžèšïŒç³»åã®èžçæ°ŽïŒ21âïŒäžã§
ã®èšæœ€ç¹æ§ã¯ãééãšå¯žæ³ãæ¢ç¥ã®ãããã²ã«ã®
å°ããªã¹ã©ãïŒè¡šâïŒåç §ïŒãèžçæ°Žäžã«æµžæŒ¬ã
ããããšã«ãã€ãŠèª¿ã¹ããã¹ã©ãã¯æµžæŒ¬ããŠãã
ïŒååŸãïŒååŸãïŒååŸãïŒååŸãïŒååŸã10å
åŸã20ååŸã30ååŸãããã³60ååŸã«åãåºãã
æ°Žåãåžåãã秀éããŠå浞挬ããããã®æäœã
平衡ã«éãããŸã§ç¶è¡ããã ãã®å®éšã¯è¡šâïŒã«ç€ºãããã«éžæããããã
ã²ã«ãçšããŠèžçæ°ŽïŒ37âïŒäžã§ç¹°ãè¿ããã ãã®å®éšã¯è¡šâïŒã«ç€ºãããã«èšæœ€å€ãšããŠãš
ã¿ããŒã«ãšã¯ãããã«ã ãšã®50ïŒ50ïŒïŒ·ïŒïŒ·ïŒæ··
åç©ïŒ21âïŒãçšããéžæãããããã²ã«ã«ã€ã
ãŠç¹°ãè¿ããã å®æœäŸ 39 æ¬å®æœäŸã§ã¯ãå®è³ªäžå®æœäŸïŒã«èšèŒãããã
ãã«ããŠïŒçš®é¡ã®2.5ãããã²ã«ã¹ã©ãã調補ã
ãããã³ãŸã«ã€ã³ãããŒã»ãã€ãŒã»ãšã€ãã»ã±ã
ã«ã«ãºç€ŸïŒB.D.H.Chemicals Ltd.ïŒã®åžè²©åãš
ãã«âïŒâã¢ãããã³ãŸãšãŒããããšã¿ããŒã«ãš
ã¯ãããã«ã æ··åç©ïŒ75ïŒ25VïŒïŒ¶ïŒ500mläžã«
宀枩ïŒ21âïŒã§æ·»å ãããã¹ã©ããè¬å€æº¶æ¶²ïŒå®€
æž©ïŒäžã«äžå€ïŒ17æéïŒèšæœ€ãããïŒè¡šâïŒå
ç §ïŒã èšæœ€ã¹ã©ããåãåºããæ°Žåãåžåãã秀éã
ãããããã®è©Šæã¯ç空ãªãŒãã³äžã§ïŒæ¥é也ç¥
ãããæªèšæœ€ã®ããªããŒãããªãã¯ã¹äžã«å«ãŸã
ãè¬å€ãå¹æçã«é€å»ãããè¬å€ãå«ãã ïŒçš®é¡
ã®ã¹ã©ãïŒïŒïŒïŒããã³ïŒïŒãèžçæ°ŽïŒ37âïŒäž
ã§åèšæœ€ããããã¹ã©ãã¯æµžæŒ¬ããŠããïŒååŸã
ïŒååŸãïŒååŸãïŒååŸã10ååŸã20ååŸã30å
åŸã60ååŸã«åãåºããæ°Žåãåžåãã秀éãã
å浞挬ããããã®æäœã平衡ã«éãããŸã§ç¶è¡ã
ãã ä»ã®ïŒçš®é¡ã®è¬å€å«æã¹ã©ãïŒïŒïŒïŒããã³
ïŒïŒãã¬ãŒãŒå®¹åšã«å ¥ãããœãŒã¬ã³ã»ã³
ïŒSorensenïŒç·©è¡æº¶æ¶²ïŒPH7.5ïŒ37âïŒ1000mläžã«
浞挬ããäžå®ã®é床ã§å転ããããè¬å€ã¯è£ 眮ã
ãæ¡æ£ããã®ã§å転ã«ãã€ãŠãã«ã¯ç·©è¡æº¶æ¶²äžãž
æ¥éã«åæ£ãããç·©è¡æº¶æ¶²ã®ã¢ãªã³ãŒãã浞挬ã
ãŠããïŒååŸãïŒååŸã10ååŸã20ååŸã30å
åŸã60ååŸã«åãåºããUVåå å 床èšïŒPERKI
âNELMER 551ïŒãçšããŠ285nmã§ã®UVåžå
床ã枬å®ãããåžå 床ã¯ãçš®ã ã®æ¢ç¥æ¿åºŠã®ãã³
ãŸã«ã€ã³ãå«æããç·©è¡æº¶æ¶²ã®åžå 床ã枬å®ãã
ããšã«ãã€ãŠæ€éããã ãã®å®éšãïŒçš®é¡ã®2.6ãããã²ã«ã¹ã©ããçš
ããŠç¹°ãè¿ããïŒè¡šâïŒåç §ïŒãæªèšæœ€ã®ããã
ã²ã«ãããªãã¯ã¹ã«å«ãŸãããã³ãŸã«ã€ã³ã也ç¥
é€å»ããåŸãïŒçš®é¡ã®ã¹ã©ãããšã¿ããŒã«ïŒã¯ã
ããã«ã ãã³ãŸã«ã€ã³æº¶æ¶²äžã§äžå€ïŒ16æéïŒå
èšæœ€ããããå åã«èšæœ€ããã¹ã©ãïŒïŒïŒïŒãã
ã³ïŒïŒãåè¿°ã®ããã«ã¬ãŒãŒå®¹åšã«å ¥ããç·©è¡æº¶
液ã«æµžæŒ¬ããå転ããããã¢ãªã³ãŒããåãåº
ããåè¿°ã®ããã«ããŠUVåžå 床ã枬å®ããã ãã®å®éšã¯ããã³ãŸã«ã€ã³æº¶æ¶²ã®è¡šç€ºä»¥å€ã¯å®
質äžïŒçš®é¡ã®2.6ãããã²ã«ã¹ã©ãã®å Žåãšåæ§
ã«ããŠïŒçš®é¡ã®2.7ãããã²ã«ã¹ã©ããçšããŠç¹°
ãè¿ããïŒè¡šâïŒåç §ïŒã ãã®å®éšã¯ããã«ããã³ãŸã«ã€ã³23.64ïœãçš
ããŠïŒçš®é¡ã®2.6ãããã²ã«ã¹ã©ãã«ã€ããŠç¹°ã
è¿ããïŒè¡šâïŒåç §ïŒãå åèšæœ€ããïŒçš®é¡ã®ã¹
ã©ãïŒïŒïŒïŒããã³ïŒïŒãåè¿°ã®ããã«ããŠã¬ãŒ
ãŒå®¹åšã«å ¥ããç·©è¡æº¶æ¶²äžã«æµžæŒ¬ããå転ããã
ã¢ãªã³ãŒããåãåºããåè¿°ã®ããã«ããŠUVåž
å 床ã枬å®ãããä»ã®ïŒçš®é¡ã®ã¹ã©ãïŒïŒïŒïŒã
ãã³ïŒïŒã¯ç空ãªãŒãã³äžã§ïŒæ¥é也ç¥ãããå
è¿°ã®ããã«ããŠã¬ãŒãŒå®¹åšå ã§åèšæœ€ãããç·©è¡
溶液äžã«æµžæŒ¬ãããå転ããããã¢ãªã³ãŒããå
ãåºããåè¿°ã®ããã«ããŠUVåžå 床ã枬å®ã
ããæŸåºã®1000ååŸã«ããŒã«âã©ã³ãã«ã®æ³å
ïŒBeerâLambert lawïŒã«åŸããªããªã€ãã®ã§å
æãäžæ¢ããã å®æœäŸ38ãš39ã®çµæãæ·»ä»å³ã«ç€ºãã 第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšãã
ããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã 第ïŒå³ã¯C1éå°ã®é¢æ°ãšããããªããŒç³»åïŒ
ã®èšæœ€çŸåçã瀺ãã 第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšãã
ããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã 第ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšããè¡šâïŒã®ããª
ããŒã®èšæœ€çŸåçã瀺ãã 第ïŒå³ã¯è¡šâïŒã®å åã«èšæœ€ããããªããŒã®æ
éã®é¢æ°ãšããçäœå€ã§ã®ãã³ãŸã«ã€ã³æŸåºé床
ã瀺ãã 第ïŒå³ã¯è¡šâïŒã®ä¹Ÿç¥ããªããŒã®æéã®é¢æ°ãš
ããçäœå€ã§ã®ãã³ãŸã«ã€ã³æŸåºé床ã瀺ãã 第ïŒå³ã¯è¡šâïŒã®å åã«èšæœ€ããããªããŒã®æ
éã®é¢æ°ãšããçäœå€ã§ã®ãã³ãŸã«ã€ã³æŸåºé床
ã瀺ãã
ãã ãCOOâåºãå«ãäžé£œåç°åŒãšãŒãã«é¡ã¯
çžåœããäžé£œåã¢ã«ãããã®ãã€ããŒã®ç·©åãªé ž
åããã³ãã®å¡©ãäŸãã°éå¡©ã®ãšã¹ãã«åã«ãã€
ãŠåŸãŠãããã ã¡ã¿ã«ãŒãããŒãé¡ãšãªãã¶ã¬ãŒãé¡ã¯ããã
ã以äžã®ãšã¹ãã«åïŒ ã«ãã€ãŠåŸãŠãããã ç¶ããªãããã¢ã¯ãã¬ã€ã³ããã©ããŒã¯åžè²©ã®
ã¢ã¯ãã¬ã€ã³ãã容æã«èª¿è£œããã容æã«ç²Ÿè£œã
åŸãããšããã³æ¬çºæãå®æœããäžã§æºè¶³ãã¹ã
ãã®ã§ããããšã匷調ããã éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã¯åŒïŒ ãåŒäžãR1ïŒR2ïŒR3ïŒR4ïŒR5ããã³ïŒ±ã¯åèš
ãšåæ矩ã㯠ïŒåŒäžãã¯é žçŽ ååãŸãã¯âNR6âåºãR6
ã¯R1ãšåæ矩ãïœã¯ïŒãŸãã¯ïŒãïœã¯ïŒãŸãã¯
ïŒãïœã¯ïŒãŸãã¯ïŒã§ããïŒäœãïœïŒïœã¯ïŒã§ã
ãïŒïŒã§è¡šãããããã®ååç©ãå«ãã§ããŠãã
ãã éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã¯ãŸãçž
åœããäžé£œåã¢ã«ãããã®å°ãªããšãïŒåã®ãã€
ããŒã®ã¢ã«ããŒã«çž®åçæç©ïŒ ç¹ã« ãå«ãã§ããŠãããã éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã¯æŽã«å°
ãªããšãäžçš®ã®äžé£œåã¢ã«ããããšããªãããã
ã·ååç©ã®ããªããã«ãšãŒãã«ïŒ ãåŒäžãR7ã¯ïœâããããã·ååç©ã®ïœäŸ¡ã®
çåæ°ŽçŽ ãŸãã¯ããªïŒãªãã·çåæ°ŽçŽ ïŒæ®åºãè¡š
ãããã®ãã€ãŒã«ã¹ãã¢ã«ããŒçæç©ãå«ãã§ã
ããã éåå¯èœãªäžé£œåç°åŒãšâãã«ïŒïŒã¯æŽã«å
åç© ãåŒäžãR8ã¯ïœäŸ¡ã®éå æ°Žå解æ§æ¶æ©æ®åºã
è¡šããããå«ãã§ãããã äžèšæåŸã®ïŒçš®ã®ååç©ã¯å®¹æã«ã¯å æ°Žå解ã
ããªããã€ããã²ã«ãäžããããããã®äœ¿çšã«ã
ããææã®å æ°Žå解é床ãæããæ¬çºæãã€ãã
ã²ã«ãæäŸããããã®äž»èŠãªæ¹æ³ãäžããã ææã®å æ°Žå解å®å®æ§ã¯ãŸãä»ã®å€ãã®ç°ãªã€
ãã¡ã«ããºã ã«ãã€ãŠãå®æœãåŸããå³ã¡ãã¢ã¯
ãã¬ã€ã³ããã©ããŒåæäœãäŸãã°ã¡ã¿ã¢ã¯ãã¬
ã€ã³ããã©ãŒãŸãã¯ã¢ã¯ãã¬ã€ã³ïŒã¡ã¿ã¢ã¯ãã¬
ã€ã³æ··åããã©ããŒã¯ãR4ã倧ãããªãã«ã€ã
ãŠå¢å ããç«äœé害ãå æ°Žå解å¯èœãªãšã¹ãã«ãŸ
ãã¯ã¢ããå®èœåºïŒžã«åãŒããããã«ãã€ãŠèªå°
äœã®å®å®æ§ãåäžããããã¢ãããžããã³ããªâ
ã«ã«ããã·ããã³ããšããŒã«æ§ããããã·çœ®æç
åæ°ŽçŽ ã¯å æ°Žå解ãæãèªå°äœã圢æãããã®äž
ã«è§Šåªäœçšã®ããé žæ§éšåãäžããïŒïŒžããã³
Xâ²ïŒããã¯åäžã§ãã€ãŠãç°ãªã€ãŠãããïŒãã
ãããCOOâãŸãã¯CH2OCOâåºãããã³ïŒºã
眮æãŸãã¯é眮æã®ãããã«ã«ãã¬ã³åºãè¡šãã
èªå°äœã¯ãŸãå æ°Žå解ã容æã«ãããããã«ãŸã
ïŒãªãããã以äžã®ã«ã«ããã·ãŸãã¯ããããã·
åºãä¿æããèªå°äœã¯æ¯èŒçé«ãã¬ãã«ã®æ°Žãå«
ã¿ãããèªäœã¯å æ°Žå解ã容æã«ããã åºR1ïŒR2ããã³R3ã¯ãããã眮æãŸãã¯é眮
æã®ãããã«ã«ãã«ãŸãã¯ãããã«ã«ãããã·åº
ãè¡šããïŒå ·äœäŸãšããŠã¯é眮æãŸãã¯ãã眮æ
C1âC4ã¢ã«ãã«ãäŸãã°ã¡ãã«ãããã¯ãšã
ã«ïŒé眮æC6âC10ã¢ãªãŒã«ãããã¯ã¢ã©ã«ãã«ã
äŸãã°ããšãã«ãŸãã¯ãã³ãžã«ïŒããã³ãªãã·å
æäœããããR4ã®å Žåãåºã®å€§ããã®å¢å ã¯å š
ãŠã®å æ°Žå解å¯èœãªãšã¹ãã«ãŸãã¯ã¢ããå®èœåº
ã«å¯Ÿããç«äœé害ãå¢å€§ãããã®çµæãã€ããã²
ã«ã®å®å®æ§ãåäžãããç¶ããªããã補é ã®å®¹æ
æ§ããã³æçšæ§ã®ç¹ã§å°ãªããšãäžåãæãŸãã
ã¯å šãŠã®R1ïŒR2ããã³R4ãæ°ŽçŽ ååã§ããã®ã
奜ãŸãããåºR3ã¯ã¢ããŸãã¯ããªçœ®æãšãã¬ã³
åºã奜ãŸããã¯é眮æãšãã¬ã³åºãè¡šãããŠãã
ããå³ã¡ãžãããïŒãã¢ïŒãã©ã³èªå°äœã§ãã€ãŠ
ãããã 奜ãŸããååç©ïŒïŒã¯ãšãŒãã«é¡ã§ããäžèš
åŒã®ååç©ãç¹ã«ãžããããã©ã³ã§ããã é©åœãªèŠªæ°Žæ§ãã¢ãŸãã¯ã³ããªããŒïŒïŒã¯å°
ãªããšãäžåã®äžèšã¢ãããŒçŸ€ïŒ (a) ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ã
ããé眮æãŸãã¯ããããã·çœ®æãšãã«ãŸãã¯
ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãããŸãã¯ïŒã¡
ã¿ïŒã¢ã¯ãªã«é žã®ããªïŒãªãã·ãšãã¬ã³ïŒãšã¹
ãã«ïŒ (b) ïŒãïŒã®ç°ååãæãã眮æãŸãã¯é眮æã®
ç°åŒã¢ããŸãã¯ããªãšãŒãã«ãŸãã¯ïŒå¡ç°ãæ
ããç°ç¶ã€ãã³ããŸã㯠(c) 眮æãŸãã¯é眮æã®ããã«ã¢ã«ã³ãŒã«ãã¢ã«
ãããããšãŒãã«ãã¢ã»ã¿ãŒã«ãã±ãã³ããšã¹
ãã«ããŸãã¯çœ®æãŸãã¯é眮æã®ïŒ®âããã«ç°
é ç°ååç© ããèªå°ãããæ®åºãå«ããããã§ïŒã¡ã¿ïŒã¢ã¯
ãªã«ã¯âã¡ã¿ã¯ãªã«âãŸãã¯âã¢ã¯ãªã«âãŸãã¯
ãã®äž¡æ¹ãè¡šããæå³ã§çšããã 矀(b)ã®ã¢ãããŒé¡ã¯ãšããã·ãé¡ãäŸãã°é žå
ãšãã¬ã³ãé žåãããã¬ã³ãïŒïŒïŒâãšããã·ã
ã¿ã³ãïŒïŒïŒâãšããã·ãã¿ã³ãã°ãªã·ãžã«ãšãŒ
ãã«é¡ãâïŒãšããã·çœ®æïŒç°é ç°ååç©ãäŸ
ãã°ïŒ®âïŒïŒïŒïŒâãšããã·ãããã«ïŒâãããªã
ã³ïŒãšããããããªã³é¡ãããèªäœã¯ç°åŒãšãŒã
ã«é¡ã§ã¯ãªããããããèªå°å¯èœãªãã¢ããã³ã³
ããªããŒé¡ãäžããïŒå ·äœçã«ã¯ãšããã«ãªã«ã
ããªã³ããšãã¯ãã«ãããªã³ããã³ãšãããã ã
ããªã³çããããä»ã®ç°åŒã¢ãâãŸãã¯ããªãšãŒ
ãã«é¡ã¯é žåããªã¡ãã¬ã³ïŒoxetaneïŒãããã©
ããããã©ã³ããžããããã©ã³ããžããããã©
ã³ããžãªããœã©ã³ãããã³ããªãªããµã³çãã
ããããããèªå°ããããã¢ããã³ã³ããªããŒé¡
ãšããŠã¯éšåçã«C1âC4ã¢ã«ãã«ã§ãšãŒãã«å
ãããã»ã«ããŒã¹é¡ããã³æŸ±ç²é¡ããŠã¬ã¿ã³ã§æ¶
æ©ãããŠããŠãããããã¢ãŸãã¯ã³ããªïŒã¢ã«ã
ã¬ã³ãªãã·ãïŒãŸãã¯äžé£œåç°åŒãšãŒãã«åºãäŸ
ãã°ããªãªãã·ã¡ãã¬ã³ãããªãšãã¬ã³ã°ãªã³ãŒ
ã«é¡ããã³ããªãããã¬ã³ã°ãªã³ãŒã«é¡ããã³ã
ãããšãžã«ã«ãã³é žïŒäŸãã°ãã¬ã€ã³é žïŒãšã®ã
ãªãšã¹ãã«é¡çãããã 矀(c)ã«ãããã¢ãããŒé¡ã¯ã¡ãã«ããã³ãšãã«
ããã«ãšãŒãã«ãã¡ãã«ããã«ã±ãã³ãã¡ã¿ã¢ãª
ã«ã¢ã«ã³ãŒã«ãâããã«ãããªãã³ãâãã
ã«ã«ã«ããŸãŒã«ãâããã«ããªãžã³ãâãã
ã«ãªããµãŸãŒã«ãâããã«ã¡ãã«ãªããµãŸãªãž
ã³ãããã«ãã«ããŒã«ãããã«ããã©ãŒã«ããã
ã«ã¡ããã·ã¢ã»ã¿ãŒã«ãå å«ãããããããèªå°
ããããã¢ããã³ã³ããªããŒé¡ã¯ããªããã«ã¢ã»
ããŒãããã³ããªããã«ã¢ã«ã³ãŒã«çãå å«ã
ãã 奜ãŸãã芪氎æ§ãã¢ãŸãã¯ã³ããªããŒé¡ã¯çŸ€(b)
ã¢ãããŒé¡ããèªå°ãããæãŸããã¯éåããé ž
åã¢ã«ãã¬ã³ãç¹ã«é žåãšãã¬ã³æ®åºãå«ãã奜
ãŸããã¯è©²èŠªæ°Žæ§ãã¢ãŸãã¯ã³ããªããŒã¯ãã¢ãŸ
ãã¯ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒãç¹ã«ã³ããª
ïŒãšãã¬ã³ãªãã·ãïŒã§ããã å®èœåºã«å¯Ÿããæ°å¹³åååéã®æ¯ïŒä»¥äžãåœé
ïŒequivalent weightïŒãšäºãïŒã750以äžã奜ãŸ
ããã¯1000以äžã®ããªãšãã¬ã³ãªãã·ãæ®åºãæ
ãããã¢ãŸãã¯ãããã¯ã³ããªïŒã¢ã«ãã¬ã³ãªã
ã·ãïŒé¡ãç¹ã«å¥œãŸãããåœéã500ãã250ãªã
ããã以äžã®ãã®ã䜿çšã§ãããããã®æ§ãªããª
ããŒã¯èšæœ€æ§ãäœããªãåŸåãããã å·ã®å 垯ãšããŠäœ¿çšããããã«ã¯ããã¢ãŸãã¯
ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒã¯åœé1200ã
1800ã奜ãŸããã¯çŽ1400ã1600ã®ããªãšãã¬ã³ãª
ãã·ãæ®åºãæãããã®ãçšããã®ã奜ãŸããã
æŸåºèª¿ç¯çµæç©ã«äœ¿çšããã«ã¯åœé1200ã4000ãª
ãããã以äžã奜ãŸããã¯çŽ1500ã3000ãäŸãã°
2000ãªãããã以äžã®ããªãšãã¬ã³ãªãã·ãæ®åº
ãæãããã¢ãŸãã¯ã³ããªïŒã¢ã«ãã¬ã³ãªãã·
ãïŒé¡ã䜿çšããã®ã奜ãŸããã ç¹ã«å¥œãŸãã芪氎æ§ããªããŒé¡ïŒïŒã¯åèšã®
ããšãåœéãæããããªïŒãšãã¬ã³ãªãã·ãïŒé¡
ã§ããã ãããã調補ããããããã²ã«é¡ã¯ä¹Ÿç¥åœ¢æ ã§
ã¯çµæ¶ã§ããã湿最ç¶æ ã§é¢æ¶²çŸè±¡ïŒsyneresisïŒ
ãçŸããããã®äž¡æ¹ã®æ§è³ªãåŸè¿°ããããšãæ¬çº
æã«æçšã§ããããšãããã€ãã éåã¢ã«ãã¬ã³ãªãã·ãæ®åºãæãã芪氎æ§ã
ã¢ãŸãã¯ã³ããªããŒé¡ã¯äŸ¿å®çã«ã¯ã¢ã«ãã¬ã³ãª
ãã·ã(a)ãäŸãã°é žåãšãã¬ã³ãšåå¿æ§æ°ŽçŽ åå
å«æååç©(b)ãäŸãã°èèªæãŸãã¯è³éŠæããã
ãã·ãã«ã«ããã·ãã¢ãããŸãã¯ã¡ã«ã«ããåå
ç©ãšã®ä»å éåã«ãã€ãŠèª¿è£œããããã®ååç©ã¯
ããèªäœãåŸããã芪氎æ§ã³ããªããŒäžã§ããã
ããã¹ïŒblockinessïŒãšãªãããªããŒãŸãã¯ãªãª
ãŽããŒã§ãã€ãŠãããããããã¯ãã¢ããªããŒ
ïŒããã§ã¯å¯äžçš®ã®ã¢ã«ãã¬ã³ãªãã·ããéåã
ãïŒãŸãã¯ã©ã³ãã ã³ããªãïŒããã§ã¯ã¢ã«ãã¬
ã³ãªãã·ãã®æ··åç©ãéåããïŒã«å°ãã¢ãããŒ
ã§ãã€ãŠããããåè ã®å ŽåãåŸãããããªããŒ
ãŸãã¯ãªãªãŽããŒã¯ããèªäœãã¢ãŸãã¯ã³ããªã
ïŒã¢ã«ãã¬ã³ãªãã·ãïŒã§ãã€ãŠããã ååç©(b)ã¯åå¿æ§æ°ŽçŽ å«æå®èœåºã§ïŒïŒïŒïŒïŒ
ãŸãã¯ãã以äžçœ®æããããã®ãå«ã¿ããããã¯
ã¢ãã¡ãªãã¯ããªãªãŽã¡ãªãã¯ãŸãã¯ããªã¡ãªã
ã¯ã§ãã€ãŠãããäžä»¥äžã®åã®æŽ»æ§æ°ŽçŽ å«æå®èœ
åºãæ°Žé žåºãã«ã«ããã·ã«åºãç¹ã«æ°Žé žåºïŒãã
ãã®åºã¯å¥œãŸããã®ã§ããïŒãšå ±ã«ååç©(b)äžã«
ååšããŠããŠããããèèªæååç©ã¯ç¹ã«å¥œãŸã
ããååç©(b)ã®æ··åç©ãçšããŠãããã ãžã«ã«ããã·ãŸãã¯ããããã·ååç©ã®äŸã¯ã
ãžã«ã«ãã³é žé¡ããžãããªãã¯ããšããŒã«é¡ãã
ãããã·é žé¡ããã³ã°ãªã³ãŒã«é¡ã§ãããæãŸã
ãã¯ççŽ æ°18以äžã奜ãŸããã¯10以äžã®ãã®ã§ã
ããäŸãã°èé žãããã³é žããã¯ãé žãã°ã«ã¿ãŒ
ã«é žãã¢ãžãã³é žãïŒïŒïŒâã·ã¯ããããµã³ãžã«
ã«ãã³é žãïŒïŒïŒâã·ã¯ããããµã³ãžã«ã«ãã³
é žãïŒïŒïŒâã·ã¯ããããµã³ãžã«ã«ãã³é žããã¿
ãŒã«é žãã€ãœãã¿ãŒã«é žããã³ãã¬ãã¿ãŒã«é žã
ïŒïŒ4â²âãžããããã·ããšãã«âïŒïŒïŒâããã
ã³ãã¬ãŸã«ã·ããŒã«ããããŒã«ããã³ãªã«ã·ããŒ
ã«ãä¹³é žãïŒâããããã·ã€ãœé ªé žã10âããã
ãã·ãã«ã³é žã12âããããã·ãªã¯ã¿ãã«ã³é žã
12âããããã·âã·ã¹âïŒâãªã¯ã¿ãã«ã³é žãïŒ
âããããã·ã·ã¯ããããµã³ã«ã«ãã³é žãïŒâã
ãããã·âïŒâããšãã«ïŒïŒ€ïŒããããªã³é žããž
ããšãã«ããããã·é ¢é žãïŒâããããã·å®æ¯éŠ
é žãïŒâããããã·å®æ¯éŠé žããã³ïŒâãããã
ã·å®æ¯éŠé žãã°ãªã³ãŒã«ããããã³ãžãªãŒã«é¡ã
ãã³ãã¿ã³ãžãªãŒã«é¡çãäŸç€ºããããã°ãªã³ãŒ
ã«é¡ã¯æãé©ããŠãããç¹ã«C2âC6ããã®äžã§
ãC2âC4ã°ãªã³ãŒã«é¡ã奜ãŸããã ãžã«ã«ãã³é žé¡ããžãããªãã¯ããšããŒã«é¡ã
ããããã·é žé¡ãšã°ãªã³ãŒã«é¡ã®æ··åç©ã䜿çšã
ãŠãããã奜ãŸããã¯ãžã«ã«ãã³é žé¡ããžãããª
ãã¯ããšããŒã«é¡ãããããã·é žããã³ã°ãªã³ãŒ
ã«é¡ãçŽéã®ãã®ã§ããã ïŒä»¥äžã®ã«ã«ããã·ãŸãã¯ããããã·åºã«ãã€
ãŠçœ®æãããååç©(b)ã®äŸã¯ããªã«ã«ãã³é žé¡ã
ããªãããªãã¯ããšããŒã«é¡ãããããã·é žé¡ã
ãã³ããªãããªãã¯ã¢ã«ã³ãŒã«é¡ãæãŸããã¯ç
çŽ æ°18以äžã奜ãŸããã¯10以äžã®ãã®ã§ããïŒäŸ
ãã°èèªæããªãªãŒã«é¡ãäŸãã°ã°ãªã³ãŒã«ããš
ãªã¹ãªããŒã«ããã³ã¿ãšãªã¹ãªããŒã«ããœã«ãã
ãŒã«ããã«ã·ããŒã«ãã€ãã·ããŒã«ãïŒâãšãã«
âïŒâããããã·âã¡ãã«ãããã³âïŒïŒïŒâãž
ãªãŒã«ããã³ïŒïŒïŒïŒïŒâãããµã³ããªãªãŒã«ïŒ
è³éŠæããªãªãŒã«é¡ãäŸãã°ïŒïŒïŒïŒïŒâããªã
ãããã·ãã³ãŒã³ãïŒïŒïŒïŒïŒâããªããããã·
ãã³ãŒã³ãïŒïŒïŒïŒïŒâããªããããã·ãã³ãŒ
ã³ïŒã¢ã«ã¢ãªãã¢ãã€ãã¯ããªãªãŒã«é¡ïŒããã
ãã·ã¢ãªãã¢ãã€ãã¯ãã¢ãªãµã€ã¯ãªãã¯ããã³
è³éŠæã«ã«ãã³é žé¡çããã³ã¯ã¬ãã¹ã»ãµã€ã¯ã«
é žãäŸãã°ãããé žããããé žãé ç³é žãïŒâã
ãããã·âïŒâã¡ãã«ïŒïŒ€ïŒãã¯ãé žãã¢ã¹ã³ã«
ãã³é žãïŒïŒïŒâãžããããã·å®æ¯éŠé žãïŒïŒïŒ
âãžããããã·å®æ¯éŠé žãïŒïŒïŒâãžããããã·
å®æ¯éŠé žãïŒïŒïŒâãžããããã·å®æ¯éŠé žãïŒïŒ
ïŒïŒïŒâããªããããã·å®æ¯éŠé žãïŒïŒïŒïŒïŒâ
ããªããããã·å®æ¯éŠé žãïŒïŒïŒïŒïŒâããªãã
ããã·å®æ¯éŠé žããã³ïŒïŒïŒïŒïŒâããªãããã
ã·å®æ¯éŠé žçã§ããã ããªã«ã«ãã³é žé¡ãããªãããªãã¯ããšããŒã«
é¡ãããããã·é žé¡ããã³ããªãããªãã¯ã¢ã«ã³
ãŒã«é¡ã®æ··åç©ã䜿çšããŠãããã奜ãŸããã¯ã
ãªã«ã«ãã³é žé¡ãããªãããªãã¯ããšããŒã«é¡ã
ããããã·é žé¡ããã³ããªãããªãã¯ã¢ã«ã³ãŒã«
é¡ãçŽéã®ãã®ã§ããã ãªãªãŽããŒãŸãã¯ããªããŒã§ãã€ãŠãããä»ã®
äŸã¯ç¡¬ããããã¯æè»ãªããªãŒã å·¥æ¥ã®åéã«è©³
ããè ã«ããç¥ãããç©è³ªãäŸãã°ãªãã·ããã
ã«åããªãªãŒã«é¡ãããããŒã«é¡ããã³åº¶ç³é¡ãª
ãã³ã«ããªãšã¹ãã«é¡ãå å«ãããç¶ããªããã
äžè¬ã«äœååéååç©ã奜ãŸãããããã¯é«åå
éã®ãã®ããã€ããã²ã«ã®èª¿è£œãããå°é£ã«ãã
çžæº¶æ§ã®åé¡ãäžããããã§ããã 芪氎æ§ããªããŒé¡ïŒïŒã¯éåã¢ã«ãã¬ã³ãªã
ã·ãæ®åºãå«ãããªããŒé¡ã§ãããå žåçã«ã¯å
è¿°ã®ããšãããŠèª¿è£œããããããã¯é žåãšãã¬ã³
ã«å ããŠå°éã®æåãå«ãã®ã奜ãŸãããäŸãã°
ãã倧ããã¢ã«ãã¬ã³ãªãã·ããäŸãã°é žåãã
ãã¬ã³ãŸãã¯é žåããã¬ã³ã§ãããå žåçã«ã¯ã
ã®éã¯ã³ããªããŒã®20ééïŒ ä»¥äžã奜ãŸããã¯10
ééïŒ ä»¥äžãªããããããå°ãªãéã§ãããç¶ã
ãªãããã®æ§ãªã³ããªããŒã¯ãããªïŒã¢ã«ãã¬ã³
ãªãã·ãïŒé¡ã®ãã¡ã§ãããªïŒãšãã¬ã³ãªãã·
ãïŒãæ¬çºæã«ç¹æã®äŸ¡å€ããããã芪氎æ§ã«ã
ã€ãŠçããç¬ç¹ã®æ§è³ªãæããŠããã®ã§ããçšè
å³ã®ãããã®ã§ã¯ãªããåŸã€ãŠæ¬çºæã®å¥œãŸãã
èŠå°ããã¯ãã®èŠªæ°Žæ§ããªããŒã¯(a)é žåãšãã¬ã³
ãš(b)èèªæãŸãã¯è³éŠæããããã·ãã«ã«ãã
ã·ãã¢ãããŸãã¯ã¡ã«ã«ããååç©ãšã®åå¿çæ
ç©ã§ããããªïŒãšãã¬ã³ãªãã·ãïŒã§ããã ïŒãªãããã以äžã®ååç©ïŒïŒã¯ïŒãŸãã¯ã
ã以äžã®ååç©ïŒïŒãšéåããŠãããã éåå¯èœãªç°åŒãšãŒãã«ïŒïŒãšèŠªæ°Žæ§ãã¢ãŸ
ãã¯ã³ããªããŒïŒïŒãéåããŠãããã²ã«ã圢
æãããéåžžããããå¿ ããããå¿ èŠã§ã¯ãªãã
ïŒïŒãšïŒïŒã¯ååŠçã«æ¶æ©ãããŠãããã²ã«
ã圢æããããŸãããã«ä»£ããŠãããããéåã
ããŠçŽéã®é«ååéç©è³ªãåŸã次ãã§ãããå¥ã®
éåãåŸãç³»äžã«åæ£ããããã®åŸãã®ç³»ãéå
ããŠè©²é«ååéç©è³ªã絡ãã ãããã¯ãŒã¯äžã«æ
ããŠãããããããã¯ããããéåããŠçæ°Žæ§ã
ããã¯ãæããã³ããªããŒã圢æããŠäž¡èŠªåªæ§ã®
ç©è³ªãåŸãŠããããããããªããååŠçæ¶æ©ãç
ããã®ã奜ãŸããã ååŠçæ¶æ©ã¯ã«ããªã³éåã«é¢äžãåŸãå°ãªã
ãšãïŒåã®åºãå«ãååç©ããã€ããã²ã«äžã«å°
å ¥ããããšã«ããè¡ãªã€ãŠãããã奜ãŸããã¯å
åŠçæ¶æ©ã¯ïŒããå€ã掻æ§æ°ŽçŽ ååãæããåå
ç©ããã€ããã²ã«äžã«å°å ¥ããããšã«ããè¡ãªã€
ãŠãããããã®æ§ãªååç©ã¯ããªãããã©ãŸãã¯
ããé«åºŠã®çœ®æãããèèªæãŸãã¯è³éŠæããã
ãã·ã«ãã«ã«ããã·ã«ãã¢ãããŸãã¯ã¡ã«ã«ãã
ååç©ãå å«ããããããã¯ïŒããå€ã掻æ§æ°ŽçŽ
ååãæããäžèšååç©(b)ã®ãããã§ãã€ãŠãã
ãããã®æ¶æ©ååç©ãååç©(b)ãšããŠå©çšããã¢
ãŸãã¯ã³ïŒããªã¢ã«ãã¬ã³ãªãã·ãïŒã圢æãã
ãããšã¯å¯èœã§ãããããã«ä»£ããŠããã®æ¶æ©å
åç©ãéåæ··åç©äžã«å°å ¥ããŠãããã ååŠçæ¶æ©ãïŒããå€ãéåå¯èœãªäžé£œåç°åŒ
ãšãŒãã«åºãæããååç©ããã€ããã²ã«äžã«å°
å ¥ããããšã«ãã€ãŠéæããŠãããããã®æ§ãªå
åç©ã®äŸã¯ååŠéè«çéã®é眮æã®ã¢ã¯ãã¬ã€ã³
ããã©ããŒãŸãã¯ããªãããã©ãŸãã¯ãã以äžã®
眮æãããèèªæãŸãã¯è³éŠæããããã·ã«ãã«
ã«ããã·ã«ãã¢ãããŸãã¯ã¡ã«ã«ããååç©ã§çœ®
æãããã¢ã¯ãã¬ã€ã³ããã©ããŒïŒäŸãã°ã¢ã¯ã
ã¬ã€ã³ããã©ããŒãã°ãªã»ããŒã«ã®ããšãããªã
ããªãã¯ã¢ã«ã³ãŒã«ã§ãšã¹ãã«äº€æããŠåŸããã
çæç©çãå«ãã ãã€ããã²ã«ã¯ãŸãåè¿°ããã¢ã«ããŒã«çž®åç
æç©ã®å Žåã®ããšããïŒåã®éåå¯èœãªäžé£œåç°
åŒãšãŒãã«åºããã³ïŒåã®åå¿æ§æ°ŽçŽ ååãŸãã¯
ïŒåã®éåå¯èœãªäžé£œåç°åŒãšãŒãã«åºããã³ïŒ
åã®åå¿æ§æ°ŽçŽ ååãå«ãååç©ã§ååŠçã«æ¶æ©
ããŠãããã ãã€ããã²ã«ãžã®ååŠéè«çéå°éã®æå
ïŒïŒã®å°å ¥ã¯ãŸãååŠçæ¶æ©ãéæããã æ¶æ©å€ã®æ··åç©ã䜿çšããŠãããã å æ°Žå解å¯èœãªãã€ããã²ã«ã¯å°ãªããšãäžçš®
ã®éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒãšå°ãªã
ãšãäžçš®ã®èŠªæ°Žæ§ãã¢ãŸãã¯ã³ããªããŒïŒïŒãš
ãå°ãªããšãäžçš®ã®æ¶æ©å€ããã³æèŠã«ããé žè§Š
åªã®ååšäžã«ã«ããªã³éåããŠèª¿è£œããŠãããã æå©ã«ã¯éåã¯ææž©äžãäŸãã°50ã120âã奜
ãŸããã¯60ã100âãç¹ã«70ã90âã§è¡ãªããåš
å²å§ãŸãã¯èªç¶å§ïŒautogenous pressureïŒã䜿
çšããŠãããã 奜é©ãªé žè§Šåªã¯ãã³ã¹ãããããã³ã«ã€ã¹é žã®
äž¡æ¹ãå«ããåè ã¯éåæ¡ä»¶äžã§ã¯ã¬ãã¯ã¹è©Šè¬
ã§ã¯ãªã匷é±é žãäŸãã°å¡©é žãç¡«é žãïœâãã«ãš
ã³ã¹ã«ãã³é žïŒtosylic acidïŒãããã·ã«é ž
ïŒbrosylic acidïŒããã³ãã®ã¡ã¿ããŒã«ä»å ç©ã
ãã³äžããåç¡ŒçŽ ãäžå¡©åç¡ŒçŽ ãäžèåç¡ŒçŽ ãäž
å¡©åã¢ã«ãããŠã ãäžèåã¢ã«ãããŠã ãäžå¡©å
ã¬ãªãŠã ãåå¡©åã²ã«ãããŠã ãåèåé«ãå¡©å
äºéããã³å¡©å第äºéçã§ãããå¡©å第äºéã奜
ãŸãããéåæ··åç©ã®0.01ãïŒééïŒ ã奜ãŸãã
ã¯0.04ãïŒééïŒ äœ¿çšããã æåïŒïŒïŒïŒïŒã®ã¢ã«æ¯ã¯åºç¯å²ã«ããã€ãŠ
å€ããŠããããããããªãããæ¬çºæã®å¥œãŸãã
æ æ§ã«ãã€ãŠã¯äžé£œåç°åŒãšãŒãã«ãååŠéè«ç
ã«èŠè«ãããéããéå°ãå žåçã«ã¯ïŒã1000é
éïŒ ã奜ãŸããã¯10ã500ééïŒ ãç¹ã«20ã100é
éïŒ éå°ã§ããã®ã奜ãŸãããé©ãã¹ãããšã«
ã¯ããã®å Žåã«ã¯äžé£œåç°åŒãšãŒãã«ãããèªäœ
ã§éåããã®ã¿ãªãããåŸãããããªããŒã®å šçž
åé¢ïŒgross phase separationïŒãçããªãã
ãšãå³ã¡ãã®ç³»ã¯ãããåäžã§ãããã³ãã€ãé
åã圢æãããŠãã€ããã²ã«ã匷åããç©çç匷
床ã®èãããé«ãæŸåºèª¿ç¯çµæç©ãäžããããšã
ããã€ãã ãã®ããšã¯æŸåºèª¿ç¯çµæç©ã«äœ¿çšãããã§ãã
ããããªãã€ã«ã ãŸãã¯ãã倧ããå¡ã«æ圢ãã
ãã€ããã²ã«ã®å Žåã«ã¯ç¹ã«éèŠã§ãããããã
åœé1200ãã1800ã®ããªãšãã¬ã³ãªãã·ãæ®åºã
å«ãããªããŒããååŠéè«çéã®åå¿è©Šå€ãçšã
ãŠäžèšç©è³ªãäœããšåŸããããããã²ã«ã¯éåžžã
也ç¥ããã³èšæœ€ãããã®ç¶æ ã§ã匱ããªãã§ãã
ããããã¯å·ã®å 垯çšã®çŽ°ç²çæç©ãåŸãã®ã«äŸ¿
å©ã§ãããä»ã®çæç©ã«ãšã€ãŠã該çæç©ãåæ±
ãããã³èšæœ€ã«èããŠïŒäŸãã°æŽ»æ§ç©è³ªãæ æã
æŸåºããããšïŒãéå°ã奜ãŸããã¯å®è³ªçã«éå°
ã®æåïŒïŒã確ä¿ããããšãç¹ã«æãŸããã ãã®æ§ãªãã€ããã²ã«ã®æ¯æ§ã¯éåžžã«äœããå€
ããã®ïŒadventitiousïŒæ°Žåã®ååšã«ãã€ãŠåœ¢æ
ããããšãã¬ã¹ãçºçãããåŸã€ãŠèããã€ã«ã
ããã³é³é ç©ãæãŸãããªãæ°æ³¡ãªãã«å®¹æã«èª¿
補ãããããŸãç©ççæ§è³ªã«å€åããããããªã
åå¿å€ã®æ¯çã®å®è³ªçãªèš±å®¹åºŠãåºãã å ããŠãïŒïŒãšã«ããªã³çã«éåãåŸãä»ã®
ååç©ãå žåçã«ã¯ãã€ããã²ã«ã®30ééïŒ ãè¶
ããªãéã奜ãŸããã¯20ééïŒ ä»¥äžééæ··åç©äž
ã«å°å ¥ããŠããããå ·äœäŸã¯ (a)â² çŽéã¢ãããã³ããªããã«ãšãŒãé¡ãäœã
ãããã¯ãããã²ã«ã«æ¥éã«å æ°Žå解ããæ§è³ª
ãäžããåŸåãããã (b)â² å°ãªããšãäžçš®ã®ïŒãŸãã¯ïŒâå¡ãªããµãŸ
ãã¯ãã¢â眮æç°ãäŸãã°ã¢ããŸãã¯ããªãšã
ãã·ãé¡ (c)â² ïŒâå¡ç°ãæããã©ã¯ãã³é¡ (d)â² ãã¬ã€ã³é žç¡æ°Žç©ãå å«ããç°åŒèèªæç¡
æ°Žç©é¡ (e)â² èèªæã¢ã«ãããé¡ (f)â² ãã«ãã©ãŒã«ããã³ãã«ãã©ãŒã«ã¢ã«ã³ãŒ
ã« (g)â² ã¢ãããã³ããªããã«è³éŠæçåæ°ŽçŽ é¡äŸ
ãã°ã¹ãã¬ã³ãã¢ã«ãã«ã¹ãã¬ã³ããã³ãžãã
ã«ãã³ãŒã³ çãããã ãããã®ååç©ã®å šãŠã¯é¡åŸ®é¡ççžåé¢ã«ãã
匷åçµæç©ãæäŸãåŸãããã®æ§ãªååç©ã®æ··å
ç©ã䜿çšããŠãããã æ¬æ现æžã«ãããŠãçšèªããã€ããã²ã«ãã¯æ°Ž
æ§åªäœã«ãã€ãŠèšæœ€ããããªããŒãæå³ããæªèš
最ã也ç¥ç¶æ ãèšæœ€ãŸãã¯æ¹¿æœ€ç¶æ ã®ãããã®ã
ãªããŒã«ã€ããŠãçšããããã 也ç¥ãã€ããã²ã«ã¯çµæ¶æ§ã瀺ããŠããããå
è¿°ã®ããšããããã¯èŠªæ°Žæ§ããªããŒïŒïŒãåœé
1000以äžã奜ãŸããã¯2000以äžã®ããªïŒãšãã¬ã³
ãªãã·ãïŒãå«ãå Žåã§ããããã®ãã€ããã²ã«
é¡äžã®åŸ®çµæ¶ã®ååšã¯äžèšã®ããšã«å ããŠã也ç¥
ãã€ããã²ã«ãŸãã¯èšæœ€ãã€ããã²ã«ã®åŒ·åºŠã«ã
ãéèŠãªè²¢ç®ãããã æ¬çºæã®ãã€ããã²ã«ã¯æãŸããã¯â120âã
ãïŒ15âã®ã¬ã©ã¹è»¢äœæž©åºŠãæãã也ç¥æïŒ10â
ããïŒ60âã®åŸ®çµæ¶èç¹ãæããã æ¬çºæãã€ããã²ã«ã¯æ¯æããããããã¯æ¯æ
ãããŠããªããã€ã«ã ãšããŠäœ¿çšããŠããããå
è ã®å Žåãæ¯æäœã¯äŸãã°ãã€ãã³çã®é£ç¶ã
ãã奜ãŸããã¯éæã®è£åŒµãæãŸãã¯ã¡ãã·ãŠã§
ãã€ãŠããããã®ãŸããã§ãã€ããã²ã«ãéåã
ããé¡åŸ®é¡ççžåé¢ã«ãã€ãŠåŒ·åãããã€ããã²
ã«ã®å Žåã¯ç¹ã«ãã€ã«ã ãæ¯æããªããŠãããã ãã€ããã²ã«ã¯ãŸãç¹ç¶ãšããŠçŽ¡ãç¹åžã«ç¹ã€
ãŠãããã æåŸã«ããã³æã奜ãŸããã¯ãã€ããã²ã«ã¯ç²
æ«ãšããŠäœ¿çšããŠãããããã®ç²æ«ã¯æã ã®è±åœ
ç¹èš±åºé¡ç¬¬8138713å·ã«é瀺ãããŠããããšãé
åã«ãããŠãããªãã«åœ¢æããŠããããããã¯å
è±åœç¹èš±åºé¡ç¬¬8118087å·ã«èšèŒããããšã圢æ
åŸã«ç²ç ããŠãããã æ¬çºæã®å¥ã®ç¹åŸŽã¯æŽ»æ§ç©è³ªãç¹ã«çç©åŠçã«
掻æ§ãªç©è³ªäŸãã°è¬ç©ïŒmedication systemïŒã
å«ãæŸåºèª¿ç¯çµæç©ããã³ããã«èšèŒã®ãã€ãã
ã²ã«ãå«ããã€ãªã€ãŒãæäŸããã è¬ç©ãšã¯äºé²ãŸãã¯æ²»çã®ããã«ã€ã³ããã«äŸ
絊ãããã®ãæãŸããå šãŠã®ççåŠçã«æŽ»æ§ãªç©
質ãæå³ããã æ¬çºæã¯æŽ»æ§ç©è³ªã®è£œå€ã«åºãé©çšæ§ãæãã
ç¹ã«ãéå®çã§ã¯ãªãããäžå®ã®é床ã§çç©åŠç
ã«æŽ»æ§ãªç©è³ªãæŸåºãåŸã補å€ã«é©çšãåŸããæ¬
çºæã®æ¯æãããæŸåºçµæç©ã«å°å ¥ããŠãããç
ç©åŠçã«æŽ»æ§ãªç©è³ªã®çŸ€ã®äŸã¯éŠæãå»è¬ãéè
å€ãéŠå³æãè¬ç©ãå¶èå€ããŠã€ã«ã¹æ²æ» å€ããŸ
ã殺è«å€ãç·è«æ²æ» å€ãè»äœåç©æ²æ» å€ã幌è«æ²
æ» å€ãªã©ã®è«æ²æ» å€ããããŠé€èå€ã殺èå€ã殺
è»å€ãå±æè¬ãããã¯ç®èç æ²»çè¬ãæµ·æŽçç©ä»
çé²æ¢å€ãé µçŽ ã®ãããªèçœè³ªãããããã埮ç
ç©ãæ€ç©æ°Žæ§å¹é€å¡©åïŒplant hydroculture
saltsïŒãæ é€çŽ ãé²è å€ãç£å»çšãã¬ãŒã¹éå±é
åç©ïŒveterinary trace metal formulationsïŒã
ããã«ä»ã®èŸ²æ¥çšæé·ä¿é²å€ïŒããšãã°æ貧è¡
è¬ãååã¹ããã€ããªã©ïŒçã§ããã ç¹ã«èå³ããæ¬çºæçµæç©ã¯çç©åŠç掻æ§ç©è³ª
ãšããŠå°ãªããšãäžçš®ã®å»è¬ãå«ããã®ã§ããã åŸã€ãŠãæ¬çºæçµæç©ã¯ç£å»ãå«ãå»åŠãå€
ç§ãã³ã³ããã¯ãïŒcontextsïŒãåèžããã³èŸ²æ¥
ãªãã³ã«ãããã®é åå€ã®ãã®ã«åºãé©çšããã
ãšããããã ãã®æŽ»æ§ç©è³ªã¯ãã°ãã°ããçšåºŠã®æ°Žæº¶æ§ãæ
ãããã氎溶æ§ã§ããå¿ èŠã¯ãªãïŒ å¿ èŠãªå šãŠã®ããšã¯æŽ»æ§ç©è³ªããããå æ°Žå解
å¯èœãªãã€ããã²ã«ãã€ãªã€ãŒäžã«å°å ¥ããéã
ãã®ãã€ãªã€ãŒãèšæœ€ããããã«äœ¿çšããæ°ŽãŸã
ã¯ææ©æº¶å€ã«æ¬çºææŸåºèª¿ç¯çµæç©ã«å¿ èŠãªæ¿åºŠ
ã«çžåœããé溶解ããããšã§ããã æ¬çºæã®æŸåºèª¿ç¯çµæç©äžã«çšããŠãããå žå
çãªäŸã¯ ããã¹ã¿ã°ã©ã³ãžã³ã®ãããªå èè¬ãå¬ç è¬ã
é®éå€ããã©ã³ãã©ã€ã¶ãŒãäžç±è¬ãæççè¬ã
æãã¹ã¿ãã³å€ãé®å³é®åœè¬ãæçæ£è¬ãçåŒç·©
å€æè «çå€ïŒäŸãã°æªæ§è «çãæ²»çããè¬ç©ïŒã
å±æ麻é å€ãããŒãã³ãœã³æ°ç æ²»çè¬ãå±æãã
ãã¯ç®èç æ²»çè¬ãå©å°¿è¬ïŒäŸãã°ãšãŠåã«ãªãŠ
ã ã®ããã«ã«ãªãŠã ãå«ãè¬ç©ïŒã粟ç¥ç æ²»çè¬
ïŒäŸãã°èºãã€ç æ²»çã«çšãããªããŠã å«æ補å€ã
ãããã¯ç²Ÿç¥åè£ç ã«çšããããã¹ã¿ã°ã©ã³ãžã³
å«æ補å€ïŒãæçæ£è¬ãæ朰çè¬ãæèå€ãå«ã
ãŠç åäœäŒææ²»ççšã®çš®ã ã®ç©è³ªãå«æãã補å€
ïŒäŸãã°åå®®è¬ïŒmetronidazoleïŒãé§è«è¬ãããŠ
ä»ã®æ®ºèå€ïŒãæãã©ãªã¢å€ãå¿èè¡ç®¡çšè£œå€ã
ãã«ã¢ã³å«æ補å€ïŒäŸãã°ç·æ§ãã«ã¢ã³
ïŒandrogenïŒãçºæ ãã«ã¢ã³ïŒestrogenïŒãããŠ
é»äœãã«ã¢ã³ïŒprogesteroneïŒãå«ã補å€ïŒã女
æ§ãã«ã¢ã³ã®ãããªæçœãªã¹ããã€ãã亀æç¥çµ
è奮å€ãäœè¡ç³çå€ãåŠåš 調ç¯å€ãæ é€å€ãçš®ã
ã®ã¿ã€ãã®å¹æã瀺ãé µçŽ ãå«æãã補å€ïŒäŸã
ã°ãã¢ããªãã·ã³ãå«ã補å€ïŒãé®çå€å«æ補å€
ïŒäŸãã°ã¢ã¹ããªã³ïŒããŸãç·è«æ²æ» å€ãä»ã®ç£å»
åŠçšè£œå€ãå«ã¿ããã®ä»ã®å€ãã®ã¿ã€ãã®å¹æã
瀺ãè¬åãããã æ¬çºææŸåºèª¿ç¯çµæç©ã¯æŽ»æ§ç©è³ªãšããŠå°ãªã
ãšãäžçš®ã®å€©ç¶ãŸãã¯åæã¹ããã€ãæ§ãã«ã¢ã³
äŸãã°ãšã¹ããã²ã³ãŸãã¯ããã²ã¹ãã²ã³ãé©åœ
ã«å«ãé¿åŠçšçµæç©ãšããŠäœ¿çšããŠãããã奜ãŸ
ããããã²ã¹ãã²ã³é¡ã¯å€©ç¶ããã²ã¹ããã³ãã
ã³åæåæäœãäŸãã°11âããããããã²ã¹ãã
ã³ããã©ã«ãã³ã21âãã«ãªãâ17âã¢ã»ããã·
âïŒâã¡ãã«ããã²ã¹ããã³ãé ¢é žã¡ãããã·ã
ãã²ã¹ããã³ãé ¢é žã¡ã²ã¹ãããŒã«ãé ¢é žã¯ãã«
ããžãã³ããšãã¹ããã³ããžã¡ãã¹ããã³ãâ
ãã«ããã²ã¹ããã³ã19âãã«ããã²ã¹ããã³ã
21âãã«ããã²ã¹ããã³ããã«ã¡ã¿ã³ããã³ãã
ã«ãšãããã¬ã«ããã«ãšãã³ããã³ãšãã®é ¢é ž
å¡©ãDLâããã³ïŒ€âãã«ãžãšã¹ãã¬ã«ããã«ãž
ãšã¹ããªãšãã³ãäºé ¢é žãšãããžãªãŒã«ããªã³ã¹
ãã¬ããŒã«ããšããã«ãšã¹ãã©ãžãªãŒã«ããªãã
ããã²ã¹ããã³ããã€ããã²ã¹ããã³ããã«ãã€
ããã¬ã«ãé ¢é žãã³ã°ãšã¹ãã©ããŒã«ããã«ãšã
ã¹ããã³ãšãã®é ¢é žå¡©åã³ãšãã³ãã«é žå¡©ãé ¢é ž
ã¢ãã²ã¹ããã³ãã¡ããã²ã¹ãã³ãã¯ããã²ã¹ã
ã³ãã¢ãªã«ãšã¹ãã¬ããŒã«åã³ã¢ãªã«ã·ã³ã²ã¹ã
ãŒã«ããããããããããã²ã¹ããã³ã奜ãŸã
ãã çºæ ãã«ã¢ã³ïŒãšã¹ããã²ã³ïŒãšããŠã¯ã倩ç¶
ã®Î²âãšã¹ãã©ãžãªãŒã«ãåã³ãã®åæé¡äŒŒç©
ïŒäž»ãšããŠãšããã«ãšã¹ãã©ãžãªãŒã«ãããã¯ã¡
ã¹ãã©ããŒã«ãªã©ïŒïŒÎ²âãšã¹ãã©ãžãªãŒã«ã®æ¹
ããã奜ãŸãããïŒãªã©ãé©åœã«ãããããã æ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ç³å°¿ç ãæªæ§è²§è¡ã®
åŠçœ®ã«ãæçšã§ãããããã§ã¯äŸãã°ã€ã³ã·ãŠãª
ã³ããã³ã³ãã©ãã³ã®æŸåºã®èª¿ç¯ã«ããããå©çš
ããŠãããã ããã«æ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ç±åž¯æ§çŸç ã
äŸãã°ãã©ãªã¢ãç©ãäœè¡åžè«çããã³èåžè«ç
ã®äºé²ããã³æ²»çã«ç¹ã«é©ããŠãããæ¬çºæã«ã
ãæŸåºçµæç©äžã®çç©æŽ»æ§ç©è³ªããããã¯ä»ã®ç±
垯æ§çŸç ã®åŠçã«äœ¿çšãåŸãè¬å€ã®äŸãšããŠã¯ã
ãã³ãã¹ã«ãã³ã¢ããé¡ããªãã¢ã ã·ã³ãã¯ãã
ã¢ãžãã³ããã¢ã³ããã·ã³ãã¯ãã«ããšãã«èªå°
äœãã¯ãã«ã°ã¢ãããã·ã¯ãã°ã¢ãã«ãããªã¡ã¿
ãã³ãã¹ã«ãã¢ãžã¢ãžã³ãããªã¡ãããªã ããã
ãªã³èªå°äœãäŸãã°ãããã³ãã¯ãããã³ããã³
ã¿ãã³ãããªããã³ããã³ã¢ã¢ãžãã³ããã©ããµ
ããªã³ãã¹ã«ãã¢ã¡ããŸãŒã«ãããã¯ãªã³ããã
ãœã³ããœãžãŠã ã¹ã«ãããœã³ãã¹ã«ããšããã³ã
ãœãžãŠã ã»ãããã«ã«ãã€ãããã³å€§é¢šåé žãã
ãªãŠã çããããç¹ã«æå¹ãªè¬å€ã¯ã·ãã°ã¢ã
ã«ãããªã¡ã¿ãã³ããã³ã¹ã«ãã¢ãžã¢ãžã³ã§ã
ãã æ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ç£å»è¡ãžã®é©çšã«ã
é©ããŠãããäŸãã°éåžžã®æè掻æ§ã®ããã®ãã
ãã³ä»çã®ã¢ããã©ãºãææç ã®åŠçœ®çšæèå€ã®
調補ïŒå€éšå¯çäœãäŸãã°ç¯è¶³åç©ãçºè²ã®åæ¢
ãã幌è«æ®µéã®ããããŒããã©ã³ã°ãŠãªãŒã
ïŒlungwormsïŒãäžè¬ã®ã¹ããã³ã®ã«ã¹é¡ãå«ã
å€éšå¯çäœããã³çœè»é¡ã®äž¡æ¹ã«å¯ŸããŠåºç¯å²ã®
掻æ§ãæäŸããããã®èª¿è£œïŒãããã¯ã¢ãã«ã¡ã¯
ãã³é¡ãå«ãã§ããŠãããïŒãã¬ã¢ããŒã
ïŒtremotodeïŒãã»ã¹ããŒãããã³åè«
ïŒroundwarmïŒææã«å¯Ÿãã掻æ§ã®æäŸçšèª¿è£œïŒ
ãããã¯ã¢ã¢ã¹ã«ããŒãããã³ãã©ãžã«ã³ãã«ã
å«ãã§ããŠãããïŒä»çäžã®ã¿ã€ã¬ãªã¢ã«å¯Ÿã掻
æ§ã®æäŸçšèª¿è£œïŒããã¯ã¡ãã¯ãã³ã®ããšãçç©
åŠçã«æŽ»æ§ãªãããããã³é¡ãå«ãã§ããŠãã
ãïŒä»çã銬ããã³ç¬ã®ããã·ãªã·ã¹ã«å¯Ÿãã掻
æ§æäŸçšèª¿è£œïŒããã¯ãã¬ãã«ãã¢ããã«ãŒãã
ãã³ãžã¢ã³ããã³ãå«ãã§ãããïŒçŸããã³ä»çŸ
ã®èåžè«é¡ããã³ãã¢ã³ã«ã³ïŒHaemonchusïŒçš®
ã«å¯Ÿãã掻æ§ã®æäŸçšèª¿å€ïŒããã¯ã¯ããµã³ãã«
ãå«ãã§ãããïŒãå å«ãããã ãã®æŽ»æ§ç©è³ªã¯åæ£ç¶æ ã§ãããšå ±ã«ãã€ãªã€
ãŒäžã«æ··åããŠããããããã奜ãŸããã¯ããã
é©åœãªç©çç圢ç¶ã«æåããåŸããã€ãªã€ãŒäžã«
å°å ¥ãããåŸã€ãŠéåžžã®çç©åŠçã«æŽ»æ§ãªç©è³ªã®
å°å ¥æ³ã¯é©åœãªç©çç圢ç¶ã§ãã€ãªã€ãŒã溶液
ïŒæ°Žæ§ã§ãã€ãŠãããïŒãçšããŠèšæœ€ããããšã§
ãããããããªãããç¹ã«ãã容æã«å æ°Žå解ã
ããã€ãªã€ãŒã§ã¯ææ©ã®èšæœ€å€ãçšããã®ã奜ãŸ
ãããææ©èšæœ€å€ã®äœ¿çšã¯ãã°ãã°æŽ»æ§ç©è³ªã溶
解ããããã«ãå¿ èŠã§ãããããã«ãããã¯æ°Žæ§
åªäœãè¶ããèšæœ€æ§ãåããããšãã§ããããã
å Žåã«ã¯ãå®å šã«éæ°Žæ§ã®ææ©æº¶å€ãäŸãã°ã¯ã
ããã«ã ããšã¿ããŒã«ïŒã¯ãããã«ã ãããã©ã
ããããã¿ã¬ã³ãããããã³ãŒã³ãå®æ¯éŠé žã¡ã
ã«ããããã©ã¯ãã³ãŸãã¯ãã³ãžã«ã¢ã«ã³ãŒã«ã
çšããŠããããèšæœ€ããã³æŽ»æ§ç©è³ªã®åžååŸãæŸ
åºèª¿ç¯çµæç©ã也ç¥ã溶å€ãé€å»ããããããã
ã¯èšæœ€ç¶æ ã§äœ¿çšããŠããããèšæœ€å·¥çšãç¹ã«èš±
容ãããããšã®å®¹ç©ã«å¯Ÿããèšæœ€æ¯ã¯ãããã䜿
çšå也ç¥ããããšããŠããã€ã³ããã«ãããæŸåº
çµæç©ã®ãã®åŸã®æåã«æ¥µããŠéèŠãªåœ±é¿ãæã
ããåŸã€ãŠã奜ãŸããã¯çç©åŠçã«ã¯æŽ»æ§ãªç©è³ª
ã®å°å ¥äžã®èšæœ€ã®çšåºŠã¯ããšã®ä¹Ÿç¥å®¹ç©100éšåœ
ã150ã700éšãç¹ã«200ã500éšã§ããã åè¿°ã®ããšãã䜿çšãããã€ãªã€ãŒã¯ãã€ãã
ã²ã«ã§ãã€ãŠãããã¯åæ也ç¥ç¶æ ã§ãããã¯å
æèšæœ€ç¶æ ã§äœ¿çšããŠããããããããã®å Žåã§
æŸåºã®ã¢ãŒãã¯ç°ãªãã也ç¥çµæ¶ã²ã«ã¯èšæœ€æã«
ããããŽã ç¶ã²ã«ãäžè¬ã«ã¯æããªãç¹æ®ãªæ§è³ª
ãæãããäŸãã°äœæ¶²ã«ããã²ã«ã®ã·ãªã³ããŒç¶
ãããµãªãŒããèšæœ€ãŸãã¯ãŽã ç¶ã®å€æ®»ãçµæ¶ç©
質ã®åšå²ã«åœ¢æããããããã¯ããç¹æ®ãªå©çã
ããããããŸããŽã ç¶ã²ã«ã§éåžžèŠãããããªã
æ¥éãªææ°ãŸãã¯t-1/2ã®æžå°ã«æ¯ã¹ãé·æéã«ã
ãã€ãŠéåžžã«åäžãªç©è³ªã®æŸåºãäžè¬ã«éæãã
ããããã«æŽ»æ§ç©è³ªãåªãã氎溶æ§ãšæ¯èŒçå°ã
ãååéãæããŠãããšãã¯æŸåºã®ãã¿ãŒã³ãçŽ
ç²ãªïŒentireïŒæŸåºçµæç©ã®æ§è³ªããããããã€
ãªã€ãŒã®æ§è³ªã«ãã€ãŠéåžžã«å€§ããã³ã³ãããŒã«
ããããã®çµæãç¹å®ã®æŸåºé床ãåŸãããã®æŸ
åºçµæç©ã®èª¿å€ã¯ããªãåçŽåãåŸããäœã氎溶
æ§ããã³ïŒãŸãã¯é«ãååéã®æŽ»æ§ç©è³ªã®å Žåã«
ã¯æŸåºã¯åã ã®ç©è³ªã«ããäŸåããã§ãããã ããããªãããé©ãã¹ãããšã«ãæ¬çºæã®å®å š
ã«èšæœ€ãããã€ããã²ã«ã¯æŽ»æ§ç©è³ªã®åæ倧æŸåº
ã®åŸã«åäžãªæŸåºãäžããããšãããã€ãããã®
ããšã¯å€ãã®è¬ç©å°±äžãé«ãæ²»çææ°ã®è¬å€ã«ã
ããŠé«ãå©çãããã 湿最ã²ã«ã¯æŽ»æ§ç©è³ªã貯èµãã枩床ãããã®äž
æã®çµæçããã€ã³ããã§ã®ãã©ã¹ã®äœçšã«ãã
æŸåºçµæç©ãã掻æ§ç©è³ªãæåºããããšã«ããã
ããã³ãã®çµæãšããŠã®ãã€ãªã€ãŒããã®æŸåºæº¶
å€ããã³æŽ»æ§ç©è³ªã®é¢æ¶²ã«ãã€ãŠæ©èœãæããŠã
ããããã®ããšã¯ãã€ãªã€ãŒã䜿çšãã枩床以äž
ã®æž©åºŠã§ã®æŽ»æ§ç©è³ªã®å°å ¥ããã³æŸåºèª¿ç¯çµæç©
ã®è²¯èµãå¿ èŠãšãããã®ãšè§£ãããããã®æ§ã«æŽ»
æ§ç©è³ªãå»è¬çšã§ãããšãããã€ãªãŒã¯äŸ¿å®çã«
ã¯20âãªãããã以äžãäŸãã°ïŒâãªããâ19â
ã®æž©åºŠã§ææçšåºŠã®æŽ»æ§ç©è³ªã®åžåããã³èšæœ€ã
éæããå»è¬æº¶æ¶²ã§åŠçããŠãããããã®æ§ã«åœ¢
æãããæŸåºçµæç©ã®æ£è ãžã®æäžã¯ãã®æž©åºŠã
äœæž©ãŸã§é«ãïŒäººéã§ã¯çŽ37âïŒã次ãã§ããªã
ãŒã®åçž®ã§æº¶å€ããã³æŽ»æ§ç©è³ªã®æåºãçããã
èšæœ€ã²ã«ã®å®å®æ§ã«é¢ããŠééãããããªãå Žå
ã§ãã䜿çšåçæéã«èšæœ€ãéæããããšãå¯èœ
ã§ããã æ¬çºæã¯ããã«ãã枩床ã§æŽ»æ§ç©è³ªãå«ã液ç¶
åªäœã§ãã€ãªã€ãŒãèšæœ€ããããšã«ãã該ãã€ãª
ã€ãŒã«æŽ»æ§ç©è³ªãå°å ¥ãã次ãã§ã第äºã®ããé«
ã枩床ç°å¢äžã§èšæœ€ãã€ãªã€ãŒãå©çšããŠã該èš
最ããªããŒãã掻æ§ç©è³ªãšæ¶²ç¶åªäœã®æåºãçã
ãããæ¹æ³ã«é¢ãããããã«æ¬çºæã¯äººãŸãã¯å
ç©ã®æ£è ã«çç©åŠçã«æŽ»æ§ãªç©è³ªãšãã€ãªã€ãŒãš
ãå«ãçµæç©ïŒè©²çµæç©ã¯çµæ¶ããã³ïŒãŸãã¯èš
最åã§ããïŒãæäžããããšãç¹åŸŽãšããã 掻æ§ç©è³ªã®ç©çç圢æ ãå«ããŠããã€ãªã€ãŒäž
ã«çç©åŠçã«æŽ»æ§ãªç©è³ªãå°å ¥ããããã«äœ¿çšã
ãæ¹æ³ã®è©³çŽ°ãªæ æ§ã¯ææã®æŸåºç¹æ§ãåŸããšäº
ã芳ç¹ããé©åœã«éžæããã°ããã第ïŒã®ç®æšã¯
é©åœãªæéå ã«èª¿ç¯ããæŸåºãéæããããšã§ã
ãã䟿å®çã«ã¯æŽ»æ§ç©è³ªã®å€§éšåãäŸãã°80ïŒ ãª
ãã90ïŒ ãéããããããšã§ãããå®è³ªäžäžå®ã®
å²åã§ã®æŸåºãå³ã¡ã»ãŒçŽç·ç¶ã®æŸåºã¯ããå Žå
ã«ã¯é©åœãªç®æšã§ãããå¹³æ¿ç¶ãŸãã¯å¹³åŠãªã·ãŒ
ãã®ãšããæ¬çºæãã€ããã²ã«ã«ããããªãã®çš
床ãŸã§éæãããã ããããªããéåžžã§ãªãæŸåºãããã¢ã€ã«ã¯é
æŸãã€ããã€ãŒãäŸãã°äžãªãããã以äžã®åã
窪ã¿ãæããäžç©ºã·ãªã³ããŒãŸãã¯ã¹ã©ããæã
ããã€ãªã€ãŒã䜿çšããããšã«ããåŸãŠãããã
ãã®æ§ãªéåäœãã€ãªã€ãŒã®æŸåºãããã¢ã€ã«ã¯
çµæçã«æ倧䟡ãéãããšãããã€ãããã®æ§ãª
幟äœåŠçæŸåºèª¿ç¯ãããã¢ã€ã«ã¯æ¹è¯æŸåºããã
ã¢ã€ã«ãåŸããã³èª¿ç¯ããä»ã®éåžžã«æçšãªæ段
ãæäŸããã ããããªãããä»ã«ãæ¬çºæã«çšãããã奜ãŸ
ãããã€ãªã€ãŒã¯é«èšæœ€é åã«ãããŠã§ããã ã
é·æéã«ããã€ãŠã»ãŒçŽç·ç¶ã®æŸåºé床ãç¶æã
ãå©ããšãªãæåã瀺ãããšãããã€ããå³ã¡ã
é©ãã¹ãããšã«ãã®ãã€ãªã€ãŒã¯ãäžåºŠçŽ10åã®
ãã¢ã¯ã¿ãŒã§èšæœ€ãããšãå žåçã«ã¯çŽïŒåã®èš
最ã¬ãã«ã«èªç¶åçž®ããããšãããã€ãã䜿çšäž
也ç¥ãã€ãªã€ãŒãèšæœ€ããããããã¯æ¹¿æœ€ãã€ãª
ã€ãŒãããã«èšæœ€ããããã掻æ§ç©è³ªã®æŸåºé床
ãäžåºŠäœäžãå§ãããšããããã«ãããã®é床ã
ããæŒãããã ããã«ãã€ããã²ã«ã®å æ°Žå解ã¯çŽç·ç¶æŸåºé
床ã®æç¶æ§ãŸãã¯å æ°Žå解ãæ¥éã«è¡ãªããããš
ãã¯æŸåºé床ã«ãããåææ倧å€ã«è²¢ç®ããã§ã
ãã掻æ§ç©è³ªã®æŸåºã®å¢å ãããããã æ¬çºæçµæç©ã®å»çãžã®å©çšã®ããåéãäŸã
ã°ãã«ã¢ã³ãçš®ã ã®æ¡ä»¶ã§ã®åŠçããã³äºé²çšè¬
å€ãäŸãã°ç åæ§åŸ®çç©ã«å¯Ÿãã掻æ§ãæããç©
質ã¯ç¹ã«è©²æŽ»æ§ç©è³ªã®è£ãŸãã¯çŽè žæäžã«ç¹ã«é©
ããŠããããããµãªãŒã¯ãã®æ§ãªçšéã«ç¹ã«æãŸ
ãããããããªããçµæç©ã¯äœã®ä»ã®éšåã®å±æ
æäžãäŸãã°å£è ãçŒã®ç æ°ãäŸãã°ç·å éã«äœ¿
çšããŠãããããã®çµæç©ã¯ãŸãçµå£æäžãŸãã¯
æ²»çããããã¯ç®èã«ãã€ãŠåžåãããè¬å€ãæŸ
åºããããã®å±éšãããããã³æ³šå ¥
ïŒimplantarionïŒã«ãã€ãŠäœ¿çšããããã«å©ç¹ã
ããã 湿最ããªããŒã»ãã€ãªã€ãŒããã®æŸåºã¢ãŒãã¯
ããçš®ã®ç¹å¥ã®çšéã«çšããŠãããããšãæå³ã
ãŠãããäŸãã°è¬å€ãæ¯æ¥å°éäœå ã«æŸåºããå¿
èŠã®ããç æ°ã®æ²»ççã§ããã人ã®äœæž©ã¯äžæ¥ã
éããŠå€åããŠãããäžè¬ã«ãµã€ã¯ã«ã圢æããŠ
ãããããªããŒã®èšæœ€ã®çšåºŠã¯æž©åºŠã«äŸåããŠã
ãã®ã§ãã®äžã«åžåãããé©åœãªè¬å€ã®æº¶æ¶²ãæ
ããèšæœ€ããªããŒã®ãã€ãªã€ãŒãäœã«æ€ãã€ããŠ
ããããããªããŒã¯äœæž©ã®å€åã«å¿çããŠåçž®ã
ãããèšæœ€ããããããåçž®æéäžãå³ã¡æŽæµæž©
床æéäžãåžåããè¬å€ã®å¢å éšåã¯ããªããŒã®
ãã€ãªã€ãŒããè¡æ¶²æµäžã«æŸåºãããè¬å€ã®æ¯æ¥
ã®ãµã€ã¯ã«æäžãæäŸããã æ¬çºæã®æŸåºèª¿ç¯çµæç©äžã«å°å ¥ããã掻æ§ç©
質ã®æ¿åºŠã¯éåžžã«é«ãããäœãç¯å²ããšãåŸãã
åŸã€ãŠãããäŸãã°1000pph以äžã«ããªããŒãèš
最ããïœâã¯ã¬ãŸãŒã«ã®ããšã液ç¶ã®çç©åŠçã«
掻æ§ãªç©è³ªãããªããŒãèšæœ€ããããã«äœ¿çšãã
ãšãã¯æŽ»æ§ç©è³ªã¯æŸåºçµæç©ã®90ééïŒ ä»¥äžå«ã
ããšãã§ããã1000pphã«èšæœ€ãã25ïŒ ã®è¬å€ã
å«ã液äœã¯ä¹Ÿç¥ããªããŒäžã«70ïŒ ä»¥äžã®è¬å€ãæ®
ãåŸãã30ã70ïŒ ã®è¬å€ãå«ãŸãããšã¯ããæ®é
ã«ãªãåŸãããšã§ãããããã«äœãè£ å¡«ãäŸãã°
1.0ã0.5ïŒ ã容æã«éæãåŸãã é«åºŠã®ããªããŒèšæœ€ïŒããã¯å¯èœã§ããïŒãšèª
ç¶ãªäœæž©ãµã€ã¯ã«ã§çãã枩床ã®åŸ®ããªçžç°ã¯å°
éã®è¬å€ãé·æéã«ããã€ãŠæ¯æ¥äœå ã«æŸåºãã
ãããšãå¯èœã«ããåŸã€ãŠãã®ããšã¯äŸãã°æ°Žæº¶
æ§ã®äœãé·æäœçšåé¿åŠè¬çã®é åã§èå³æ·±ãã 湿最ããªããŒã®å¥ã®å¿çšã¯å»è¬åéå€ã«ãã
ããäžã€ã®èŸ²æ¥çšçšéã¯è²¯èµç§èã®éé µã®æå¶ã«
ããããã®éé µã¯é«æž©ã§ä¿é²ãããã®ã§ãäžææž©
床ã§æŽ»æ§åãããæå¶å€ãæãŸããããã掻æ§ç©
質ãšããŠéé µæå¶å€ãå«ãèšæœ€ããªãšãã¬ã³ãªã
ã·ããåšå²æž©åºŠãäœãæã«è²¯èµç§èäžã«æ³šå ¥ãã
ãšã枩床ã®äžæã¯ããªããŒãåçž®ãããŠæå¶å€ã
æŸåºã貯èµç§èã®éé µãé²æ¢ãŸãæå¶ããã ããªããŒã®èšæœ€ã®æž©åºŠäŸåæ§ã¯ãŸã埮éæåã
å¿ é æè²æåã幎ãŸãã¯æ¥ãããšã«ããŠåå£äžã«
æŸåºãããã®ãå¯èœã«ããå€ã®æž©åºŠã®äžæã«ã€ã
ãŠãèšæœ€ããªãšãã¬ã³ãªãã·ãã«ãåžåããã埮
éæåãçè²æå溶液ãæŸåºããããåŸã€ãŠæ¬çº
æçµæç©ã§ã®åå£ã®åŠçã¯éé¢æ¶²æ©æ§ã§çããæŸ
åºã®çšåºŠã«ããããæ°å¹Žã«ããã€ãŠæå¹ã§ããã æ¬çºæçµæç©ã®ä»ã®çšéã¯æŒã®æž©åºŠã®äžæã®çµ
æãšããŠæã¹ã©ã€ã å€ïŒãŸãã¯æ®ºè»å€ïŒã®é©çšã«
ããã¹ã€ãã³ã°ã»ããŒã«ã®è»ã®ããšãã¹ã©ã€ã ã®
圢æã®é²æ¢ãããã³è²¯èµéåæ§ã¢ãããŒäžã®æž©åºŠ
ã®äžæã«å¿çããéåæå¶å€ã®æŸåºã«ããéåã®
æå¶çãããããããã®å Žåãèšæœ€ããªãšãã¬ã³
ãªããµã€ãäžã«åžåããã掻æ§ç©è³ªã¯ããããæ
ã¹ã©ã€ã å€ïŒãŸãã¯æ®ºè»å€ïŒããã³éåæå¶å€ã§
ãããæ¬çºæã®æŸåºèª¿ç¯çµæç©ã¯ä¹Ÿç¥ç¶æ ã§çµæ¶
ãããªãã¯ã¹äžãžã®å°å ¥ã«ããäœçœ®çã«äžå®å®ãª
ååç©ã®è²¯èµå®å®æ§ã«ãããŒãå¹æã«é¢ããŠãé
èŠã§ããã 掻æ§ç©è³ªã®åœ¢æã«ãããŠæ¬çºæã«äœ¿çšãããé
åãã€ãªã€ãŒã®äžè¬çãªå©ç¹ããæ¬ç®çã®ããã«
åœè©²æè¡åéã«ãããŠèšèŒãããŠããä»ã®ããªã
ãŒé¡ãšæ¯èŒããŠä»¥äžã«èŠçŽããããã®ããªããŒã¯
éçŽç·ç¶ã§ãæ¶æ©ãããæ¬è³ªçã«æ°Žããã³ææ©æº¶
å€ã«äžæº¶æ§ã§ããé«åœéç³»ïŒhigh equivalent
weight systemsïŒã§ãããæ°Žããã³é氎系溶å€
ã®äž¡æ¹ã§é«åºŠã®èšæœ€æ§ã瀺ãã也ç¥ããã³æ¹¿æœ€å
äž¡æ¹ã§åŒ·é±ãªç©è³ªã圢æããïŒäœãåŸè ã®å Žåã
ããå°ããç¯å²ã«ãªãïŒãéåãã€ãªã€ãŒã¯ãŸã
也ç¥ã²ã«äžã«ååšããçµæ¶å床ãŸãã¯æ¹¿æœ€ããªã
ãŒã§åŸãããé¢æ¶²å¹æã®ããããã§æå¶ããã奜
ãŸããæŸåºãããã¢ã€ã«ã瀺ãã åŸã€ãŠæ¬çºæã¯ããã«æŽ»æ§ç©è³ªããã³ãã®ãã
ã®éåãã€ãªã€ãŒãå«ãæŸåºèª¿ç¯çµæç©ãå«ã¿ã
該ãã€ãªã€ãŒã¯ããªãšãã¬ã³ãªãã·ããå«ã¿ã也
ç¥åœ¢æ ã§é©åºŠã®çµæ¶å床ãæã湿最ç¶æ ã§é¢æ¶²ã
瀺ãããšãç解ãããã§ããããäžã§äœ¿çšããã
çšèªãé¢æ¶²ãã¯100âãããïŒâã«ãããæ¹ãæ°Ž
æ§åªäœäžã§å®è³ªçã«å€§ããèšæœ€ãè¡ãªãæ§è³ªãæ
å³ããŠãããçµæ¶å床ã¯ä¹Ÿç¥åã®æ£ç¢ºãªåæãè¡
ãªãå©ããšãªãã 以äžãå®æœäŸã«ããæ¬çºæã説æããã å®æœäŸ ïŒã37 ãããµã³âïŒïŒïŒïŒïŒâããªãªãŒã«ïŒHTïŒ
ãã¢ã«ããªãã瀟ïŒAldrich Chem.Co.ïŒåžè²©åã
宀枩ã§24æéç空也ç¥ãããã®ã2.443ïœãã觊
åªãšããŠã®ç¡æ°Žå¡©å第äºéïŒã¢ã«ããªãã瀟ã®åž
販åãã³ãŒã«ããã€ã³ã¬ãŒã³ã³ãã³ãµãŒå ã§æè¯
ãããããšã«ãã€ãŠããã«ç²Ÿè£œãããã®ïŒ0.5349
ïœãšããŒã«ãŒå ã§æ··åãããæ··åç©ã90âã§15å
éæŸçœ®ããæ°å¹³åååé3100ã®ããªãšãã¬ã³ãªã
ã·ãïŒPEOïŒããã€ãŒç€ŸïŒHythe Chemicals
Ltd.ïŒã®åžè²©åã也ç¥çªçŽ ããŒãžäžãç空ã§ïŒã
ïŒæé也ç¥ãããã®ã40ïœãå ããæªææ··åãã
æ··åç©ã90âã§15åéæŸçœ®ãããèžçããã¢ã¯ã
ã¬ã€ã³ããã©ããŒïŒC1ïŒãã«ããã€ã¢ã³ã»ã€ã³ã
ã¹ããªãŒãºç€ŸïŒCanadian Industries Ltd.ïŒã®æ
äŸåããæ·»å ããŠïŒåéæªæãããã¢ã¯ãã¬ã€ã³
ããã©ããŒã¯çªçŽ æ°æµäžã§ã®æžå§äžã§ïŒåèžçã
ããæåŸã®èžçã«ãããŠã¯ãæåã®çåïŒ10ïŒ ïŒ
ãšæåŸã®çåïŒ20ïŒ ïŒãé€ããäžéã®çåïŒæ²žç¹
78ã80âïŒãäžæŽ»æ§é°å²æ°äžã«æéãã䜿çšãã
ãŸã§ã¬ã©ã¹ã¢ã³ãã«ã«å°ã蟌ãã ãæ··åç©ã¯äºç±
ããããªãããã¬ã³è£œã¢ãŒã«ãå ã«æ³šã蟌ã¿ãæ
æ°ãã¢ã³ãåããéæ°å®€å ã«ãããŠ90âã§4.5æ
éä¿æããããšã«ãã€ãŠç¡¬åãããã å¡©å第äºé觊åªã®äœ¿çšéã¯åå¿æåã®å šééã®
0.1ïŒ ãšããããããµã³ããªãªãŒã«ã®äœ¿çšéã¯ã
ãªãšãã¬ã³ãªãã·ãã®1.394ã¢ã«åœéãšããã䜿
çšããã¢ã¯ãã¬ã€ã³ããã©ããŒã¯24ïŒ éå°ãšã
ãã ã¢ãŒã«ãããªãŒãã³ããåãåºãã宀枩ãŸã§å·
åŽããããããã²ã«ãã¢ãŒã«ãããåãåºããã¹
ã©ã€ã¹ãåãåããçµæ¶å床ãšæ°Žäžã§ã®ééå¢å
ã枬å®ãããïŒãã匟æ§ã®ãããã²ã«ã¯ã¢ãŒã«ã
ããåãåºãåã«â25âã§çŽïŒæéå·åŽãããïŒ çµæ¶å床ã¯è解ç±ã®æž¬å®ãã決å®ããïŒããªã
ãŒã®è解ç±ã¯çµæ¶å床ã«æ¯äŸããïŒããããã²ã«
ã®è解ç±ã¯åŸ®çµæ¶ãè解ããã®ã«å¿ èŠãªç±ã枬å®
ããããšã«ãã€ãŠæ±ºå®ããçµæ¶å床ïŒïŒ ïŒã¯ãå®
å šãªçµæ¶æ§è©ŠæããåŸãããå€ã«å¯Ÿãããã®å€ã®
æ¯ããèšç®ããããå®å šãªçµæ¶æ§è©Šæã¯å ¥æã§ã
ãªãã€ãã®ã§ãçŽç²ãªPEOã®è解ç±ãçšããã
ãã®å€ã¯ãã©ãŠã³ãã«ãã€ãŠ220.12Jg-1ãšæ±ºå®ã
ããŠããïŒBraun et al.Kolloid Zeit.第215å·»ã
第10é ã1967幎ïŒãã æå®éïŒçŽ10ã40mgïŒã®ãããã²ã«è©Šæã®è解
ãšã³ãã°ã©ã ïŒfurion endogramsïŒãç±åæåš
ïŒããŠãã³ç€Ÿè£œ910åããã³990åïŒãçšããŠïŒå
æããåã ã®è解ãšã³ãã°ã©ã ã®äžã®é¢ç©ããã©
ãã¡ãŒã¿ãŒãçšããŠæž¬å®ãããããŒã¯ã®äžã®æž¬å®
é¢ç©ã®å¹³åå€ããè解ç±ãèšç®ããã æ°Žäžã§ã®ééå¢å ã¯ãééãšåãïŒçŽ1.35±
0.2mmïŒãæ¢ç¥ã®è©Šæã¹ã©ã€ã¹ãèžçæ°Žäžã«æµžæŒ¬
ãã宀枩ïŒçŽ20âïŒã§çŽ24æéæŸçœ®ããããšã«ã
ã€ãŠæ±ºå®ãããã¹ã©ã€ã¹ãåãåºããæ°Žåããã
ã·ãŠãçšããŠåžåãã秀éããã å®æœäŸïŒã37ã¯ãããšå®è³ªäžåãæäœã§ãããª
ã€ãã觊åªãšããŠãã·ã«é žïŒtosylicacidïŒïŒïŒ°â
ãã«ãšã³ã¹ã«ãã³é žïŒïŒPTSAïŒããã€ãœã³ãºç€Ÿ
ïŒFisonsïŒããäžæ°Žåç©ãšããŠåžè²©ãããŠããã
ã®ããããŒã³ã»ã¹ã¿ãŒã¯ãã©ããïŒDeanïŒStark
trapïŒãåãããã©ã¹ã³å ã«ãããŠãã«ãšã³250
cm3ãšå ±ã«ä¹Ÿç¥çªçŽ ããªãŒãäžã§ïŒæééæµããŠè±
æ°Žããæ¿çž®ããç空äžã§åçµä¹Ÿç¥ãããã®ããçš
ãããšãã¯ãåå¿æåã®å šééã®0.35ïŒ ãšããã
PTSAãçšãããšãã¯ããããã²ã«ã®èåãé²ã
ããã«è§Šåªã溶é¢ãããå¿ èŠããã€ãã è¡šâïŒã«ãããŠããB.I.F.ãã¯20æé以å ã«ã
ã©ã°ã¡ã³ãã«ç Žå£ããããšãæå³ããã PTSAãçšããŠãããã²ã«ã調補ãããšçµæ¶å
床ãé«ããªããçŽïŒãïŒæ¥éæŸçœ®ãããšèåãã
ïŒãããã²ã«ãçŽâ25âã«åçµãããšå¹Ÿåé·ãæ
éã芳枬ãããïŒãèåããè©Šæã¯å®¹æã«æ°Žåã
ãã厩å£ããåŸåãã¿ãããããã®äžå©ãªç¹ã¯ã
調補çŽåŸã®ããªããŒãæ°Žäžã«æµžæŒ¬ãã也ç¥ããã
ãšã«ãã€ãŠå®å šã«å æãããïŒãã®äœçšã¯è§Šåªã
浞åºããããã®ãšèããããïŒãFeCl3ãçšããŠ
調補ãããããã²ã«ã¯ãã®ãããªæåã瀺ããªã
ã€ãã HTãšC1ã®äž¡æ¹ã®æ¯ãå¢å ããã«ã€ããŠçµæ¶å
ã¯å¢å ããæ°Žã®åžæ°Žã¯æžå°ãããéå°ã®C1ã®äœ¿
çšã¯çµæ¶å床ãçŽ56ïŒ ãçŽïŒïŒ ã«ããã€ãŠå€åã
ãããŸãæ°Žã®åžåãçŽ956ïŒ ãçŽ103ïŒ ã«ããã€ãŠ
å€åãããç¹ã«æçšãªæè¡ã§ãã€ããC1ããèª
äœãããªããŒã®æ¶æ©å¯åºŠãå€åãããããšãçµæ
ããæããã§ããã å®æœäŸ 38 æ¬å®æœäŸã«ãããŠã¯ãåã ïŒçš®é¡ã®ãããã²ã«
ããæãïŒç³»åã®è©Šæãå®è³ªäžå®æœäŸïŒã«èšèŒã
ãããã«ããŠèª¿è£œããããããã®è©Šæã®çµæã¯æ¬¡
ã®éãã§ããã ç³»åïŒïŒPEOïŒoïŒ3100ïŒïŒHTïŒ1.394ïŒïŒC1 ïŒ1.ååŠéè«éïŒ ïŒ2.9.789ïŒ éå°ïŒ ïŒ3.17.27ïŒ éå°ïŒ ïŒ4.24.03ïŒ éå°ïŒ ïŒ5.57.8ïŒ éå°ïŒ ïŒ6.12.5ïŒ éå°ïŒ ïŒ7.200ïŒ éå°ïŒ ç³»åïŒïŒPEOïŒïœïŒ7000ïŒïŒHT(2)ïŒC1 ïŒ1.ååŠéè«éïŒ ïŒ2.10ïŒ éå°ïŒ ïŒ3.20ïŒ éå°ïŒ ïŒ4.30ïŒ éå°ïŒ ïŒ5.50ïŒ éå°ïŒ ïŒ6.100ïŒ éå°ïŒ ïŒ7.200ïŒ éå°ïŒ ãããã²ã«ã®äžèšïŒç³»åã®èžçæ°ŽïŒ21âïŒäžã§
ã®èšæœ€ç¹æ§ã¯ãééãšå¯žæ³ãæ¢ç¥ã®ãããã²ã«ã®
å°ããªã¹ã©ãïŒè¡šâïŒåç §ïŒãèžçæ°Žäžã«æµžæŒ¬ã
ããããšã«ãã€ãŠèª¿ã¹ããã¹ã©ãã¯æµžæŒ¬ããŠãã
ïŒååŸãïŒååŸãïŒååŸãïŒååŸãïŒååŸã10å
åŸã20ååŸã30ååŸãããã³60ååŸã«åãåºãã
æ°Žåãåžåãã秀éããŠå浞挬ããããã®æäœã
平衡ã«éãããŸã§ç¶è¡ããã ãã®å®éšã¯è¡šâïŒã«ç€ºãããã«éžæããããã
ã²ã«ãçšããŠèžçæ°ŽïŒ37âïŒäžã§ç¹°ãè¿ããã ãã®å®éšã¯è¡šâïŒã«ç€ºãããã«èšæœ€å€ãšããŠãš
ã¿ããŒã«ãšã¯ãããã«ã ãšã®50ïŒ50ïŒïŒ·ïŒïŒ·ïŒæ··
åç©ïŒ21âïŒãçšããéžæãããããã²ã«ã«ã€ã
ãŠç¹°ãè¿ããã å®æœäŸ 39 æ¬å®æœäŸã§ã¯ãå®è³ªäžå®æœäŸïŒã«èšèŒãããã
ãã«ããŠïŒçš®é¡ã®2.5ãããã²ã«ã¹ã©ãã調補ã
ãããã³ãŸã«ã€ã³ãããŒã»ãã€ãŒã»ãšã€ãã»ã±ã
ã«ã«ãºç€ŸïŒB.D.H.Chemicals Ltd.ïŒã®åžè²©åãš
ãã«âïŒâã¢ãããã³ãŸãšãŒããããšã¿ããŒã«ãš
ã¯ãããã«ã æ··åç©ïŒ75ïŒ25VïŒïŒ¶ïŒ500mläžã«
宀枩ïŒ21âïŒã§æ·»å ãããã¹ã©ããè¬å€æº¶æ¶²ïŒå®€
æž©ïŒäžã«äžå€ïŒ17æéïŒèšæœ€ãããïŒè¡šâïŒå
ç §ïŒã èšæœ€ã¹ã©ããåãåºããæ°Žåãåžåãã秀éã
ãããããã®è©Šæã¯ç空ãªãŒãã³äžã§ïŒæ¥é也ç¥
ãããæªèšæœ€ã®ããªããŒãããªãã¯ã¹äžã«å«ãŸã
ãè¬å€ãå¹æçã«é€å»ãããè¬å€ãå«ãã ïŒçš®é¡
ã®ã¹ã©ãïŒïŒïŒïŒããã³ïŒïŒãèžçæ°ŽïŒ37âïŒäž
ã§åèšæœ€ããããã¹ã©ãã¯æµžæŒ¬ããŠããïŒååŸã
ïŒååŸãïŒååŸãïŒååŸã10ååŸã20ååŸã30å
åŸã60ååŸã«åãåºããæ°Žåãåžåãã秀éãã
å浞挬ããããã®æäœã平衡ã«éãããŸã§ç¶è¡ã
ãã ä»ã®ïŒçš®é¡ã®è¬å€å«æã¹ã©ãïŒïŒïŒïŒããã³
ïŒïŒãã¬ãŒãŒå®¹åšã«å ¥ãããœãŒã¬ã³ã»ã³
ïŒSorensenïŒç·©è¡æº¶æ¶²ïŒPH7.5ïŒ37âïŒ1000mläžã«
浞挬ããäžå®ã®é床ã§å転ããããè¬å€ã¯è£ 眮ã
ãæ¡æ£ããã®ã§å転ã«ãã€ãŠãã«ã¯ç·©è¡æº¶æ¶²äžãž
æ¥éã«åæ£ãããç·©è¡æº¶æ¶²ã®ã¢ãªã³ãŒãã浞挬ã
ãŠããïŒååŸãïŒååŸã10ååŸã20ååŸã30å
åŸã60ååŸã«åãåºããUVåå å 床èšïŒPERKI
âNELMER 551ïŒãçšããŠ285nmã§ã®UVåžå
床ã枬å®ãããåžå 床ã¯ãçš®ã ã®æ¢ç¥æ¿åºŠã®ãã³
ãŸã«ã€ã³ãå«æããç·©è¡æº¶æ¶²ã®åžå 床ã枬å®ãã
ããšã«ãã€ãŠæ€éããã ãã®å®éšãïŒçš®é¡ã®2.6ãããã²ã«ã¹ã©ããçš
ããŠç¹°ãè¿ããïŒè¡šâïŒåç §ïŒãæªèšæœ€ã®ããã
ã²ã«ãããªãã¯ã¹ã«å«ãŸãããã³ãŸã«ã€ã³ã也ç¥
é€å»ããåŸãïŒçš®é¡ã®ã¹ã©ãããšã¿ããŒã«ïŒã¯ã
ããã«ã ãã³ãŸã«ã€ã³æº¶æ¶²äžã§äžå€ïŒ16æéïŒå
èšæœ€ããããå åã«èšæœ€ããã¹ã©ãïŒïŒïŒïŒãã
ã³ïŒïŒãåè¿°ã®ããã«ã¬ãŒãŒå®¹åšã«å ¥ããç·©è¡æº¶
液ã«æµžæŒ¬ããå転ããããã¢ãªã³ãŒããåãåº
ããåè¿°ã®ããã«ããŠUVåžå 床ã枬å®ããã ãã®å®éšã¯ããã³ãŸã«ã€ã³æº¶æ¶²ã®è¡šç€ºä»¥å€ã¯å®
質äžïŒçš®é¡ã®2.6ãããã²ã«ã¹ã©ãã®å Žåãšåæ§
ã«ããŠïŒçš®é¡ã®2.7ãããã²ã«ã¹ã©ããçšããŠç¹°
ãè¿ããïŒè¡šâïŒåç §ïŒã ãã®å®éšã¯ããã«ããã³ãŸã«ã€ã³23.64ïœãçš
ããŠïŒçš®é¡ã®2.6ãããã²ã«ã¹ã©ãã«ã€ããŠç¹°ã
è¿ããïŒè¡šâïŒåç §ïŒãå åèšæœ€ããïŒçš®é¡ã®ã¹
ã©ãïŒïŒïŒïŒããã³ïŒïŒãåè¿°ã®ããã«ããŠã¬ãŒ
ãŒå®¹åšã«å ¥ããç·©è¡æº¶æ¶²äžã«æµžæŒ¬ããå転ããã
ã¢ãªã³ãŒããåãåºããåè¿°ã®ããã«ããŠUVåž
å 床ã枬å®ãããä»ã®ïŒçš®é¡ã®ã¹ã©ãïŒïŒïŒïŒã
ãã³ïŒïŒã¯ç空ãªãŒãã³äžã§ïŒæ¥é也ç¥ãããå
è¿°ã®ããã«ããŠã¬ãŒãŒå®¹åšå ã§åèšæœ€ãããç·©è¡
溶液äžã«æµžæŒ¬ãããå転ããããã¢ãªã³ãŒããå
ãåºããåè¿°ã®ããã«ããŠUVåžå 床ã枬å®ã
ããæŸåºã®1000ååŸã«ããŒã«âã©ã³ãã«ã®æ³å
ïŒBeerâLambert lawïŒã«åŸããªããªã€ãã®ã§å
æãäžæ¢ããã å®æœäŸ38ãš39ã®çµæãæ·»ä»å³ã«ç€ºãã 第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšãã
ããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã 第ïŒå³ã¯C1éå°ã®é¢æ°ãšããããªããŒç³»åïŒ
ã®èšæœ€çŸåçã瀺ãã 第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšãã
ããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã 第ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšããè¡šâïŒã®ããª
ããŒã®èšæœ€çŸåçã瀺ãã 第ïŒå³ã¯è¡šâïŒã®å åã«èšæœ€ããããªããŒã®æ
éã®é¢æ°ãšããçäœå€ã§ã®ãã³ãŸã«ã€ã³æŸåºé床
ã瀺ãã 第ïŒå³ã¯è¡šâïŒã®ä¹Ÿç¥ããªããŒã®æéã®é¢æ°ãš
ããçäœå€ã§ã®ãã³ãŸã«ã€ã³æŸåºé床ã瀺ãã 第ïŒå³ã¯è¡šâïŒã®å åã«èšæœ€ããããªããŒã®æ
éã®é¢æ°ãšããçäœå€ã§ã®ãã³ãŸã«ã€ã³æŸåºé床
ã瀺ãã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšãã
ããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã第ïŒå³ã¯
C1éå°ã®é¢æ°ãšããããªããŒç³»åïŒã®èšæœ€çŸå
çã瀺ãã第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢
æ°ãšããããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã第
ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšããè¡šâïŒã®ããªããŒ
ã®èšæœ€çŸåçã瀺ãã第ïŒå³ã¯è¡šâïŒã®å åã«èš
最ããããªããŒã®æéã®é¢æ°ãšããçäœå€ã§ã®ã
ã³ãŸã«ã€ã³æŸåºé床ã瀺ãã第ïŒå³ã¯è¡šâïŒã®ä¹Ÿ
ç¥ããªããŒã®æéã®é¢æ°ãšããçäœå€ã§ã®ãã³ãŸ
ã«ã€ã³æŸåºé床ã瀺ãã第ïŒå³ã¯è¡šâïŒã®å åã«
èšæœ€ããããªããŒã®æéã®é¢æ°ãšããçäœå€ã§ã®
ãã³ãŸã«ã€ã³æŸåºé床ã瀺ãã
ããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã第ïŒå³ã¯
C1éå°ã®é¢æ°ãšããããªããŒç³»åïŒã®èšæœ€çŸå
çã瀺ãã第ïŒå³ããã³ç¬¬ïŒå³ã¯ïŒæéïŒ1/2ã®é¢
æ°ãšããããªããŒç³»åïŒã®èšæœ€çŸåçã瀺ãã第
ïŒå³ã¯ïŒæéïŒ1/2ã®é¢æ°ãšããè¡šâïŒã®ããªããŒ
ã®èšæœ€çŸåçã瀺ãã第ïŒå³ã¯è¡šâïŒã®å åã«èš
最ããããªããŒã®æéã®é¢æ°ãšããçäœå€ã§ã®ã
ã³ãŸã«ã€ã³æŸåºé床ã瀺ãã第ïŒå³ã¯è¡šâïŒã®ä¹Ÿ
ç¥ããªããŒã®æéã®é¢æ°ãšããçäœå€ã§ã®ãã³ãŸ
ã«ã€ã³æŸåºé床ã瀺ãã第ïŒå³ã¯è¡šâïŒã®å åã«
èšæœ€ããããªããŒã®æéã®é¢æ°ãšããçäœå€ã§ã®
ãã³ãŸã«ã€ã³æŸåºé床ã瀺ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ïŒïŒ åŒïŒ åŒäžãR1ãšR2ã¯åäžãŸãã¯ç°ãªãæ°ŽçŽ å
åããŸãã¯çœ®æãŸãã¯é眮æã®ãããã«ã«ãã«
ãããã¯ãããã«ã«ãããã·åºïŒR3ã¯çœ®æãŸ
ãã¯é眮æã®ã¡ãã¬ã³ããšãã¬ã³ããŸãã¯ïŒïŒ
ïŒâãããã¬ã³åºã瀺ãã§è¡šããããäžé£œå
ç°åŒãšãŒãã«åºãæããéåå¯èœãªã¢ãããŒïŒ
ããã³ ïŒïŒ åœéãå°ãªããšã250ã§ããããªã¢ã«ã
ã¬ã³ãªãã·ãæ®åºãæãã芪氎æ§ãã¢ãŸãã¯ã³
ããªã㌠ãšãåå¿ãããŠåŸãããéåéšåãå«ããã€ãã
ã²ã«ã ïŒ ãã€ããã²ã«ãæ°Žæ§åªäœäžã§å æ°Žå解ãåŸã
第ïŒé èšèŒã®ãã€ããã²ã«ã ïŒ ïŒïŒãå æ°Žå解å¯èœãªå®èœåºãå«ã第ïŒé
ãŸãã¯ç¬¬ïŒé èšèŒã®ãã€ããã²ã«ã ïŒ ïŒïŒãå æ°Žå解å¯èœãªå®èœåºãå«ã第ïŒé
ãŸãã¯ç¬¬ïŒé ã«èšèŒã®ãã€ããã²ã«ã ïŒ ãã€ããã²ã«ãå æ°Žå解å¯èœãªã«ã«ããã·ãš
ã¹ãã«ãã«ãŒãããŒããšã¹ãã«ãã¢ããããŠã¬ã¿
ã³ãŸãã¯ã°ãªã³ã·ãå®èœåºãæãã第ïŒé ãã第
ïŒé ããããã«èšèŒã®ãã€ããã²ã«ã ïŒ éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒãåŒïŒ åŒäžãR1ïŒR2ãããã³R4ã¯åäžãŸãã¯ç°ãª
ã€ãŠããããããããæ°ŽçŽ ååãŸãã¯çœ®æããã
ã¯é眮æã®ãããã«ã«ãã«ãããã¯ãããã«ã«ã
ããã·åºãè¡šããïŒ R3ã¯çœ®æãŸãã¯é眮æã®ã¡ãã¬ã³ããšãã¬ã³ã
ãŸãã¯ïŒïŒïŒâãããã¬ã³åºãè¡šããïŒ R5ã¯ïŒäŸ¡ã®éåå¯èœãªåºïŒãã㳠ã¯åŒïŒ ïŒåŒäžãã¯é žçŽ ååãŸãã¯âNR6âåºã§ã
ããR6ã¯R1ãšåæçŸ©ïŒ ïœã¯ïŒãŸãã¯ïŒïŒ ïœã¯ïŒãŸãã¯ïŒïŒ ïœã¯ïŒãŸãã¯ïŒïŒ ïœã¯ïŒãŸãã¯ïŒïŒ äœããïœãŸãã¯ïœã®å°ãªããšãïŒã€ã¯ïŒã§ã
ãïŒ ããããã瀺ãã§è¡šãããã第ïŒé ãã第ïŒé
ããããã«èšèŒã«ãã€ããã²ã«ã ïŒ ïŒžãâCOOâãŸãã¯âCH2OCOâãè¡šãã
第ïŒé èšèŒã®ãã€ããã²ã«ã ïŒ éåå¯èœãªäžé£œåç°åŒãšãŒãã«ãåŒïŒ
ãåŒããŸã㯠ãåŒããæãã第ïŒé èšèŒ ã®ãã€ããã²ã«ã ïŒ éåå¯èœãªäžé£œåç°åŒãšãŒãã«ãåŒïŒ åŒäžãRâ²1ïŒRâ²2ããã³Râ²4ã¯åäžãŸãã¯ç°ãª
ã€ãŠããããããããR1ïŒR2ããã³R4ãšåæ矩
ãæãã第ïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ éåå¯èœãªäžé£œåç°åŒãšãŒãã«ãã¢ã¯ãã¬
ã€ã³ã»ããã©ããŒã§ãã第ïŒé èšèŒã®ãã€ããã²
ã«ã ïŒïŒ éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã
åŒïŒ åŒäžãR1ïŒR2ïŒR3ïŒR4ããã³R5ã¯åèšãšå
æ矩ïŒããã³ïŒžã¯åŒïŒ ïŒåŒäžãã¯é žçŽ ååãŸãã¯âNRïŒâåºãè¡š
ããR6ã¯R1ãšåæçŸ©ïŒ ïœã¯ïŒãŸãã¯ïŒïŒ ïœã¯ïŒãŸãã¯ïŒïŒ ïœã¯ïŒãŸãã¯ïŒïŒ äœããïœïŒïœã¯ïŒãè¡šããïŒã瀺ããæãã
第ïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ éåå¯èœãªäžé£œåç°åŒãšãŒãã«ïŒïŒã
åŒïŒ ãåŒããŸã㯠ãåŒã åŒäžãR1ïŒR2ïŒR3ããã³R4ã¯åèšãšåæ
矩ïŒRâ²1ïŒRâ²2ïŒRâ²3ïŒRâ³1ïŒRâ³2ïŒRâ³3ããã³Râ³4ã¯
åäžãŸãã¯ç°ãªã€ãŠããããããããR1ïŒR2ã
ãã³R3ãšåæ矩ïŒR7ã¯ïœâããããã·ååç©ã®
ïœâ䟡ã®ãã€ããã«ãŒãã³ãŸãã¯ããªïŒãªãã·ã
ã€ããã«ãŒãã³ïŒæ®åºïŒR8ã¯ïœâ䟡ã®å æ°Žå解
ãããªãæ¶æ©ïŒbridgingïŒæ®åºãè¡šãããæã
ã第ïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ R1ïŒR2ãŸãã¯R4ã®å°ãªããšãïŒåã¯æ°ŽçŽ
ååã§ãã第ïŒé ãã第ïŒé ã第ïŒïŒé ãŸãã¯ç¬¬
ïŒïŒé ããããã«èšèŒã®ãã€ããã²ã«ã ïŒïŒ R3ã¯ã¢ãâãŸãã¯ããªâ眮æãããã¯é
眮æã®ãšãã¬ã³åºãè¡šãã第ïŒé ãã第ïŒé ã第
ïŒïŒé ãã第ïŒïŒé ããããã«èšèŒã®ãã€ããã²
ã«ã ïŒïŒ éåå¯èœãªäžé£œåç°åŒååç©ããšãŒãã«ã§
ãã第ïŒé ã第ïŒé ã第ïŒïŒé ãŸãã¯ç¬¬ïŒïŒé ã
ãããã®ãã€ããã²ã«ã ïŒïŒ 芪氎æ§ãã¢ãŸãã¯ã³ããªããŒïŒïŒãå°ãª
ããšãïŒåã®äžèšã®ã¢ãããŒçŸ€ïŒ (a) ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ã
ããŸãã¯é眮æã®ãŸãã¯ããããã·çœ®æãšãã«
ãŸãã¯ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãããŸãã¯
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žã®ããªïŒãªãã·ãšãã¬ã³ïŒ
ãšã¹ãã«ïŒ (b) ïŒãïŒåã®ç°ååãæãã眮æãŸãã¯é眮æ
ã®ç°åŒã¢ããŸãã¯ããªãšãŒãã«ãŸãã¯ïŒåã®ç°
ååãæããç°åŒã€ãã³ïŒãŸã㯠(c) 眮æãŸãã¯é眮æã®ããã«ã¢ã«ã³ãŒã«ãã¢ã«
ãããããšãŒãã«ãã¢ã»ã¿ãŒã«ãã±ãã³ããšã¹
ãã«ãŸãã¯çœ®æãããã¯é眮æã®ïŒ®âããã«ç°
é ç°åŒååç© ããèªå°ãããæ®åºãå«ã第ïŒïŒé èšèŒã®ãã€ã
ãã²ã«ã ïŒïŒ 芪氎æ§ãã¢ãŸãã¯ã³ããªããŒïŒïŒãéå
é žåã¢ã«ãã¬ã³æ®åºãå«ã第ïŒïŒé ããã³ç¬¬ïŒïŒ
é ããããã«èšèŒã®ãã€ããã²ã«ã ïŒïŒ é žåã¢ã«ãã¬ã³ãé žåãšãã¬ã³ãå«ã第ïŒ
ïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ 芪氎æ§ãã¢ãŸãã¯ã³ããªããŒããã¢ãŸãã¯
ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒã§ãã第ïŒïŒé ã
第ïŒïŒé ãŸãã¯ç¬¬ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ 芪氎æ§ãã¢ãŸãã¯ã³ããªããŒããã¢ãŸãã¯
ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒã§ãã第ïŒïŒé ãŸ
ãã¯ç¬¬ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ ãã¢ãŸãã¯ã³ããªïŒã¢ã«ãã¬ã³ãªãã·ãïŒ
ãå®èœåºã«å¯Ÿããæ°å¹³åååéã®æ¯ã1000以äžã®
ããªãšãã¬ã³ãªãã·ãæ®åºãæãã第ïŒïŒé ãŸã
ã¯ç¬¬ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ 該æ®åºãå®èœåºã«å¯Ÿããæ°å¹³åååéã®æ¯
1500以äžãæãã第ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ æ®åºãå®èœåºã«å¯Ÿããæ°å¹³åååéã®æ¯
2000以äžãæãã第ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ ãã€ããã²ã«ã也ç¥ç¶æ ã§çµæ¶æ§ã§ããã
湿最ç¶æ ã§é¢æ¶²ã瀺ã第ïŒé èšèŒã®ãã€ããã²
ã«ã ïŒïŒ ããªãšãã¬ã³ãªãã·ãã(a)é žåãšãã¬ã³ãš
(b)èèªæãŸãã¯è³éŠæããããã·ã«ãã«ã«ããã·
ã«ãã¢ãããŸãã¯ã¡ã«ã«ããååç©ã§ãã第ïŒïŒ
é ãã第ïŒïŒé ããããã«èšèŒã®ãã€ããã²ã«ã ïŒïŒ (b)ããžãŸãã¯ããªããããã·ã«çœ®æèèªæ
ååç©ãå«ã第ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ ïŒïŒãšïŒïŒãååŠçã«æ¶æ©ãããŠãã€
ããã²ã«ã圢æããã第ïŒé èšèŒã®ãã€ããã²
ã«ã ïŒïŒ ååŠçãªæ¶æ©ãïŒä»¥äžã®æŽ»æ§æ°ŽçŽ ååãæ
ããååç©ããã€ããã²ã«äžã«å°å ¥ããããšã«ã
ãè¡ãªã€ã第ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ 該ååç©ãïŒä»¥äžã®æ°Žé žåºãæãã第ïŒïŒ
é èšèŒã®ãã€ããã²ã«ã ïŒïŒ ååŠçæ¶æ©ããïŒä»¥äžã®ç°åŒãšãŒãã«åºã
å«ãååç©ããã€ããã²ã«äžã«å°å ¥ããããšã«ã
ã€ãŠè¡ãªã第ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ ååŠçæ¶æ©ããååŠéè«çéå°éã®ïŒïŒ
ããã€ããã²ã«äžã«å°å ¥ããããšã«ãã€ãŠè¡ãªã
第ïŒïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ â120âããïŒ15âã®ã¬ã©ã¹è»¢ç§»æž©åºŠãæ
ãã第ïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ ïŒ10âããïŒ60âã®åŸ®çµæ¶èç¹ãæãã第
ïŒé èšèŒã®ãã€ããã²ã«ã ïŒïŒ ç²ç¶ã§ãã第ïŒé ãã第ïŒïŒé ããããã«
èšèŒã®ãã€ããã²ã«ã ïŒïŒ å·çšå 垯ã«æçšãªç¬¬ïŒé ãã第ïŒïŒé ãã
ããã«èšèŒã®ãã€ããã²ã«ã
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8118088 | 1981-06-12 | ||
| GB8118090 | 1981-06-12 | ||
| GB8118089 | 1981-06-12 | ||
| GB8118088 | 1981-06-12 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4193908A Division JPH0753672B2 (ja) | 1981-06-12 | 1992-07-21 | æŸåºèª¿ç¯çµæç© |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS585316A JPS585316A (ja) | 1983-01-12 |
| JPH0480052B2 true JPH0480052B2 (ja) | 1992-12-17 |
Family
ID=10522464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57101271A Granted JPS585316A (ja) | 1981-06-12 | 1982-06-12 | ãã€ããã²ã« |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS585316A (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5160328A (en) * | 1991-08-07 | 1992-11-03 | Ndm Acquisition Corp. | Hydrogel bandage |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4742983Y1 (ja) * | 1968-10-03 | 1972-12-26 | ||
| JPS5296723A (en) * | 1975-12-29 | 1977-08-13 | Uni Sutorasukuraido Za | Improvevement of injectionable pharmacevtical composition |
| JPS5441319A (en) * | 1977-06-28 | 1979-04-02 | Uni Sutorasukuraido Za | Pharmaceutical composition for treating tropic desease |
-
1982
- 1982-06-12 JP JP57101271A patent/JPS585316A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4742983Y1 (ja) * | 1968-10-03 | 1972-12-26 | ||
| JPS5296723A (en) * | 1975-12-29 | 1977-08-13 | Uni Sutorasukuraido Za | Improvevement of injectionable pharmacevtical composition |
| JPS5441319A (en) * | 1977-06-28 | 1979-04-02 | Uni Sutorasukuraido Za | Pharmaceutical composition for treating tropic desease |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS585316A (ja) | 1983-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0067671B1 (en) | Hydrogels | |
| JP2511222B2 (ja) | ã«ãã»ã«åç²åå«æçµæç© | |
| US12030986B2 (en) | Sustained release composition using biobased biodegradable hyperbranched polyesters | |
| US11191842B2 (en) | Injectable thermoresponsive polyelectrolytes | |
| US6984393B2 (en) | Biodegradable elastomer and method of preparing same | |
| DE69837443T3 (de) | Abbaubare polyethyleneglycolhydrogele mit kontrollierter halbwertzeit und ihre vorprodukte | |
| US4882168A (en) | Polyesters containing alkylene oxide blocks as drug delivery systems | |
| US5968543A (en) | Polymers with controlled physical state and bioerodibility | |
| US4894238A (en) | Controlled release compositions | |
| DE2602994A1 (de) | Orthoesterpolymere und verfahren zu deren herstellung | |
| Graham | Poly (ethylene glycol) gels and drug delivery | |
| EP0113505B1 (en) | Water-soluble polyesters | |
| JP3351523B2 (ja) | ããæ äœææããè¬åŠçããã³ïŒãŸãã¯çç©åŠçæçšç©è³ªãåŸæŸããããã®æ¹è¯ãããåŸæŸã·ã¹ãã | |
| CN106474536A (zh) | äžç§çšäºæå䌀ç液äœç»·åžŠ | |
| Ma et al. | A dual network cross-linked hydrogel with multifunctional Bletilla striata polysaccharide/gelatin/tea polyphenol for wound healing promotion | |
| US5079009A (en) | Controlled release compositions including polyethylene oxide with urethane cross-linking | |
| JP4015194B2 (ja) | å¶åŸ¡ãããç©ççç¶æ ãšçç©äŸµé£æ§ãæã€ããªã㌠| |
| JPH0480052B2 (ja) | ||
| JPH0730177B2 (ja) | ããªïŒãªã«ãã«ãŒãããŒãã¢ã»ã¿ãŒã«ïŒçäœå解æ§ããªã㌠| |
| CN106474537A (zh) | äžç§å¶å€çšäºæå䌀ç液äœç»·åžŠçæ¹æ³ | |
| US5096896A (en) | Sustained release compositions |